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Abstract
Communication between neurons within the brain occurs at chemical synapses
and is fundamental for all brain functions. Modulation of the strength of communication
is controlled by both presynaptic and postsynaptic mechanisms and is termed synaptic
plasticity. One postsynaptic structure postulated to regulate synaptic strength is the
postsynaptic density (PSD), a large electron dense protein complex located just below
the synaptic membrane.

The PSD, which is composed of signaling, scaffold and

cytoskeletal proteins, supports and organizes neurotransmitter receptors within the
synaptic membrane in addition to bridging signaling with the actin cytoskeletal network.
The protein composition and structure of PSDs is known to change in response to
synaptic activity and several PSD proteins are implicated in neurological conditions
characterized by synaptic dysfunction.

However, there is a lack of information

regarding the variability of PSD structure and composition from individual PSDs across
the brain.

In order to address this deficiency, PSDs were isolated from adult rat

cerebella, hippocampi and cerebral cortices three brain regions with unique neuronal
populations. The structure and composition of morphologically identified PSDs from
these regions was then compared through immunogold analysis and electron
tomography. Tomographic reconstructions revealed that while the majority of PSDs
shared a similar dense protein organization, there were cerebellar PSDs which
displayed a latticelike protein organization. PSDs from cortices and cerebellar were
iv

also approximately twice as thick as hippocampal PSDs and thicker than previously
reported measurements.

This suggests that the PSD extends further into the

postsynaptic spine than previously appreciated, presumably facilitating interactions with
the spine cytoskeletal network.

Immunogold analysis of PSD scaffold proteins

suggested that the underlying PSD scaffold is quite variable across the brain, and even
within brain regions.

Additionally, an immunogold analysis of two key molecules

documented to play roles in synaptic plasticity, CaMKII and the proteasome, supported
their potential role in structural modifications of the PSD.

Together, these results

indicate that PSDs exhibit remarkable diversity in their composition and morphology,
presumably as a reflection of the unique functional demands placed on different
synapses.
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Chapter 1. Introduction
1.1.

Chemical Synapses
The mammalian brain is composed of billions of neurons which communicate at

synapses, the site of contact between two neurons where information is physically
passed from one neuron to another in the form of chemicals or electrical charge.
Synapses were directly visualized by electron microscopy in the mid-twentieth century
and this work established the basic ultrastructure of chemical synapses (Palay, 1956,
Gray, 1959b). These studies revealed that presynaptic processes are frequently found
in close opposition to postsynaptic membranes of dendritic spines. These early studies
describe dendritic spine heads as approximately 2 μm long with the dendritic neck as
narrow as 100 nm and often containing a spine apparatus (Gray, 1959b).

The

presynaptic process, which often contained mitochondria (Palay, 1956, Gray, 1959b)
and vesicles between 20-65 nm (Palay, 1956), has been described as approximately 1
μm in diameter with the presynaptic neck between 200 nm and 300 nm in diameter
(Gray, 1959b). Figure 1.1 is a micrograph of thin sectioned neuronal tissue in which
dendritic spines are evident; several presynaptic terminals, filled with synaptic vesicles,
can be seen in close opposition to postsynaptic spines and the area between the
presynaptic and postsynaptic membranes, termed synaptic cleft, is visible.

The

synaptic cleft is approximately 20-30 nm in width and electron dense material sits
between the two synaptic membranes (Palay, 1956, Gray, 1959b). Just below the
postsynaptic membrane is a larger electron dense band termed the postsynaptic
density (PSD) (Gray, 1959b), also evident in Figure 1.1, which on average extends
approximately 46 nm into the postsynaptic spine and is believed to be present in the
majority of excitatory chemical synapses (Gray, 1959a).
1

Chemical synapses are categorized as either excitatory or inhibitory depending
on the type of neurotransmitters released. The majority of synapses, and the synapses
focused on in this work, release the excitatory neurotransmitter glutamate (Sheng and
Hoogenraad, 2007). During synaptic transmission, illustrated in Figure 1.2, presynaptic
action potentials result in an influx of calcium (Ca2+) into the presynaptic terminal, which
results in the fusion of synaptic vesicles with the plasma membrane and release of
glutamate into the synaptic cleft (Sheng and Hoogenraad, 2007). Glutamate can then
bind glutamate receptors on the postsynaptic membrane, including α-amino-3-hydroxy5-methyl-4-isoxazolepropionic acid receptors (AMPARs) and N-methyl-D-aspartic acid
receptors (NMDARs), resulting in a postsynaptic influx of sodium ions that depolarize
the postsynaptic cell (Figure 1.2) (Sheng and Hoogenraad, 2007).

Depolarization

above a specific voltage threshold results in a significant increase in postsynaptic Ca2+
through NMDARs, which triggers a cascade of postsynaptic signaling resulting in longterm potentiation (LTP) or long-term depression (LTD), two models of learning which
represent the long lasting changes associated with learning and memory (Sheng and
Kim, 2002).

The strength of synaptic transmission is important for brain function

including learning and memory (Malenka and Bear, 2004, Sheng and Hoogenraad,
2007).

Activity-dependent alterations in the strength of communication between

neurons is the basis of information storage, and the strength of neuronal
communication depends on the number of synapses and strength of synaptic
transmission (Chklovskii et al., 2004, Sheng and Hoogenraad, 2007), that can be
modulated by both presynaptic and postsynaptic mechanisms, termed synaptic
plasticity (Sheng and Kim, 2002).

2

Figure 1.1. Synapses in Thin Sectioned Neuronal Tissue.
Cross-section through dendritic spines from a micrograph of thin sectioned neuronal
tissue. Included in this micrograph are several examples of presynaptic terminals and
postsynaptic densities (PSD). Adapted with permission from: Synapse Web, Kristen M.
Harris, PI, http://synapses.clm.utexas.edu/. Micrograph by J. Spacek. Scale bar = 500
nm.

3

Figure 1.2. Overview of Chemical Transmission.
Action potentials in the presynaptic cell drive Ca2+ ions into the presynaptic
compartment, which results in the fusion of synaptic vesicles with the plasma
membrane and release of neurotransmitter glutamate into the synaptic cleft. Once in
the synaptic cleft, glutamate can bind and activate AMPARs and NMDARs on the
postsynaptic membrane, increasing postsynaptic sodium levels.

4

1.2.

The Postsynaptic Density
PSDs were first described as electron-dense synaptic specializations present at

all mature glutamatergic synapses (Palay, 1956, Gray, 1959b, Cotman et al., 1974), as
discussed above and shown in Figure 1.1 and in Figure 1.2 as the gray postsynaptic
oval structure. PSDs are approximately 100-500 nm in diameter, 40-60 nm thick, have
an average mass of 1 GDa and are composed of hundreds of proteins including
signaling, scaffolding and cytoskeletal proteins, as well as neurotransmitter receptors
(Cotman et al., 1974, Chen et al., 2005, Collins et al., 2006, Dosemeci et al., 2007).
PSDs function to support and organize the neurotransmitter receptors located in the
synaptic plasma membrane and to form functional protein modules bridging
neurotransmitter receptors with cytoplasmic signaling proteins that are crucial for
synaptic transmission and are implicated in disorders of neurologic dysfunction (Kim
and Sheng, 2004, Sheng and Kim, 2011).

1.2.1. Major Proteins of The Postsynaptic Density
Proteomic analyses of postsynaptic density fractions have identified a long list of
proteins that are associated with PSDs (Jordan et al., 2004, Li et al., 2004, Peng et al.,
2004, Yoshimura et al., 2004, Collins et al., 2005, Cheng et al., 2006, Dosemeci et al.,
2006, Dosemeci et al., 2007) with a consensus of approximately 400 proteins including
a variety of signaling, cytoskeletal and scaffolding molecules as well as an array of
receptors and channels (Collins et al., 2005).

Semiquantitative measurements of

protein complexes from PSD fractions that were affinity-purified for the major PSD
scaffold protein PSD-95, revealed 288 PSD proteins (Dosemeci et al., 2007). Included
in the 50 most abundant were, in order; Ca2+/calmodulin-dependent protein kinase II
5

(CaMKII), PSD-95, actin, Shank3, Homer, Shank1, Shank2, NMDAR subunit NR2b,
SAP102, NMDAR subunit NR1, and α-actinin (Dosemeci et al., 2007). The proposed
functions, protein-protein interactions and implications in neurologic dysfunction for
these PSD proteins are discussed below. Table 1.1 summarizes the molecular weight
(kDa), relevant protein interactions and the estimated number of each protein within an
average PSD for these PSD proteins, while Figure 1.3 illustrates the relevant protein
interactions in a stick model and Figure 1.4 models a possible organization for these
proteins within PSDs. (For reviews on PSD proteins see (Kennedy, 2000, Okabe,
2007, Sheng and Hoogenraad, 2007)).

1.2.1.1.

CaMKII

The major PSD protein CaMKII (Kennedy et al., 1983), which is estimated to
represent 2-6% of the total mass of the PSD (Chen et al., 2005), is a holoenzyme
composed of 12 subunits of varying ratios of αCaMKII and βCaMKII, two isoforms of
CaMKII, organized into two stacked rings of 6 subunits each (Kolodziej et al., 2000,
Gaertner et al., 2004a, Swulius and Waxham, 2008). CaMKII is postulated to be a
crucial element in NMDAR-dependent LTP, a form of synaptic plasticity (Malenka et al.,
1989, Fink and Meyer, 2002, Lisman et al., 2002, Colbran and Brown, 2004, Lisman et
al., 2012), and in structurally organizing the PSD (Lin and Redmond, 2009, Hell, 2014).
CaMKII translocates to PSDs in animal models of ischemia (Aronowski et al., 1992,
Kolb et al., 1995) and in response to NMDAR activation (Strack et al., 1997, Shen and
Meyer, 1999) and high levels of potassium (Dosemeci et al., 2001). CaMKII can selfassociate (Hudmon et al., 2005) and αCaMKII directly binds NMDAR subunits,
6

transmembrane protein densin-180, actin binding protein α-actinin, synGAP (Colbran,
2004) and the proteasome (Bingol et al., 2010, Djakovic et al., 2012), while βCaMKII
can bind α-actinin and actin (Colbran, 2004). Immunogold labeling experiments on
isolated PSDs determined that within PSDs, CaMKII is typically located 25 nm
underneath the synaptic face clustering toward the cytoplasmic edge (Petersen et al.,
2003), and although there are variable concentrations of CaMKII within PSDs
(Petersen et al., 2003), it is approximated that 80 holoenzymes exist within each PSD
(Chen et al., 2005). Imaging of isolated PSDs by electron tomography has allowed
visual identification of the holoenzymes (Fera et al., 2012), which are barrel shaped
and approximately 20 nm in diameter and height (Kolodziej et al., 2000), within
individual PSD structures.
After

activation

of

CaMKII

Ca2+-bound

by

calmodulin,

CaMKII

can

autophosphorylate and remain activate until dephosphorylated (Miller and Kennedy,
1986, Swulius and Waxham, 2008).

The αCaMKII and βCaMKII isoforms have

differential affinities for Ca2+/CaM (Gaertner et al., 2004b) and effects on synaptic
transmission (Thiagarajan et al., 2002). The active kinase can phosphorylate many
PSD proteins (Dosemeci and Jaffe, Yoshimura et al., 2002), including the proteasome
(Djakovic et al., 2012), synGAP, a Ras GTPase-activating protein (Oh et al., 2004), the
NR2 subunits of the NMDAR (Omkumar et al., 1996, Strack and Colbran, 1998),
AMPAR subunits, and scaffolds PSD-95, Homer (Yoshimura et al., 2002), GKAP and
Shank (Dosemeci and Jaffe), often significantly increasing their activity level.

In

response to NMDAR activation, βCaMKII, which binds monomeric and filamentous
actin, modifies the synaptic actin network by regulating actin polymerization and
structure (Okamoto et al., 2007, Sanabria et al., 2009, Hoffman et al., 2013),
7

suggesting a role for βCaMKII in synaptic maturation by regulating synaptic
cytoskeletal structure (Fink et al., 2003). In further support of CaMKII’s importance in
synaptic function, inhibitory phosphorylation of CaMKII blocks LTP (Elgersma et al.,
2002, Lisman et al., 2012), a form of synaptic plasticity and CaMKII has been
implicated in several neurological diseases characterized by synaptic dysfunction
including Angelman syndrome (Weeber et al., 2003, van Woerden et al., 2007) and
Parkinson’s disease (Picconi et al., 2004). For a review of CaMKII’s role in PSDs see
(Hell, 2014).

1.2.1.2.

PSD-95

PSD-95 is a scaffold protein, which contains a PDZ domain allowing selfassociation and formation of multiprotein complexes. Other scaffolds within the PSD95 family include PSD-93, SAP102, and SAP97. PSD-95 is believed to organize the
postsynaptic density by bridging signaling molecules with receptors at the synaptic
membrane, including both AMPARs and NMDARs. PSD-95 can interact with a variety
of proteins through its PDZ domain including NMDAR subunits, potassium channels,
synGAP, neuroligin a trans-synaptic protein which helps align the presynaptic and
postsynaptic membranes, and stargazin proteins which bind AMPARs at the synaptic
membrane. PSD-95 can also bind GKAP, another PSD scaffold protein that bridges
PSD-95 and Shank, due to a SH3 domain (Kim and Sheng, 2004, Zheng et al., 2011).
Proteomic analysis by mass spectrometry measured PSD-95 to be three times more
abundant than scaffolds GKAP and Shank combined (Peng et al., 2004), while another
study estimates that PSD-95 comprises 2.3% of total PSD mass, with approximately
8

300 copies of PSD-95 per PSD (Chen et al., 2005), further confirming PSD-95’s status
as the major PSD scaffold.
Within PSDs, PSD-95 is located approximately 10-20 nm underneath the
synaptic membrane as determined by immunogold labeling experiments on thin
sectioned neuronal tissue (Valtschanoff and Weinberg, 2001) and by tomography of
isolated PSDs (Petersen et al., 2003, DeGiorgis et al., 2006, Chen et al., 2008, Chen et
al., 2011). When present in PSDs the scaffold is in an extended conformation forming
a layer of vertical filaments approximately 10-20 nm from the postsynaptic membrane
(Chen et al., 2008), presumably bridging glutamate receptors with proteins further
inside the PSD (Chen et al., 2011). Additionally PSD-95 levels within PSDs increase
throughout development (Swulius et al., 2010) appearing to replace the PDZ scaffold
SAP102 (Sans et al., 2000, Petralia et al., 2005).
Mice lacking PSD-95 have alterations in spatial learning and both LTP and LTD,
two NMDAR-dependent forms of plasticity (Migaud et al., 1998). Overexpression of
PSD-95 resulted in increased number of AMAPRs, dependent on palmitoylation of
PSD-95, and enhanced AMPAR signaling (El-Husseini et al., 2000). Palmitoylation of
PSD-95, the addition of a palmitate moiety, is crucial for accumulation of PSD-95 in
synapses (Craven et al., 1999), and depalmitoylation of PSD-95 is required for
glutamate driven endocytosis of AMPARs (El-Husseini Ael et al., 2002). PSD-95 is
also degraded by the ubiquitin proteasome system in response to activation of
NMDARs, and results in the internalization of AMPARs (Colledge et al., 2003).
Additionally, soluble amyloid beta (Aβ), implicated in Alzheimer’s disease as a cause of
synaptic dysfunction, has been shown to induce PSD-95 degradation through activation
of NMDARs (Roselli et al., 2005). While the exact functions of PSD-95 are not entirely
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clear, there is overwhelming evidence that PSD-95 is crucial for organization of
glutamate receptors and synaptic transmission, by influencing synaptic size and
strength.

1.2.1.3.

SAP102

SAP102, as mentioned above, is also a scaffold in the PDZ domain containing
PSD-95 family (Kim and Sheng, 2004, Zheng et al., 2011). SAP102 is highly abundant
early in development, decreasing in concentration as PSD-95 increases significantly
throughout postnatal development in both hippocampal tissue (Sans et al., 2000) and
PSDs (Petralia et al., 2005). The developmental switch between SAP102 and PSD-95
mimics a switch in NMDAR subunits from NR2b in early postnatal hippocampal tissue
to NR2a (Sans et al., 2000, Petralia et al., 2005), suggesting preferred binding between
SAP102 and NR2b, and PSD-95 and NR2a.

These results are supported by co-

immunoprecipitation experiments in adult hippocampal tissue (Sans et al., 2000).
SAP102 is composed of three PDZ domains, a SH3 and a GK domain, same as PSD95, allowing SAP102 to interact with NMDAR subunits, potassium channels, synGAP,
neuroligin, stargazin, and GKAP (Kim and Sheng, 2004, Zheng et al., 2011). SAP102
helps establish early postsynaptic organization through interactions with NR2b and
GKAP which forms a complex with scaffolds SAP102, Shank and Homer (Petralia et
al., 2005, Zheng et al., 2011). SAP102 is more mobile than PSD-95 in PSDs and this
was attributed to association with the highly mobile actin network through the SH3 or
GK domains (Zheng et al., 2010), presumably trough interactions with GKAP.
Additionally SAP102 and PSD-95 appear to differentially interact with and regulate
glutamate receptors; overexpression of PSD-95 leads to increases in functional
10

synaptic AMPARs (El-Husseini et al., 2000).

In contrast, functional increases in

NMDARs result from overexpression of SAP102 (Zheng et al., 2011).

1.2.1.4.

Shank Proteins

The Shank family of proteins, comprised of Shank1, Shank2 and Shank3, are
also believed to function as PSD scaffolds, containing a SH3 domain and a PDZ
domain among others (Sheng and Kim, 2000). The Shank family interacts with PSD
scaffolds GKAP and Homer through their PDZ and SH3 domains (Sheng and Kim,
2000, Kim and Sheng, 2004).

All three scaffolds are expressed in the brain with

varying abundance and expression patterns (Boeckers et al., 1999a, Boeckers et al.,
1999b, Sheng and Kim, 2000) and are enriched in PSDs (Lim et al., 1999, Naisbitt et
al., 1999).

It is estimated that the ratio of PSD-95: GKAP: Shank: Homer is

approximately 6: 2: 2: 1 in forebrain PSDs, with Shank2 as the most abundant Shank in
forebrain PSDs and Shank1 the least abundant (Cheng et al., 2006). In addition to
interacting with PSD scaffolds GKAP and Homer, Shank proteins can also directly bind
some metabotropic glutamate receptors (mGluRs) (Tu et al., 1999), several actin
binding proteins including cortactin which binds F-actin (Du et al., 1998), other Shank
proteins (Sheng and Kim, 2000), and GRIP which interacts with AMPARs (Sheng and
Kim, 2000). Through interactions with PSD-95, Homer and GRIP, Shank can indirectly
form protein complexes with NMDARs, mGluRs, and AMPARs and presumably bridge
together these protein modules through Shank-Shank interactions (Sheng and Kim,
2000), which are hypothesized to form the core structural framework of the PSD (Baron
et al., 2006). Similar to scaffolds PSD-95 (Colledge et al., 2003) and GKAP, Shanks
are also targeted and degraded by the ubiquitin proteasome system (Ehlers, 2003).
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Shank can also indirectly interact with the actin network through cortactin, further
supporting the notion that Shanks form the PSD core bridging receptor protein modules
to the cytoskeletal network.

Immunogold labeling experiments on thin sectioned

neuronal tissue determined Shank to be located within PSDs approximately 24 nm
underneath the synaptic membrane (Valtschanoff and Weinberg, 2001) and
significantly more Shank is detected by immunogold labeling on the cytoplasmic face
compared to the synaptic face (Petersen et al., 2003). Overexpression of Shank alters
spine morphology and induces recruitment of F-actin to spines further suggesting that
Shank functionally connects synaptic activity to the spine cytoskeleton (Sala et al.,
2001).
The importance of Shank in synaptic function is highlighted by several studies
which have implicated Shank in neurological disorders and diseases such as autism
spectrum disorders (Durand et al., 2007, Moessner et al., 2007, Gauthier et al., 2009,
Berkel et al., 2010, Arons et al., 2012, Sato et al., 2012) and Alzheimer’s disease
(Gong et al., 2009, Roselli et al., 2009, Pham et al., 2010, Grabrucker et al., 2011b,
Grabrucker et al., 2011d). Mutations in each of the three Shank proteins have been
associated with autism spectrum disorders (Durand et al., 2007, Moessner et al., 2007,
Gauthier et al., 2009, Kumar and Christian, 2009, Berkel et al., 2010, Grabrucker et al.,
2011c, Sato et al., 2012). Autism spectrum disorder related mutations in Shank1 and
Shank2 are believed to caused synaptic dysfunction through their influence on spine
morphology and glutamate receptor signaling, while mutations in Shank3 disrupt
transsynaptic singling via neuroligin (Arons et al., 2012).

Shank protein-protein

interaction are also heavily regulated by synaptic zinc levels and zinc is required for
Shank to associate with PSDs (Baron et al., 2006, Grabrucker et al., 2011a).
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Intriguingly zinc deficiencies in the brain have been associated with problems in
learning and memory (Takeda, 2000) and many other neurological disorders including
Parkinson’s disease and Down’s syndrome (Grabrucker et al., 2011b). Alzheimer’s
disease associated Aβ can sequester synaptic zinc and application of soluble Aβ has
been shown to decrease synaptic levels of Shank (Roselli et al., 2009, Grabrucker et
al., 2011d) and Homer, and is associated with a reduction of PSD size (Roselli et al.,
2009). This is an interesting finding given the reductions in synaptic zinc (Suh et al.,
2000) and Shank (Pham et al., 2010) in the hippocampi of human Alzheimer’s disease
patients.

1.2.1.5.

Homer

Homer, the binding partner of Shank proteins, is enriched in the brain and in
PSDs (Xiao et al., 1998). Homer can bind the PSD scaffold Shank, mGluRs, IP3
receptors, and other Homer molecules forming multimers (Tu et al., 1998, Xiao et al.,
1998). In fact, the mesh-like structure formed by Homer-Shank interactions is believed
to form the core scaffold of the PSD (Hayashi et al., 2009). Homer is believed to assist
in regulating synaptic Ca2+, spine morphology and synaptic transmission through
interactions with mGluRs (Foa and Gasperini, 2009). Interestingly, the effects of Shank
overexpression on spine morphology and F-actin translocation, described previously,
are dependent upon Homer, presumably mediated by the ability of Homer to regulate
intracellular Ca2+ levels through direct interactions with mGluRs and IP3 receptors
(Sala et al., 2001). Homer knockout mice are deficient in formation of fear memories
(Inoue et al., 2009) and Homer has also been implicated in Fragile X and Alzheimer’s
disease, among other pathologic conditions (Foa and Gasperini, 2009).
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Within

forebrain PSDs, it is estimated that for every two Shank molecules there is one Homer
molecule (Cheng et al., 2006) and Homer, like Shank, lies closer to the cytoplasmic
PSD face (Petralia et al., 2005).

1.2.1.6.

NMDA-type Glutamate Receptors

NMDARs are glutamate receptors that allow Ca2+ to enter the postsynaptic
compartment in response to synaptic depolarization. Activation of NMDARs can trigger
LTP or LTD, two forms of long lasting changes in synaptic plasticity associated with
learning and memory (Sheng and Kim, 2002). The receptors are composed of four
subunits, two NR1subunits and two NR2 subunits all of which are enriched in PSDs (AlHallaq et al., 2001, Lee et al., 2001, Okabe, 2007, Sorokina et al., 2011). The NR2
subunits NR2a and NR2b, which accounts for approximately 1% of the total PSD
protein (Okabe, 2007), can directly bind PDZ proteins in the PSD-95 family (Sorokina et
al., 2011). NR2 subunits also bind CaMKII, situating the Ca2+-dependent kinase in a
favorable position to receive Ca2+ flowing through open NMDAR channels (Strack and
Colbran, 1998, Kennedy, 2000). NR1 subunits can also bind calmodulin, the Ca2+
binding protein required for activation of CaMKII, further highlighting the connection
between NMDARs and the CaMKII pathway. NR1 and NR2b subunits can also directly
bind α-actinin, bridging NMDARs to the actin network as α-actinin binds actin
(Wyszynski et al., 1997). Intriguingly, NMDAR knockout mice had no observable defect
in either synaptic morphology or protein composition (Okabe, 2007), although activation
of NMDAR results in phosphorlyation of over 100 PSD proteins (Coba et al., 2009,
Sheng and Kim, 2011). Immunogold studies on synapses (Racca et al., 2000) and
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proteomic analysis of PSD fractions (Cheng et al., 2006) suggest that approximately 10
NMDARs are present in individual synapses.

1.2.1.7.

Actin and α-Actinin

Actin is highly enriched in spines and is thought to contribute to spine size and
morphology, molecular transport, and anchoring of the PSD and neurotransmitter
receptors (Cingolani and Goda, 2008, Schoenenberger et al., 2011). Actin directly
binds βCaMKII, α-actinin and cortactin (Okabe, 2007); α-actinin bridges actin to
NMDARs (Wyszynski et al., 1997), αCaMKII and βCaMKII (Okabe, 2007), while
cortactin links actin to the Shank/GKAP/PSD-95 scaffold complex through Shank (Du et
al., 1998, Naisbitt et al., 1999, Kim and Sheng, 2004, Okabe, 2007). Actin exists in a
monomeric form, G-actin, and a filamentous form, F-actin, both of which interact with
βCaMKII which in turn regulates actin polymerization and F-actin bundling in an
activity-dependent manner (Okamoto et al., 2007, Sanabria et al., 2009, Hoffman et al.,
2013). Treadmilling of PSD associated actin is believed to organize the internal PSD
structure which is highly dynamic (Blanpied et al., 2008, Kerr and Blanpied, 2012);
depolymerization of F-actin reduced synaptic NMDARs and AMPARs (Allison et al.,
1998) as well as the mobility of PSD scaffolds PSD-95, GKAP, Shank and Homer
(Kuriu et al., 2006). Given that βCaMKII modulates actin binding and F-actin structure
in response to calcium influxes through NMDARs (Okamoto et al., 2007, Sanabria et
al., 2009, Hoffman et al., 2013), presumably the internal organization of the PSDs is
also regulated by CaMKII in an activity-dependent manner.
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αCaMKII

Type of PSD
Protein

Molecular
Weight

Signaling

55 kDa

Relevant Binding
Partners
NR2

Estimated Copies within
PSD

α‐actinin
proteasome
αCaMKII

≈ 80 Mixed Holoenzymes

G-actin
βCaMKII

Signaling

60 kDa

F‐actin
α‐actinin

PSD-95

Scaffold

95 kDa

GKAP
NR2
stargazin

≈ 300

neuroligin
PSD-95
SAP102

x

SAP102

Scaffold

105 kDa

Shank1

Scaffold

120-240 kDa

Shank2

Scaffold

160 kDa

Shank3

Scaffold

190 kDa

GKAP
Homer
cortactin
Shank

≈ 150

mGluRs
neuroligin
mGluRs

Homer

Scaffold

45 kDa

Shank

≈ 50

Homer
βCaMKII
Actin

Scaffold

42 kDa

α‐actinin

x

cortactin
actin
αCaMKII
α-actinin

Scaffold

100 kDa

βCaMKII

x

NR1
NR2
NR1

Receptor

α-actinin

105 kDa

CaM
αCaMKII

NR2b

Receptor

PSD‐95

166 kDa

≈10 - 20 NMDARs

SAP102
α‐actinin

Table 1.1. Major PSD Proteins.
For review of PSD protein interactions see (Sheng and Kim, 2000, Kim and Sheng,
2004, Okabe, 2007, Sheng and Hoogenraad, 2007, Foa and Gasperini, 2009) and for
estimated copies within PSDs see (Cheng et al., 2006, Okabe, 2007, Sheng and
Hoogenraad, 2007).
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Figure 1.3. Summary of Major PSD Protein Interactions.
Summary of the major protein interactions for the PSD proteins described in this
chapter and referenced through this dissertation.
Solid lines indicate direct
interactions, while dashed lines indicate indirect interactions. The double line just
below the NMDAR and AMPAR represents the synaptic plasma membrane. For review
of PSD protein interactions see (Sheng and Kim, 2000, Kim and Sheng, 2004, Okabe,
2007, Sheng and Hoogenraad, 2007, Foa and Gasperini, 2009).
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Figure 1.4. Organization of Major PSD Proteins.
Possible organization of key PSD proteins based on protein interactions and estimated
location within PSDs (Sheng and Kim, 2011).
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1.2.2. PSD Morphology and Structural Organization
PSD morphology has been described from thin sectioned neuronal tissue
(Palay, 1956, Gray, 1959b, a, 1961, Cohen and Siekevitz, 1978, Harris et al., 1992) as
well as from biochemically isolated PSDs, which are morphologically consistent with
PSDs in the native synaptic environment (Cotman et al., 1974, Cohen et al., 1977,
Matus and Taff-Jones, 1978, Carlin et al., 1980, Petersen et al., 2003). Historically
PSDs have been described as dense cup-shaped structures between 0.2-1 μm in
diameter and approximately 60 nm thick composed of smaller but poorly resolved
particles (Cotman et al., 1974, Cohen et al., 1977, Cohen and Siekevitz, 1978), with a
distinct cleft and cytoplasmic faces (Petersen et al., 2003). More recently, through the
use of cryo and stain electron tomography, protein substructures of filamentous and
globular proteins have been resolved (Swulius et al., Chen et al., 2008, Fera et al.,
2012, Swulius et al., 2012).

Isolated PSDs have also been treated with various

detergents (Matus and Taff-Jones, 1978) and reducing agents (Blomberg et al., 1977)
to strip away proteins in order to describe the underlying lattice presumed to be the
core scaffold of the PSD.
The morphologic changes in PSDs during synaptic maturation have also been
described; early in development PSDs appear to be thin lattices of protein and through
development proteins are recruited to the PSD (Swulius et al., 2010), significantly
increases the density of the PSD structure (Swulius et al., 2012).

Similarly PSD

morphology (Dosemeci et al., 2001) and PSD protein composition (Ehlers, 2003)
change in response to synaptic activity. PSD composition is dynamically regulated by
protein phosphorlyation (Dosemeci and Jaffe, Yoshimura et al., 2002, Cheng et al.,
2006), palmitoylation (El-Husseini Ael et al., 2002), reorganization (Kuriu et al., 2006,
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Blanpied et al., 2008, Tao-Cheng et al., 2010, Zheng et al., 2010, Yang et al., 2011,
Kerr and Blanpied, 2012), degradation (Ehlers, 2003, Yi and Ehlers, 2005), synthesis
(Steward and Schuman, 2003, Schuman et al., 2006) and recruitment (Strack et al.,
1997, Djakovic et al., 2009).

These changes in PSD composition and protein

organization are hypothesized to modulate synaptic transmission and therefore
contribute to learning and memory (Kennedy, 2000). To better understand the PSD
composition and eventually how it is dynamically regulated, numerous proteomic
studies have been targeted at defining the PSD proteome (Jordan et al., 2004, Li et al.,
2004, Peng et al., 2004, Yoshimura et al., 2004, Collins et al., 2005, Cheng et al., 2006,
Dosemeci et al., 2007).

Compositional changes in PSDs throughout development

(Sans et al., 2000, Petralia et al., 2005, Swulius et al., 2010) and in response to activity
(Ehlers, 2003) have also been investigated and several groups have also employed
immunogold labeling to assess PSD protein organization (Valtschanoff and Weinberg,
2001, Petersen et al., 2003, DeGiorgis et al., 2006, Chen et al., 2008, Swulius et al.,
2010), indentifying several PSD proteins which redistributed within PSDs in response to
activity (Tao-Cheng et al., 2010, Yang et al., 2011). For reviews on PSD structure see
(Okabe, 2007, Sheng and Hoogenraad, 2007, Sheng and Kim, 2011).
However, there is a lack of information regarding the variability of PSD
morphology and protein composition across the brain. It is hypothesized that different
areas of the brain place unique demands on the process of synaptic transmission and
that the PSD protein composition, and therefore PSD structure, likely change across
the brain to support these unique demands. Gross differences in morphology have
been described between PSDs isolated from cerebral cortices and cerebella from postmortem canine brains (Carlin et al., 1980); cortical PSDs were thicker while cerebellar
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PSDs appeared to be more latticelike in structure (Carlin et al., 1980). Additionally a
proteomics study measured 43 PSD proteins which statistically differed in
concentration between cortical and cerebellar derived PSD including neurotransmitter
receptors, signaling and scaffold molecules (Cheng et al., 2006). However PSDs are
heterogeneous, each one is compositionally and structurally unique based on the
activation history of that particular synapse. Therefore while proteomic approaches
provide valuable information regarding the bulk composition of PSD fractions, a more
direct comparison of PSD morphology and protein composition of individual PSDs from
across the brain is still needed and is the focus of this dissertation.
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Chapter 2: Methodology
2.1. Isolation of Postsynaptic Densities from Cerebella, Hippocampi, and Cerebral
Cortices
PSDs were isolated following a previously reported protocol (Swulius et al.,
2010, Swulius et al., 2012), which was adapted from a widely used PSD enrichment
procedure (Cohen et al., 1977), in order to remove PSDs from the crowded
environment of synapses for morphological and compositional analyses. For a single
preparation, brains were removed within 30 seconds of decapitation from nine adult
male Sprague-Dawley rats (176-200 g) and placed in an ice-cold isotonic sucrose
solution (buffer A) of 0.5 mM HEPES/KOH pH 7.4, 0.32 M sucrose, 1 mM MgCl2, 0.5
mM CaCl2 and 1 μg/ml leupeptin.

The cerebella, hippocampi, and cortices were

immediately dissected, as shown in Figure 2.1, and separately homogenized in a total
volume of 45 ml buffer A with a motor-driven glass/Teflon homogenizer (0.2 mm
clearance). All steps of the following protocol were accomplished at 4˚C. For each
region, homogenates were spun at 1,400 x g for 10 minutes in a JA20 rotor.
Supernatants were saved and pellets were resuspended in 12.5 ml buffer A (2 pellets
from cortical tissue and 1 pellet each from cerebellar and hippocampal tissue) and spun
again at 1,400 x g for 10 minutes. The supernatants were combined and pelleted at
13,800 x g for 10 minutes.

The resulting pellets were resuspended and hand

homogenized in a second sucrose solution, buffer B, (0.5 mM HEPES/KOH pH 7.4,
0.32 M sucrose and 1 μg/ml leupeptin), applied to sucrose gradients (<12 ml sample in
buffer B, 12 ml 1.0 M sucrose, 13 ml 1.4 M sucrose) and spun at 112,000 x g for 120
minutes in a SW32 rotor. The synaptosomal fraction, at the 1.0/1.4 M interface, was
collected, diluted in an equal volume of buffer B, and then an equal volume of triton
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extraction buffer (5 mM HEPES/KOH pH 7.4, 0.32 M sucrose, 1% TX-100) was added.
The sample was homogenized and continuously mixed on a rotator for 15 minutes
before being spun at 32,800 x g for 20 minutes. The resulting pellet was suspended in
buffer B, applied to a second sucrose gradient (2 ml of sample in buffer B, 2 ml 1.0 M
sucrose, 4 ml 1.5 M sucrose, 2 ml 2.1 M sucrose) and spun for 120 minutes at 271,000
x g in a SW41 rotor. The synaptic junction fraction, the interface between the 1.5 M
and 2.1 M sucrose, was then brought to 3 ml with 5 mM HEPES/KOH, pH 7.4, before
the addition of an equal volume of a triton extraction buffer and rotated for 30 minutes.
To produce the PSD fraction, the material was then added to the final sucrose gradient
(6 ml sample, 4 ml 1.5 M sucrose, 2 ml 2.1 M sucrose) and spun at 210,000 x g for 20
minutes. The postsynaptic density material at the 1.5/2.1 M interface was then diluted
to 5 ml with 5 mM HEPES/KOH pH 7.4, pelleted at 48,500 x g for 15 minutes in a
SW55 rotor, resuspended in 300-500 μl 20% glycerol in 5 mM HEPES/KOH pH 7.4,
and stored as aliquots at -80˚C. All spins were performed in either the Avanti® J-E
Centrifuge or Optima XPN-80 Ultracentrifuge, both from Beckman Coulter. Gradients
were spun with acceleration and deceleration program 1, resulting in a 2 minute
acceleration to and deceleration from 170 RPM, respectively. The isolation protocol is
summarized in Figure 2.2.
The data described in this dissertation, regarding PSDs from different brain
regions, were produced from two independent PSD preparations that each contained
the three isolated brain regions from nine rats. It is important to acknowledge that the
process of isolating the PSD from the brain has the potential to alter its structure and
composition. This limitation should be kept in mind when attempting to place the
findings in this dissertation in the context of PSD structure and function in vivo.
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Figure 2.1. Dissection of Adult Rat Cerebellum, Hippocampi and Cortices.
First, the cerebellum was dissected out by cutting along the plane of the line marked 1,
isolating it away from the rest of the forebrain. The two hemispheres of the cortex were
then separated by cutting along the plane of the line marked 2 in order to isolate the
two hippocampi from the rest of the cerebral cortex.
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Figure 2.2. Isolation of PSDs from Cortices, Hippocampi, and Cerebella.
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2.2. Protein Assays, SDS Page and Western Blotting
Protein concentrations were determined in triplicate and averaged using either
the Bio-Rad Protein Assay (BIORAD, #500-006) or Pierce BCA Protein Assay Kit
(Pierce, #23225), with serial dilutions of BSA standards in buffers matching that of the
unknown sample. The Bio-Rad assay is not compatible with detergents, while the
Pierce assay is not compatible with glycerol concentrations above 10%.
For protein staining, 3-5 μg of total protein from PSD fractions were separated
by SDS-PAGE with 10% polyacrylamide gels. Gels were incubated for 1 hr in excess
fixation solution (30% methanol, 7.5% acetic acid) before staining with Amersham
Deep Purple Total Protein Stain (GE Healthcare) diluted 1 part stain to 200 parts 100
mM sodium borate, pH 10.5 for 1 hr. After staining, gels were washed for 30 min in
wash solution (30% methanol) and then 30 min in fixation solution. After a 5 min rinse
in fixation solution, gels were imaged on the Typhoon scanner, using the green laser
(532 nm) at 500 PMT and 10 μm resolution; ImageQuant was used to estimate the
molecular weight and intensity of each band. All incubations were performed at room
temperature on an orbital shaker.
For Western blotting, 5-10 μg of total protein from homogenate, synaptosome,
synaptic junction, or PSD fractions from cerebella, hippocampi, cortices, and forebrains
were separated by SDS-PAGE with 8%, 10%, or 15% polyacrylamide gels, in running
buffer (25 mM Tris Base, 192 mM Glycine, 0.1% SDS).

Separated proteins were

transferred (transfer buffer: 25 mM Tris Base, 192 mM Glycine, 0.02% SDS, 30%
methanol) to nitrocellulose membranes at 4˚C for 2 hours at 80 volts and membranes
were then incubated in blocking buffer (5% dry milk in wash buffer (10 mM Tris, pH 8.0,
150 mM NaCl, and 0.05% NP40)).

Membranes were then incubated in primary
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antibodies including α-actinin (mouse, Sigma, A5044, 1:2500), actin (rabbit, Sigma,
A2066, 1:500), PSD-95 (mouse, Thermo-Scientific, MA1-046, 1:2000-5000), Homer
(mouse, Santa Cruz, sc-17842, 1:1000), SAP102 (mouse, Neuromab, 75-058, 1:2500),
Shank1 (mouse, Neuromab, 75-064, 1:1000), Shank2 (mouse, Neuromab, 75-088,
1:1000), Shank3 (mouse, Neuromab, 75-109, 1:1000), αCaMKII (mouse, produced in
house, 1:2000), βCaMKII (mouse, Invitrogen 13-9800, 1:2000), CaM (mouse, Upstate
05-173, 1:1000), NR1 (mouse, Millipore, MAB363, 1:2500), NR2b (mouse, Millipore,
MAB5778, 1:2500), RPT6 (mouse, Enzo Life Science, PW9265, 1:2500) and SV2
(mouse, Developmental Studies Hybridoma Bank, AB 2315387, 1:1000) diluted in
blocking buffer, for 1 hour. Primary antibody information is summarized in Table 2.1.
Blots were then rinsed twice in wash buffer before a 1 hour incubation in secondary
antibodies.

Secondary antibodies included HRP anti-mouse (goat, Pierce, 31430,

1:1250-5000), HRP anti-rabbit (goat, Pierce, 31460, 1:2000), or Alexa 488 anti-mouse
(goat, Molecular Probes, A-11029, 1:5000).

Secondary antibody information is

included in Table 2.2. After incubation with secondary antibodies, membranes were
rinsed twice with wash buffer prior to imaging on a Typhoon Trio+ scanner (GE
Healthcare), with the green laser (532 nm), a PMT value ranging between 400-550 and
a resolution between of at least 50 μm. The Pierce® ECL 2 system (Thermo Scientific)
was used for developing blots incubated with either HRP secondary antibody. This
included replacing the wash buffer with 0.1% TWEEN in phosphate buffered saline
throughout blot development and a 5 minute incubation in substrate working solution,
which contains the substrate to be oxidized by HRP, prior to imaging on a Typhoon
Trio+ scanner (GE Healthcare), with the blue laser (488 nm), a PMT value ranging
between 400-550 and a resolution between of at least 50 μm.
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Western blots were performed for each primary antibody to test specificity on
adult forebrain PSD fractions. Each antibody stained the appropriate molecular weight
band on the gel and these bands are shown in Figure 2.3. As expected, single bands
for α-actinin, actin, PSD-95, Homer, SAP102, Shank1, Shank2, Shank3, αCaMKII,
βCaMKII, NR1, NR2b, RPT6, and SV2 were detected at 100 kDa, 42 kDa, 95 kDa, 45
kDa, 105 kDa, 205 kDa, 160 kDa, 190 kDa, 55 kDa, 60 kDa, 110 kDa, 170 kDa, 48
kDa, and 95 kDa, respectively.
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Figure 2.3. Western Blots against PSD Proteins.
Lanes were loaded with between 5 and 10 ug of adult forebrain PSDs and blots were
developed using HRP secondary antibodies and the Pierce® ECL 2 system. The SV2
blot was loaded with 8 μg of cortical homogenate, as SV2 is a presynaptic protein not
detected in PSD fractions, and was developed with the Alexa 488 goat anti-mouse
secondary.
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2.3. Immunogold Labeling of Isolated Postsynaptic Densities
Five microliters of PSDs, approximately 0.7 μg, were added to freshly glowdischarged formvar/carbon coated copper grids (Ted Pella) for 5 minutes. All steps
were performed at room temperature in a humidified chamber. After blotting excess
liquid, grids were floated upside down on 35 µL drops of blocking buffer (5% BSA in
HEPES Buffered Saline: 20 mM HEPES, 150 mM KCL, pH 7.4) for 10 minutes. After
blotting, grids were then placed on top of 25 µL drops of primary antibody for 30
minutes. Primary and secondary antibodies were diluted to working concentration in
blocking buffer. Primary antibodies, summarized in Table 2.1, included those to: αactinin (mouse, Sigma, A5044, 1:20), actin (rabbit, Sigma, A2066, 1:20), PSD-95
(mouse, Thermo-Scientific, MA1-046, 1:20), Homer (mouse, Santa Cruz, sc-17842,
1:50), SAP102 (mouse, Neuromab, 75-058, 1:10), Shank1 (mouse, Neuromab, 75-064,
1:20), Shank2 (mouse, Neuromab, 75-088, 1:50), Shank3 (mouse, Neuromab, 75-109,
1:10), αCaMKII (mouse, produced in house, 1:20), βCaMKII (mouse, Invitrogen 139800, 1:100), CaM (mouse, Upstate 05-173, 1:5), NR1 (mouse, Millipore, MAB363,
1:5), NR2b (mouse, Millipore, MAB5778, 1:20), RPT6 (mouse, Enzo Life Science,
PW9265, 1:10). After incubation with the primary antibody, grids were rinsed three
times by floating on top of 35 µL drops of blocking buffer, blotting in between. Grids
were then placed on 25 µL drops of gold conjugated secondary antibody, diluted in
blocking buffer, for 30 minutes.

Secondary antibodies, summarized in Table 2.2,

included 12nm Colloidal Gold-AffiniPure anti-mouse (goat, Jackson Immunoresearch,
115-205-068, 1:5) or 12nm Colloidal Gold-AffiniPure anti-rabbit (goat, Jackson
Immunoresearch, 111-205-144, 1:5). Afterwards, grids were placed on a final 35 µL
drop of blocking buffer. Each grid was then negatively stained by rinsing twice with 5
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µL of MilliQ water, once briefly with 5 µL NanoW (Nanoprobes) and afterwards with 5
µL of NanoW for 30 seconds.
Grids were allowed to dry at room temperature for at least 30 minutes and then
imaged on a JEOL 1400 electron microscope operated at 120 kV.

Images were

collected on an Orius camera (Gatan) at 32-64kx magnifications at the image plane.
Labeling density was calculated as the total number of gold particles contained within
the surface area of the PSD as measured in ImageJ (NIH).

A representative

immunogold labeled PSD is shown in Figure 2.4, alongside cross-sections through a
final cryotomographic reconstruction of a representative immunogold labeled PSD
illustrating gold labeling throughout the z-dimension of the PSD. The average labeling
density was calculated by averaging 20 individual immunogold labeled PSDs for each
region and antibody. Titrations for every primary and secondary antibody were done to
ensure asymptotic labeling for a given target protein and Western blots were performed
for each primary antibody to test specificity. Negative controls (no primary antibody)
were run in each experiment and the number of background gold/surface area was
subtracted from the average labeling density. Statistical significance was defined as a
p-value < 0.05, as determined through two-tailed t tests in Excel.
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Antibody

Species

Manufacturer

Catalog Number

WB Dilution

IG Dilution

α-actinin

mouse

Sigma

A5044

1:2500

1:20

actin

rabbit

Sigma

A2066

1:500

1:20

PSD-95

mouse

Thermo-Scientific

MA1-046

1:2000-5000

1:20

Homer

mouse

Santa Cruz

sc-17842

1:1000

1:50

SAP102

mouse

Neuromab

75-058

1:2500

1:10

Shank1

mouse

Neuromab

75-064

1:1000

1:20

Shank2

mouse

Neuromab

75-088

1:1000

1:50

Shank3

mouse

Neuromab

75-109

1:1000

1:10

αCaMKII

mouse

Waxham Lab

--

1:2000

1:20

βCaMKII

mouse

Invitrogen

13-9800

1:2000

1:100

CaM

mouse

Upstate

05-173

1:1000

1:5

NR1

mouse

Millipore

MAB363

1:2500

1:5

NR2b

mouse

Millipore

MAB5778

1:2500

1:20

RPT6

mouse

Enzo Life Science

PW9265

1:2500

1:10

SV2

mouse

Developmental Studies
Hybridoma Bank

AB 2315387

1:1000

--

Table 2.1. Antibody Information for all Primary Antibodies Used.
Information includes: the species in which antibody was raised, manufacturer, catalog
number, Western blot dilution and immunogold labeling dilution.
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Antibody

Species

Manufacturer

Catalog Number

WB Dilution

IG Dilution

HRP anti-mouse

goat

Pierce

31430

1:1250-5000

--

HRP anti-rabbit

goat

Pierce

31460

1:2000

--

Alexa 488

goat

Molecular Probes

A-11029

1:5000

--

115-205-068

--

1:5

111-205-144

--

1:5

12 nm Gold antimouse
12 nm Gold antirabbit

goat
goat

Jackson
Immunoresearch
Jackson
Immunoresearch

Table 2.2. Antibody Information for all Secondary Antibodies Used.
Information includes: the species in which antibody was raised, manufacturer, catalog
number, Western blot dilution and immunogold labeling dilution.
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Figure 2.4. Immunogold Labeling.
A) Electron micrograph of cortical PSD immunogold labeled for βCaMKII. Labeling
density is calculated as the number of gold divided by surface area. Surface area is
calculated in ImageJ by measuring the number of pixels within a boundary freely drawn
around the PSD, similar to left panel, and multiplying by the pixel size, which is
reported by the Gatan software when imaging. Labeling density can also be reported
as the number of gold per PSD. B) Ten-nanometer cross-sections through a final
cryotomographic reconstruction of a representative hippocampal PSD immunogold
labeled for the proteasome (6 nm gold) and βCaMKII (12 nm gold). The cross-sections
illustrate gold labeling throughout the entire z-dimension of the PSD, suggesting that
PSDs are permeable to gold conjugated secondary antibodies. C) Side views of the
same immunogold labeled PSD, from B, illustrating gold labeling through the xdimension (yz view). Scale bars = 100 nm.
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2.4. Spatial Analysis of Immunogold Labeling
For 2D spatial analysis of gold labeling, I employed a Ripley’s K-function based
analysis to determine whether the gold distribution for a given PSD deviated from
spatial randomness, as previously described (Swulius et al., 2010). Briefly, coordinates
representing the boundary of the PSD and gold were recorded and a MATLAB
(MathWorks) model was generated. The 2D spatial distribution of the gold was then
compared to 1000 simulations of complete spatial randomness, within the same
boundary given the same number of gold particles. This procedure was accomplished
for every PSD where spatial analysis was employed.
For each immunogold labeled PSD, like the example shown in Figure 2.5.A,
Photoshop (Adobe) was used to create a binary image of points outlining the PSD
boundary and depicting gold distribution. To achieve this, a new layer was created for
each image and the PSD border was defined in points using the paintbrush function at
15 pt and 100% hardness in as few points as needed to define the boundary. On the
same layer, a point was created for each gold particle within the PSD boundary using
the paintbrush function at 9 pt and 50% hardness. The layer was then saved as a
grayscale image and opened in ImageJ. In ImageJ, the threshold function was used to
select all of the points in the binary image. Using the analyze particles function, set to
measure center of mass, the coordinates of each point were reported. For boundary
points, the size entered into the analyze particle interface was 60-infinity, while for gold
coordinates 1-50 was entered as the size. A text file was created for each image with
boundary point coordinates ordered clockwise starting with the point closest to the top
of the image and gold coordinates were listed below. All boundary coordinates were
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denoted with a 1 before the x and y coordinates, while gold coordinates were denoted
with a 2 prior to the x and y coordinates.
MATLAB (MathWorks) was then used to create coordinate models, like the
example shown in Figure 2.5.B, for each PSD using the text files. The coordinate
models were then used to create 1000 examples of complete spatial randomness
(CSR) in MATLAB using the same boundary and same number of gold particles as the
coordinate model. To determine whether the gold particle distribution deviates from
random, the gold distribution was compared to the 1000 examples of CSR, using
Ripley’s K-function (Ripley, 1976, 1977, Kiskowski et al., 2009). Ripley’s K-function
uses concentric circles of various radii to calculate the average number of gold particles
over distance from the center of each particle (Ripley, 1976, 1977). For example,
Ripley’s K-function analysis of clustered gold would show an increased number of gold
particles at small radii as compared to examples of CSR. The example shown in
Figure 2.4 C shows the H-function variant of Ripley’s K-function, which is normalized so
that the expected function is 0 (Loosmore and Ford, 2006). In the example shown in
Figure 2.5, the experimental data from Figure 2.5.B is shown as a red line in Figure
2.5.C and CSR is the black line at 0. If the experimental data, red line, moves outside
of the upper or lower envelopes, dashed lines, the data is said to deviate from random.
In this example the data deviates at smaller radii from the upper envelope, indicating
clustering and at larger radii drops below the envelope, indicating dispersion at larger
distances (Figure 2.5).
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Figure 2.5. Example Ripley’s K-Function Analysis.
Ripley’s K-function analysis of a cerebellar PSD immunogold labeled for PSD-95. A)
Negative stain electron micrograph of a PSD from cerebella immunogold labeled for
PSD-95. B) Coordinate model for the PSD in A. The boundary is defined by red
points, while the gold is represented in black points. C) H-function for example PSD.
Simulated complete spatial randomness (black solid line) was normalized to zero and
the Ripley’s K-function of the experimental data is shown as a red line. Non-random
distribution was determined by whether the red line crossed either the maximum and
minimum envelopes (dashed lines), defined by 1000 simulations of complete spatial
randomness. Scale bar = 100 nm.
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2.5. Electron Tomography
Fiducial markers were prepared by adding 125 μL of 5% BSA in HBS to 200 μL
of 10 nm colloidal gold for 5 min at RT. The gold was then spun at 14,000 x g for 18
min and resuspended in 5 mM HEPES, pH 7.4. PSDs were thawed, diluted in 5 mM
HEPES, pH 7.4, spun down at 14,000 x g for 18 min, and resuspended in 5 mM
HEPES buffer, pH 7.4 containing BSA coated colloidal gold as fiducial markers. For
negative stain tomography, 5 μL of PSDs with gold were applied to freshly glowdischarged formvar/carbon coated copper grids (Ted Pella) for 5 min.

Grids were

blotted, rinsed twice with 5 μL MilliQ water and stained twice with 5 μL NanoW
(Nanoprobes), a 2% solution of methylamine tungstate. For electron cryotomography,
5 μL of PSDs with gold were applied to 200 mesh copper 2/2 Quantifoil grids (EMS).
Grids were blotted by hand and plunged into liquid ethane cooled with liquid nitrogen.
The resulting grid preparations are modeled in Figure 2.6 in order to illustrate the
differences between dehydrated negatively stained PSD samples and the non-stained
hydrated cryo-preserved PSD samples. For all tomography, grids were imaged on a
Technai F30 Polara, using FEI’s Batch Tomography software at 2x binning with a Tietz
4K x 4K CCD. Negatively stained PSDs were imaged at 1˚ tilt angles from -60˚ to 60˚
at ~10 μm defocus with a total dose less than 300 e-/Å2 and a final pixel size of 0.9215
nm/pixel. For cryotomography, PSDs were imaged every 2˚ from -60˚ to 60˚ between
10 and 15 μm defocus with a total dose less than 180 e-/Å2 and a final pixel size of
1.193 nm/pixel. Individual PSDs were selected for tilt series collection based on gross
morphologic criteria including diameter.
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2.6. Tomographic Reconstruction and Image Processing
The resulting image stacks were aligned to create three-dimensional
reconstructions in ETomo within the IMOD suite of programs (Mastronarde, 1997)
http://bio3d.colorado.edu/imod/. When aligning a new tomogram in ETomo, the file
was selected, axis defined and header scanned for information.

Missing header

information was supplied, such as fiducial diameter, and com scripts were created. For
pre-processing, a fixed stack was created and viewed. The cross correlation was then
calculated for the fixed stack and a coarse aligned stack was created and viewed. Next
the fiducial model was generated, at least 10 fiducial markers around the subject of
interest were selected, and the seed model was tracked.
corrected and tracking was rerun.

Gaps in tracking were

The alignment was then computed and if the

residual error mean or standard deviation were above 0.5 and 0.3, respectively,
residual vectors were examined, corrected and alignment recomputed. A 3x binned
sample tomogram was created for positioning of the tomogram. The sample tomogram
was opened, the X and Y dimensions flipped and 3 parallel lines created to define the
orientation of the PSD throughout the Z dimension.

Once the orientation was

determined for the PSD, the final alignment could be created. Then, the default cubic
interpolation was employed for negative stain tomography, while linear interpolation
was selected for cryotomography, to reduce noise. The file was then binned to 1k and
gold was erased. Low pass two-dimensional filtering was employed for cryotomograms
to further reduce noise; cutoff and sigma values were 0.1 and 0.05, respectively. Once
the full aligned stack was created, the full tomogram was generated, trimmed, pixels
scaled and rotated around the x-axis.
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Additional filtering steps were employed when reconstructing cryotomograms to
increase the signal to noise ratio. Cryotomograms are inherently noisier than negative
stain tomography and were collected at approximately half the dose, reducing the total
signal. Increasing the signal to noise ratio was important for increasing the range
between pixel intensities for buffer and protein in cryotomograms in order to calculate
the protein-to-volume ratio of cryo-preserved PSDs.

Figure 2.6 illustrates how

additional filtering of the same cryotomogram can significantly increase visual contrast,
although, at the cost of losing finer detail. Table 2.3 summarizes the average pixel
intensity for buffer and for protein for each of the examples shown in Figure 2.6. The
range between the average pixel intensities for buffer and for protein significantly
increases with additional filtering, most intensely with the addition of low pass twodimensional filtering (Table 2.3).

For reconstruction of cryotomograms, linear

interpolation and low pass two-dimensional filtering with a cutoff value of 0.1 was
selected to be a part of the standard protocol, as this provided improved signal to noise
ratio, while still maintaining finer detail.

A description of the filtering options and

suggested filtering conditions for tomographic reconstruction can be found online
(http://bio3d.colorado.edu/imod/doc/tomoguide.html#Filtering2D).
To accomplish the protein-to-volume analysis, only PSDs that were centered
within the holes of the quantifoil grids could be used to allow for the distinction between
protein density and surrounding buffer. Because the PSDs had a tendency to attach to
the carbon surface, the number of reconstructed images fitting this criterion was limited
to 12 per group. Amira (v 5.3.3; Visage Imaging Inc. San Diego, CA) was used to
calculate the protein-to-volume ratios of cryo-preserved PSDs from the final
tomographic reconstructions using the following steps. For each individual tomogram,
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the PSD boundary was defined in the XY dimensions every 5th slice through the zdimension, enclosing the voxels representing both protein and open space within the
PSD complex, and then the program interpolated the boundary enclosing the whole
PSD volume. A pixel intensity threshold was then determined for each tomogram in
order to distinguish between pixels representing protein and pixels representing buffer
enclosed in the PSD volume. The threshold was set as the mid-point between the
mean buffer and mean protein pixel intensities, as determined by calculating the
statistical mean pixel intensity for 10x10x10 voxel cubes of only buffer and of PSD
protein material, determined through the clip stats command in 3DMOD (IMOD). Using
the threshold value, the voxels representing protein within the PSD boundary were
segmented, quantified and the protein-to-volume ratio determined. Values are reported
as the total number of voxels above the threshold value divided by the total number of
voxels enclosed within the PSD boundary.
PSD thickness was determined by multiplying the number of tomographic slices
that contained PSD protein density in the Z-dimension, determined in 3DMOD, by the
pixel sizes of the reconstructions. Surface areas were determined by multiplying pixel
size by the total number of pixels within the X-Y boundary of each PSD.

The

boundaries were set manually in ImageJ using the full projections of the tomograms
created in 3DMOD. Differences were considered significant if P < 0.05 in a 2-tailed t
test.
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Figure 2.6. Grid
Reconstruction.

Preparation

and

Differential

Filtering

of

a

Tomographic

Shown for comparison in A) are cartoon models including a top down view of an EM
grid as well as side views of both a dehydrated negatively stained PSD grid and a
hydrated cryo-preserved PSD grid. Included in B-D) are 10 nm cross-sections through
the same tomographic reconstruction of a cryo-preserved cortical PSD with differential
filtering conditions employed throughout the reconstruction process.
The
reconstructions were identical until the creation of the final aligned stack. The example
in B) was filtered only with the default cubic interpolation, while C) was filtered by linear
interpolation. Examples D-E) were filtered by linear interpolation and low pass 2D
filtering. The cutoff value for 2D filtering in D) was the default value, 0.1, while the
value employed for E) was 0.05. Scale bar = 100 nm.
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Image

Filtering Conditions

Pixel Intensity
for Buffer

Pixel Intensity
for Protein

Range

A

Default

150.3

130.4

20.7

B

Linear Interpolation

148.5

124.0

25.2

C

Linear + 2D filtering (0.1 cutoff)

147.6

106.2

41.6

D

Linear + 2D filtering (0.05
cutoff)

146.6

92.1

54.0

Table 2.3. Differential Filtering of a Tomographic Reconstruction.
The average pixel intensity for buffer and for protein was calculated for each
reconstruction shown in Figure 2.5, to test the effect on differential filtering on the pixel
intensity range between protein and buffer. This table lists the average pixel intensity
for buffer, the average pixel intensity for protein and the difference between the two,
termed range, for each example from Figure 2.5. Average pixel intensity was
determined by measuring the mean pixel intensity for the same 10x10x10 voxel cubes
of only buffer and of mostly protein for each reconstruction.
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Chapter 3. Isolation of Postsynaptic Densities from Adult Rat Cerebral Cortices,
Hippocampi, and Cerebella
3.1. Enrichment of PSDs from Brain Tissue
PSDs have been successfully biochemically isolated from synapses for decades
(Cotman et al., 1974, Cohen et al., 1977), providing the ability to study the threedimensional gross morphology of the synaptic organelle through electron microscopy
(Cotman et al., 1974, Cohen et al., 1977, Carlin et al., 1980, Swulius et al., 2010, Fera
et al., 2012, Swulius et al., 2012), and its protein composition through SDS-page
(Blomberg et al., 1977, Carlin et al., 1980, Swulius et al., 2010), Western blotting
(Petralia et al., 2005, DeGiorgis et al., 2006), immunogold labeling (Petersen et al.,
2003, DeGiorgis et al., 2006, Swulius et al., 2010) and more recently through proteomic
approaches (Jordan et al., 2004, Li et al., 2004, Peng et al., 2004, Yoshimura et al.,
2004, Cheng et al., 2006, Dosemeci et al., 2006, Dosemeci et al., 2007). However,
there has not been a comprehensive comparison of morphologic structure and protein
composition for PSDs from different brain regions.

The work presented in this

dissertation is the first use of negative stain and cryo electron tomography to directly
compare the three-dimensional structure of PSDs isolated from cerebella, hippocampi,
and cerebral cortices.

It is also the first application of immunogold labeling to

determine how the PSD protein composition and organization differs between individual
morphologically identified PSDs from these brain regions.
PSDs were isolated from cerebral cortices, hippocampi, and cerebella, three
brain areas amenable to straightforward isolation with unique population of neuronal
cells. PSDs were isolated as described in the experimental procedures, adapted from
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an established and widely used protocol (Cohen et al., 1977), similar to previously
published protocols from the Waxham lab (Swulius et al., 2010, Swulius et al., 2012),
and as briefly illustrated in Figure 3.1. Cerebella, hippocampi, and cortices from whole
adult rat brains were rapidly dissected and separately homogenized. The homogenate
fraction was refined through two low-speed centrifugations, prior to a medium-speed
centrifugation, which produced a pellet enriched with pinched off nerve endings
(synaptosomes) that were purified on a discontinuous sucrose gradient. Detergent
treatment with TX-100 and centrifugation of synaptosomes lysed the pre- and
postsynaptic elements, leaving synaptic junctions, which are composed of the PSD and
residual

presynaptic

and

postsynaptic

plasma

membranes.

A

high-speed

centrifugation of a discontinuous sucrose gradient further refined the synaptic junction
fraction. A second detergent treatment with TX-100 and centrifugation removed the
remaining synaptic membranes providing the PSD fraction, which was purified with a
final high-speed centrifugation of a discontinuous sucrose gradient.
Enrichment for PSDs through the steps of the isolation was monitored by
Western blot (Figure 3.2). Eight total micrograms of the homogenate, synaptosome,
synaptic junction and PSD fractions from each brain region were separated by SDSPAGE and probed using antibodies against PSD-95 and SV2 (Figure 3.2). PSD-95 is a
PSD scaffold protein, which served as a marker for PSDs, while SV2 is a synaptic
vesicle protein, which served as a presynaptic marker. As anticipated, PSD-95
undergoes significant enrichment moving from the homogenate fraction (Hom.) to the
PSD fraction, with a major enrichment coming at the step of synaptic junction (Syn. J.)
enrichment (Figure 3.2). In contrast, SV2 becomes undetectable when synaptosomes
(Syn.) are lysed with detergent to create the synaptic junction fraction (Figure 3.2), as
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soluble presynaptic elements have been removed. Overall the enrichment and loss
patterns of PSD-95 and SV2, respectively, were similar amongst the fractions from
cerebella, hippocampi and cortices (Figure 3.2), confirming enrichment for PSD-95 rich
material absent of presynaptic elements.
Representative electron micrographs of negatively stained synaptic junctions
and PSDs from cerebella, hippocampi and cortices are shown in Figure 3.3. Negative
stained synaptic junction fractions were lipid heavy, as expected since synaptic
junctions are composed of the PSD and both presynaptic and postsynaptic
membranes, and comparable to negative stain micrographs of isolated synaptic
junctional complexes (Cotman et al., 1974, Matus and Taff-Jones, 1978) and isolated
synaptosomal membrane fractions (Cohen et al., 1977). Most of the protein material
appeared to bind directly to the grid with the lipid material resting on top, as shown in
the left column of Figure 3.3. Synaptic junctions were circularly shaped, similar to
isolated PSDs (right column Figure 3.3), with well-defined boundaries and diameters
ranging from several hundred nanometers to well over a micron. The negative stained
PSDs appeared to attach to the carbon surface with either their cytoplasmic or synaptic
faces, giving them a general disc shape with irregular yet well-defined boundaries like
the examples shown in the right column of Figure 3.3. PSDs were quite variable with
respect to their diameters, which were typically several hundred nanometers, and
displayed wide ranges of surface topology or texture like the examples in Figure 3.3.
To further characterize the enrichment of PSDs from cortices, hippocampi, and
cerebella, the protein profiles for the homogenate, synaptic junction and PSD fractions
were compared for each brain region (Figure 3.4). Three micrograms of total protein
from each fraction were separated by SDS-PAGE and stained with deep purple stain;
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the major bands in each lane are indicated with asterisks (Figure 3.4). For all regions,
the protein profile is similar between the homogenate and synaptic junction fractions,
while the profile differs for the PSD fraction (Figure 3.4), similar to previous
comparisons of SDS-PAGE protein profiles between homogenates, synaptosomes and
PSDs from adult rat forebrain PSDs (Swulius et al., 2010) and between synaptic
membrane fractions and PSDs from canine cortices (Blomberg et al., 1977).

The

protein profiles are almost identical between cortical homogenate and synaptic junction
fractions, as well as between hippocampal homogenate and synaptic junction fractions
(Figure 3.4). The cerebellar synaptic junction fraction contains many but not all of the
major bands present in the cerebellar homogenate fraction (Figure 3.4). For all brain
regions, several of the protein bands are present in all fractions, but PSD fractions
contain unique bands enriched from both the synaptic junction and homogenate
fractions (Figure 3.4). Additionally, the intensity of some of the higher molecular weight
bands is increased in the PSD fractions; these bands may represent PSD scaffolds like
Shank proteins, which are enriched in the PSD fraction (Tao-Cheng et al., 2010). The
protein patterns for the individual fractions are also similar when compared across the
different regions, although there is some variety in the profiles of the PSD fractions
(Figure 3.4), suggesting that PSDs from cerebella, hippocampi, and cortices have
unique protein compositions which is consistent with previous SDS-PAGE protein
profiles comparing cerebellar and cortical PSD fractions (Carlin et al., 1980, Cheng et
al., 2006).
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Figure 3.1. Isolation of Postsynaptic Densities.
Synapses are separated from homogenized whole brain tissue through centrifugation.
Further homogenization and centrifugation produces fractions enriched for
synaptosomes, which when solubilized with TX-100 produces synaptic junctions,
composed of the presynaptic and postsynaptic plasma membranes and the PSD.
Treatment of synaptic junctions with TX-100 further solubilizes the remaining synaptic
membranes isolated PSDs.
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Figure 3.2. Loss of Presynaptic Elements and Enrichment of Postsynaptic Elements.
Western blots illustrating loss of synaptic vesicle protein, SV2, and enrichment of PSD
scaffold, PSD-95, through the isolation of PSDs from cerebella, hippocampi, and
cortices. SV2 loss is seen in synaptic junction (Syn. J) and PSD fractions in
comparison to brain homogenate (Hom) and synaptosome (Syn) fractions. PSD-95
increases significantly from homogenate to PSD fraction. Eight micrograms of total
protein were loaded into each lane and the secondary antibody was Alexa 488 goat
anti-mouse (Molecular Probes).
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Figure 3.3. Electron Micrographs of Synaptic Junctions and PSDs.
Representative negative stain electron micrographs of synaptic junction material and
isolated PSDs from cerebella, hippocampi, and cortices. Scale bars = 100 nm.
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Figure 3.4. Protein Profiles of Homogenate, Synaptosome and PSD fractions.
Comparison of homogenate (Hom.), synaptosome (Syn,) and PSD protein profiles for
cortical, hippocampal and cerebellar fractions, through deep purple staining of SDSPAGE-separated proteins. Three micrograms of total protein were loaded into each
lane. The major bands in each lane are indicated with asterisks. Molecular weights
(kDa) are indicated to the left of the gel. Major bands were defined as bands whose
intensities were at least twice the average band intensity within each sample as
measured in ImageQuant.
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3.2. Gross Morphology of Isolated PSDs from Negative Stain Micrographs
For initial morphologic descriptions, isolated PSDs from each region were
loaded onto glow discharged carbon formvar copper grids, stained with methylamine
tungstate and then electron micrographs were collected.

Low magnification

micrographs shown in Figures 3.5-3.7 are representative fields of isolated PSDs from
each region. Figure 3.5 is a low magnification micrograph of a typical field of negatively
stained isolated cortical PSDs and three cortical PSDs, which are highlighted with
arrows. Cortical preparations typically produced the best yield of isolated PSDs and
this is well represented in Figure 3.5, as there is a high density of PSDs relative to the
other regions. Detergent resistant lipids, described in more detail in Chapter 4, are also
visible in the micrograph and the variability in PSD size is evident (Figure 3.5). Figure
3.6 is a low magnification micrograph of a field of negatively stained isolated
hippocampal PSDs. The density of hippocampal PSDs is not as high as cortical PSDs,
but this is representative of typical hippocampal PSD yields.

Two well-defined

hippocampal PSDs are highlighted with arrows (Figure 3.6). The filament in the top left
of Figure 3.6 should be noted, as filaments are often seen in the PSD enriched fraction;
it is likely the filament is composed of neurofilament proteins, which are known
contaminants in PSD enriched fractions (Peng et al., 2004, Cheng et al., 2006,
Dosemeci et al., 2006). Figure 3.7 is a low magnification micrograph of a field of
isolated and negatively stained cerebellar PSDs. The density of cerebellar PSDs is
more comparable to that of hippocampal PSDs and three well-defined cerebellar PSDs
are highlighted with arrows (Figure 3.7).
Figures 3.5-3.7 also highlight the range of negative staining that naturally results
from the staining protocol.

The high density of material on the cortical PSD grid
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plausibly helped to pool the stain providing sufficient and fairly even contrast between
protein and the carbon background (Figure 3.5). The image in Figure 3.6, which has
less PSD material on the grid, has areas of thicker stain around lipid and protein
materials, like the highlighted hippocampal PSDs.

Figure 3.7 is an example more

similar to positive staining, where the protein is stained as opposed to the background,
leaving the PSDs darker, or more electron dense, than the carbon surface.
Individual micrographs were collected of well-stained isolated PSDs from each
region to assess the gross morphology of the different PSDs.

Representative

examples of individual PSDs from each region, imaged at high magnification, are
shown in Figures 3.8-3.10. Figure 3.8 includes nine examples of cortical PSDs, and
Figures 3.9 and 3.10 each include nine examples of hippocampal and cerebellar PSDs,
respectively. From the negative stain micrographs collected and analyzed, cortical
PSDs can be described as enormous protein complexes that are roughly disc-shaped.
They had well-defined edges that were typically irregular in shape as seen in Figure
3.8. Cortical PSDs also varied greatly in diameter, as seen in Figure 3.8, where PSD
diameters ranged from approximately 400 nm to a micron. Lipids were also often seen
on and around individual PSDs and appeared attached to the protein density. Three
PSDs in Figure 3.8 have intact detergent resistant lipid membranes clearly visible and
the other PSDs appear to have remnants of lipid material. Texturally cortical PSDs
were very similar amongst each other, composed of finely packed proteins forming a
topology of ridges and valleys; ridges of lightly stained protein and dark valleys lacking
in protein density, where stain has pooled.
Hippocampal PSDs were morphologically similar to cortical PSDs. Hippocampal
PSDs, like the representative examples in Figure 3.9, were generally disc-shaped, with
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irregular boundaries, some better defined than others. The hippocampal PSD in the
middle of the bottom row and the example in the bottom right corner of Figure 3.9 have
boundaries that are not as well-defined as the other examples. The example in the
bottom right corner also has filaments near the upper left edge of the PSD, although it’s
unclear whether the filaments are interacting with the PSD from this example as they
could have separately bound to the carbon surface of the grid.

The diameter of

hippocampal PSDs also greatly varied and the examples in Figure 3.9 range from
approximately 400 nm to over a micron, similar to the cortical PSDs in Figure 3.8.
Hippocampal PSDs also appear to have lipid membranes attached to the protein
density and Figure 3.9 includes several PSDs with large lipid membranes, several with
smaller lipid structures and two examples of what seems to be lipid remnants.
Texturally hippocampal PSDs were also similar to cortical PSDs in that they appeared
to be composed of finely compacted proteins organized into ridges of protein and
valleys absent of protein where stain pooled, however, some of the material within
hippocampal PSDs was not as crisp or finely resolved as in cortical PSDs. This could
be due to the particular staining of the grids or perhaps some hippocampal PSDs have
more lipid within their structure, which does not image as crisp as protein.
The texture of cerebellar PSDs ranged significantly; some cerebellar PSDs were
composed of finely packed and crisply defined protein organized into ridges and
valleys, although the areas absent of protein appeared smaller on average in cerebellar
PSDs, like the representative cerebellar PSDs in the middle position of the top row and
the left and right columns of the middle row in Figure 3.10. Some cerebellar PSDs, like
the examples in left column of the top and bottom rows and the right column of the
bottom row of Figure 3.10, were more cloudy in appearance, or not as crisp as others
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and these structures appeared to have larger valleys or areas lacking in protein
density, than the finer pack and more crisply imaged cerebellar PSDs, which more
closely resembled hippocampal and cortical PSDs.

Cerebellar PSDs were still

generally describable as disc-shaped protein densities with irregularly shaped
boundaries, which appeared to not be as well-defined as and more irregular than both
hippocampal and cortical PSDs. Similar to hippocampal and cortical PSDs, lipids were
often seen bound to cerebellar PSDs and the diameter of cerebellar PSDs was also
quite variable, with the examples in Figure 3.10 ranging from 400 nm to over a micron.
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Figure 3.5. Low Magnification Micrograph of Negatively Stained Cortical PSDs.
Low magnification micrograph showing a typical field of isolated negatively stained
cortical PSDs. Three well-defined cortical PSDs are highlighted with arrows. Scale bar
= 1 μm.
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Figure 3.6. Low Magnification Micrograph of Negatively Stained Hippocampal PSDs.
Low magnification micrograph showing a typical field of isolated negatively stained
hippocampal PSDs. Two well-defined hippocampal PSDs are highlighted with arrows.
Scale bar = 1 μm.
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Figure 3.7. Low Magnification Micrograph of Negatively Stained Cerebellar PSDs.
Low magnification micrograph showing a typical field of isolated negatively stained
cerebellar PSDs. Three well-defined cortical PSDs are highlighted with arrows. Scale
bar = 1 μm.
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Figure 3.8. High Magnification Micrographs of Negatively Stained Cortical PSDs.
High magnification negative stain micrographs of representative isolated cortical PSDs.
Scale bar = 100 nm.
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Figure 3.9. High Magnification Micrographs of Negatively Stained Hippocampal PSDs.
High magnification negative stain micrographs of representative isolated hippocampal
PSDs. Scale bar = 100 nm.
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Figure 3.10. High Magnification Micrographs of Negatively Stained Cerebellar PSDs.
High magnification negative stain micrographs of representative isolated cerebellar
PSDs. Scale bar = 100 nm.

61

3.3. Surface Area of Isolated PSDs from Negative Stain Micrographs
Qualitative similarities and differences in gross morphologic characteristics were
observed across PSDs from cortices, hippocampi, and cerebella, as well as within each
PSD group. Most notable was the less densely packed protein arrangement in some
cerebellar PSDs relative to those from either hippocampi or cortices (Figures 3.8-3.10).
The detailed morphological characteristics as determined by electron tomography are
described in Chapter 4, but a quantitative assessment of the relative surface area of
PSDs was first accomplished by analyzing 120 randomly chosen PSDs from each
preparation.

Histograms of the binned surface areas (Figure 3.11) provide an

assessment of the size distribution amongst PSDs and show the mode to be
approximately 0.2 μm2 for all PSD types, similar to the peak surface area of 0.15 μm2
reported previously for PSDs isolated from adult rat forebrains, which contained PSDs
from both the cerebral cortices and hippocampi (Swulius et al., 2010).

The mean

surface area of PSDs from cerebella, hippocampi and cortices were determined to be
0.37, 0.34 and 0.35 μm2 (all ± 0.02 μm2), respectively and were not significantly
different from each other.
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Figure 3.11. Distribution of PSD Surface Areas.
Histograms depicting surface area distribution for PSDs isolated from cerebella,
hippocampi and cortices. The peak for all PSD types was approximately 0.2 μm2.
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Chapter 4. Morphology of Postsynaptic Densities from Adult Rat Cerebella,
Hippocampi, and Cerebral Cortices
4.1. Morphology of Isolated PSDs from Negative Stain Electron Tomography
Due to its potential to produce relatively high-resolution three-dimensional
structural information, electron tomography is currently the best imaging option to
reveal morphological details of individual macromolecular complexes like the PSD
(Murphy and Jensen, 2007). Using this technique, a detailed comparative anatomical
analysis of PSDs isolated from cerebella, hippocampi and cortices was accomplished
using both negative stain and cryo electron tomography.

Negative stain electron

tomography provides increased contrast making visualization easier; however the
application of stain and dehydration of the sample may distort the structure. These
distortions are not a limitation with cryo electron tomography and the unique strengths
of both of these techniques were utilized for the structural morphologic analysis. These
distinct PSD preparations are modeled in Figure 2.6.

A total of 49 tilt series of

cerebellar PSDs (29 negative stained and 20 cryo-preserved), 37 of hippocampal PSDs
(12 negative stained and 25 cryo-preserved) and 59 of cortical PSDs (14 negative
stained and 45 cryo-preserved) were reconstructed for morphological and quantitative
analyses.
Tilts series of negatively stained isolated PSDs from each region were collected
and reconstructed in order to obtain higher resolution detail of the three-dimensional
structure of each PSD. In Figure 4.1, full projection images of negatively stained PSDs
from cerebral cortices, hippocampi, and cerebella are shown and compared to 10 nm
cross-sections through the center of the final tomographic reconstructions for the same
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PSDs to demonstrate the increased resolution available from the tomographic
reconstructions.
From negative stain tomographic reconstructions, cortical PSDs were roughly
disc-shaped, with well-defined boundaries as shown in the cross-sections through final
tomographic reconstructions in Figure 4.2, consistent with the negative stain
micrographs described in Chapter 3. It was also easily visible from the high contrast
cross-sections that cortical PSDs were composed of tightly packed protein with few
areas of low or absent protein density. In the representative examples in Figure 4.2
areas of dense protein packing are highlighted with black horizontal arrows and several
examples of low protein density are indicated with black vertical arrows. As noted from
the negative stain micrographs in Chapter 3, another prominent ultrastructural
component was the presence of detergent resistant lipids intimately attached to the
protein density of cortical PSDs, as seen in two of the tomographic examples in Figure
4.2. The lipids were well integrated into the PSD protein density around the PSD
edges, as seen in Figure 4.2, and within the PSD volume as shown in the close-up
cross-section of the cortical PSD in the right panel of Figure 4.7. Protein particles were
often associated with the detergent resistant lipids membranes as in the tomographic
cross-section through a cortical PSD shown in Figure 4.1.
From close-up views of the tomographic cross-sections, like shown in Figure
4.7, it was evident that cortical PSDs were composed of a variety of globular and
filamentous proteins, highlighted by white vertical and horizontal arrows, respectively.
Many of the globular proteins within cortical PSDs resembled the structure of CaMKII,
which is barrel shaped and approximately 20 nm in diameter and height (Kolodziej et
al., 2000, Swulius and Waxham, 2008). This was expected as CaMKII is the most
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abundant protein in cortical PSDs (Dosemeci et al., 2007) and CaMKII has previously
been identified in tomographic reconstructions of isolated PSDs (Fera et al., 2012,
Swulius et al., 2012) through comparison with three-dimensional electron microscopic
structures of purified CaMKII (Kolodziej et al., 2000, Gaertner et al., 2004a).
Negative stain tomographic reconstructions, like the examples shown in Figure
4.3, showed that hippocampal PSDs exhibited similar morphology to cortical PSDs.
Hippocampal PSDs were disc-like in shape with irregular well-defined edges and were
also composed of densely packed proteins with sparse areas absent of protein density
(Figure 4.3). Black horizontal and vertical arrows highlight regions of tightly packed
protein and areas of low protein density, respectively, within tomographic crosssections of hippocampal PSDs. Figure 4.3 also shows examples of detergent lipid
membranes (white asterisks) which were connected to proteins both on the edges and
interior of PSDs. All of the lipid membranes associated with hippocampal PSDs in the
negative stain tomographic reconstructions appeared to be studded with protein, as
evident in Figure 4.3, similar to the cortical PSD in Figure 4.1. Also similar to cortical
PSDs, hippocampal PSDs were composed of a combination of globular and
filamentous proteins, as shown in Figure 4.7 where globular CaMKII-like proteins,
easily visible within the tomographic reconstruction, are indicated with white vertical
arrows and filamentous proteins are highlighted with white horizontal arrows.
In contrast to the relatively consistent architecture of cortical and hippocampal
PSDs, three distinct morphological classes of PSDs isolated from cerebella were
identified (Figures 4.4-4.6). Figure 4.4 includes three representative cross-sections
through cerebellar PSDs that exhibit mostly densely packed protein with small areas
absent of protein that closely resembles the morphology of cortical and hippocampal
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PSDs.

This type of dense cerebellar PSD was also disc-like with distinct protein

boundaries (Figure 4.4) and had lipids associated with the protein density, as indicated
with asterisks in Figure 4.4 and Figure 4.7.
Other cerebellar PSDs were identified that exhibited a more granular protein
substructure (Figure 4.5) or a latticelike substructure (Figure 4.6), both which appeared
to have smaller areas of dense protein packing. The granular-like cerebellar PSDs
lacked larger regions of dense protein and instead had smaller regions of protein
clusters about 40 nm in diameter with areas of low protein density between clusters
(Figure 4.5), but were disc-shaped with distinct edges, similar to cortical, hippocampal
and dense cerebellar PSDs.

Three representative cross-sections through final

tomographic reconstructions of granular cerebellar PSDs are shown in Figure 4.5,
where black horizontal arrows highlight several small areas of protein clustering, black
vertical arrows indicate areas lacking protein density and an asterisk highlights lipid
material associated with one of the PSDs. The lacier cerebellar PSDs had a latticelike
structure, with distinct filamentous proteins connecting regions of protein density
(Figure 4.6). There also appeared to be significantly less protein density, evident as
increased areas absent of protein density within the PSD boundaries, as highlighted by
black vertical arrows within the representative tomographic cross-sections shown in
Figure 4.6.

The latticelike cerebellar PSDs were also roughly disc-shaped but in

contrast to other PSD types their edges were more web-like, lacking a distinct
boundary or perimeter.
In contrast to these larger scale differences, close examination of the fine
structural details of PSDs isolated from cerebella indicated that they were all comprised
of small filamentous and globular proteins (Figure 4.7), similar to hippocampal and
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cortical PSDs. The larger scale differences for all PSD morphologies appeared to arise
from the ratio and packing density of these smaller substructures as in the examples
shown in Figure 4.7. Globular proteins resembling the structure of CaMKII were also
evident in all cerebellar PSDs and examples are highlighted with white vertical arrows
within a representative tomographic reconstruction for each cerebellar PSD
morphologic class (Figure 4.7).
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Figure 4.1. Negative Stain Tomographic Reconstructions of PSDs Isolated from Adult
Rat Cortices, Hippocampi, and Cerebella.
Full projections of entire reconstructions are shown in the left panel while 10 nm crosssections through the center of reconstructions are shown in the right panel for
comparison. Gold is used as a fiducial marker to align image series during
reconstruction. Scale bar = 100 nm.
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Figure 4.2. Tomographic Reconstructions of Negatively Stained Cortical PSDs.
Ten-nanometer cross-sections through final tomographic reconstruction of negatively
stained cortical PSDs. Horizontal arrows indicate areas of dense protein, vertical
arrows indicate areas without protein density and asterisks highlight detergent resistant
membranes attached to the PSDs. Gold is used as a fiducial marker to align image
series during reconstruction. Scale bar = 100 nm.
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Figure 4.3. Tomographic Reconstructions of Negatively Stained Hippocampal PSDs.
Ten-nanometer cross-sections through final tomographic reconstruction of negatively
stained hippocampal PSDs. Horizontal arrows indicate areas of dense protein, vertical
arrows indicate areas without protein density and asterisks highlight detergent resistant
membranes attached to the PSDs. Gold is used as a fiducial marker to align image
series during reconstruction. Scale bar = 100 nm.
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Figure 4.4. Tomographic Reconstructions of Negatively Stained Cerebellar PSDs with
Dense Morphology.
Ten-nanometer cross-sections through final tomographic reconstruction of negatively
stained cerebellar PSDs categorized as dense in morphology, similar to cortical and
hippocampal PSDs. Horizontal arrows indicate areas of dense protein, vertical arrows
indicate areas without protein density and asterisks highlight detergent resistant
membranes attached to the PSDs. Gold is used as a fiducial marker to align image
series during reconstruction. Scale bar = 100 nm.
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Figure 4.5. Tomographic Reconstructions of Negatively Stained Cerebellar PSDs with
Granular Morphology.
Ten-nanometer cross-sections through final tomographic reconstruction of negatively
stained cerebellar PSDs categorized as granular in morphology. Horizontal arrows
indicate small areas of dense protein, approximately 40 nm in diameter, vertical arrows
indicate areas without protein density and asterisks highlight detergent resistant
membranes attached to the PSDs. Gold is used as a fiducial marker to align image
series during reconstruction. Scale bar = 100 nm.
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Figure 4.6. Tomographic Reconstructions of Negatively Stained Cerebellar PSDs with
Lacy Morphology.
Ten-nanometer cross-sections through final tomographic reconstruction of negatively
stained cerebellar PSDs categorized as lacy in morphology. Vertical arrows indicate
areas without protein density and asterisks highlight detergent resistant membranes
attached to the PSDs. Gold is used as a fiducial marker to align image series during
reconstruction. Scale bar = 100 nm.
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Figure 4.7. Fine Morphology of Isolated PSDs from Negative Stain Tomographic
Reconstructions.
Ten-nanometer cross-sections through final tomographic reconstruction of
negatively stained PSDs. The panels include the different morphologies observed
among A) cortical, B) hippocampal, and C-D) cerebellar PSDs. Enlargements of each
image are included, respectively, in the right column of panels illustrating the finer
structural features of isolated PSDs. All PSDs were composed of filamentous and
globular proteins, indicated with white horizontal and vertical arrows, respectively. Gold
is used as a fiducial marker to align image series during reconstruction. Scale bar =
100 nm.
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4.2. Morphology of Isolated PSDs from Cryo Electron Tomography
Tilt series were also collected for cryo-preserved PSDs from each region in
order to assess their morphological structure without dehydration and negative stain.
Since the PSDs were preserved in vitreous ice, rather than negatively stained, the
contrast is reversed from the negative stain tomographic reconstruction and protein
density

is

represented

by

darker

voxel

intensity

in

the

final

tomographic

reconstructions, like the cross-sections shown in Figures 4.8-4.12. The morphology of
PSDs as determined by cryo electron tomography confirmed and extended the findings
from negative stain electron tomography.
Cortical PSDs were disc-like in shape with distinctive edges defining the protein
density, and were composed of densely packed protein with occasional areas absent of
protein, as shown in the representative cross-sections in Figure 4.8. Cortical PSDs
also had lipid-structures attached to the protein density (Figure 4.8), as seen in the
negative stain tomographic reconstructions (Figure 4.2). Figure 4.8 nicely illustrates
the variable size of the associated lipids, indicated with asterisks, present within cortical
PSDs. Hippocampal PSDs were morphologically similar to cortical PSDs, confirming
the results from the negative stain tomography. As Figure 4.9 illustrates, hippocampal
PSDs had well-defined boundaries and irregular but disc-like perimeters and were
composed of dense layers of proteins with holes in the density as highlighted by
vertical arrows. Detergent resistant lipids were also associated with the cryo-preserved
hippocampal PSDs (Figure 4.9). It was also evident from the morphological analysis of
cryo-preserved cerebellar PSDs that three separate classes of cerebellar PSDs existed
with respect to protein texture or protein packing (Figures 4.10-4.12).

The dense

cerebellar PSDs, as shown in Figure 4.10, were also composed of large regions of
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densely packed protein, with the occasional area absent of protein density within their
well-defined perimeter, similar to the dense cerebellar PSDs from negative stain
tomographic reconstructions (Figure 4.4).

The cryo-preserved granular cerebellar

PSDs (Figure 4.11) were also morphologically the same as the granular cerebellar
PSDs imaged by negative stain electron tomography (Figure 4.5), lacking the larger
regions of dense proteins which comprise cortical, hippocampal, and dense cerebellar
PSDs and were instead composed of smaller areas of protein approximately 40 nm in
diameter. These small protein granules are well represented in the example crosssections through final tomographic reconstructions of cryo-preserved granular
cerebellar PSDs shown in Figure 4.11, and several are highlighted with horizontal
arrows. Three representative cross-sections through cryo-preserved lacy cerebellar
PSDs are included in Figure 4.12. In these cross-sections, the latticelike structure is
evident as filamentous proteins connecting much larger regions of densely packed
protein, just as described from the negative stain tomographic examples (Figure 4.6).
Lipid-like material was also associated with cryo-preserved cerebellar PSDs from all
three morphologic classes, and examples of these are indicated with asterisks in
Figures 4.10-4.12.
In total, dense cerebellar PSDs (Figures 4.4 and 4.10) represented 20 of 49
(41%) of the cerebellar PSDs analyzed by both negative stain and cryo electron
tomography. Granular cerebellar PSDs (Figures 4.5 and 4.11) represented 12 of 49
(24%) of cerebellar PSDs, and 17 of 49 (35%) cerebellar PSDs were classified as
latticelike in morphology (Figures 4.6 and 4.12). Cerebellar PSDs have previously
been described as lacy or latticelike and it was postulated that they were from inhibitory
synapses rather than excitatory synapses (Carlin et al., 1980). However, the results of
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my immunogold labeling experiments, discussed further in Chapter 5, suggest that the
PSDs isolated and described in this dissertation were only from excitatory synapses.
Additionally, not all of the cerebellar PSDs isolated were lacy in morphology,
suggesting isolation of differential PSD populations.
The presence of lipid-like structures obvious in the reconstructions was also
quantified for each of the PSD types, from both the negative stain and cryo
tomographic reconstructions. Lipids were associated with 78% (46 of 59) of cortical
PSDs, while hippocampal PSDs had lipid present in 62% (21 of 37) and cerebellar
PSDs in 63% (31 of 49). Within the cerebellar PSD group, lipid membrane structures
were associated with 60% (12 of 20) of the dense cerebellar PSDs, 50% (6 of 12) of
the granular cerebellar PSDs and 76% (13 of 17) of the lacy cerebellar PSDs. Lipidlike structures associated with PSDs have been described in previous publications
(Cohen et al., 1977, Matus and Taff-Jones, 1978, Swulius et al., 2010, Swulius et al.,
2012) and are hypothesized to be lipid raft-like (Suzuki et al., 2001, Swulius et al.,
2012) as they are composed of raft-associated lipid GM1 in forebrain PSDs (Swulius et
al., 2012).

4.3. Protein-to-Volume Ratios of Isolated PSDs
From the visual assessment of PSD morphology described above from both
negative stain and cryo electron tomography, differences were evident in the packing
density of structures within different cerebellar PSDs.

Therefore subsets of cryo-

preserved PSDs were chosen for analysis of protein-to-volume ratios, a measure of
PSD protein occupancy, in the absence of stain/dehydration artifacts.
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Twelve

cryotomograms of PSDs from each region were selected for analysis and protein-tovolume ratios were calculated as described in the methodology, Chapter 2 section 2.6,
and the results are shown in a whisker plot in Figure 4.13. The protein-to-volume
ratios, which were calculated by taking the number of voxels representing protein and
dividing by the total voxels within each PSD boundary, were more variable for cortical
PSDs with a range from 0.19 to 0.53, than for hippocampal PSDs which ranged from
just over 0.2 to 0.34 (Figure 4.13). As expected, cerebellar PSDs had the largest range
of protein-to-volume ratios, ranging from 0.15 to over 0.5, and uniquely half (6 of 12) of
the PSDs evaluated clustered near a protein-to-volume ratio of 0.175 while the others
cerebellar PSDs ranged from approximately 0.25 to just over 0.5 (Figure 4.13). This
suggests that a distinct group of less dense cerebellar PSDs existed with respect to
protein volume, and consistent with the visual observations, the lower protein-tovolume ratios corresponded to the lacy cerebellar PSDs. Most hippocampal PSDs
clustered around a protein-to-volume ratio of 0.325, while most cortical PSDs clustered
around a ratio of 0.35 (Figure 4.13), and this was well represented by the calculated
average protein-to-volume ratios, as reported in Table 4.2. Figure 4.13 also includes a
surface rendering of a representative cryo-preserved hippocampal PSD to illustrate a
PSD with a typical protein-to-volume ratio. Overall, the mean protein-to-volume ratios
for cerebellar, hippocampal, and cortical PSDs were 0.29 ± 0.04, 0.31 ± 0.01, and 0.35
± 0.03, respectively but did not reach statistically significant differences (Table 4.2).

4.4. PSD Thickness from Tomographic Reconstructions
Average PSD thickness and surface area were also calculated for the same 12
cryo-preserved PSDs to assess PSD size in the absence of dehydration and staining
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(Table 4.1). The mean surface areas were 0.24 ± 0.04 μm2, 0.28 ± 0.04 μm2, and 0.27
± 0.06 μm2 for cryo-preserved cerebellar, hippocampal and cortical PSDs, respectively
(Table 4.1). These values were not statistically different from each other and were well
within the distribution of surface areas measured from negative stain micrographs
(Figure 3.11).

The mean thickness of cryo-preserved hippocampal PSDs was

calculated to be 112 ± 9 nm and was statistically different than both cryo-preserved
cortical and cerebellar PSDs, which had mean thicknesses of 169 ± 22 nm and 210 ±
13 nm, respectively (Table 4.2). This finding cannot be ascribed to differences in the
isolation procedure as the samples from all three regions were processed
simultaneously and were imaged under identical conditions, suggesting that cortical
and cerebellar PSDs are significantly thicker than hippocampal PSDs. However, these
thicknesses are significantly larger than historically reported for PSDs (Cohen et al.,
1977, Carlin et al., 1980, Harris et al., 1992), and it is plausible that the discrepancy in
PSD thickness could be the result of the negative stain and dehydration employed in
the earlier studies.
For a direct comparison, I measured the thickness and surface area of PSDs
from negative stain tomographic reconstructions using the identical procedure to that
described for the cryo-preserved PSDs, and the values are reported in comparison to
the measurements of cryo-preserved PSDs in Table 4.2. The mean surface areas
calculated for the PSDs imaged by negative stain tomography were statistically the
same as the average surface areas for cryo-preserved PSDs (Table 4.2), suggesting
that dehydration and stain do not significantly affect PSD surface area. In contrast, the
mean thicknesses for negatively stained cerebellar and cortical PSDs (115 ± 11 nm
and 94 ± 5 nm, respectively, were significantly thinner, approximately 2-fold, than for
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cryo-preserved PSDs from the same brain regions (210 ± 13 nm and 169 ± 22 nm,
respectively) (Table 4.2). However, negatively stained hippocampal PSDs had a mean
thickness of 94 ± 7 nm, which was not statistically different than cryo-preserved
hippocampal PSDs (112 ± 9 nm) (Table 4.2). These results provide evidence that the
application of stain and dehydration causes collapse of cortical and cerebellar PSDs
along their Z dimension, and that PSDs from these brain regions are significantly
thicker than hippocampal PSDs, extending further into the synaptic compartment. The
impact of dehydration and stain on hippocampal PSDs was not significant, suggesting
that the molecular organization of hippocampal PSDs prevents the structure from
collapsing under negative stain conditions.
Morphologic analysis of PSDs by negative stain and cryo electron tomography
established that there were significant differences in PSD morphology among
cerebellar PSDs and in the variability of protein-to-volume ratios between PSD types,
as well as in PSD thickness. The described differences in PSD structure were believed
to be most likely due to differences in the molecular composition of the PSDs from the
different brain regions. In fact, proteomic approaches already provided evidence to
support this conclusion (Cheng et al., 2006). To directly assess whether PSD protein
composition and organization of specific proteins within individual PSDs was different
for PSDs from each region, immunogold labeling and EM localization was employed,
using antibodies to different functional classes of PSD associated proteins and is
discussed in Chapter 5.
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Figure 4.8. Tomographic Reconstructions of Cryo-Preserved Cortical PSDs.
Ten-nanometer cross-sections through final tomographic reconstruction of cryopreserved cortical PSDs. Horizontal arrows indicate areas of dense protein, vertical
arrows indicate areas without protein density and asterisks highlight detergent resistant
membranes attached to the PSDs. Gold is used as a fiducial marker to align image
series during reconstruction. Scale bar = 100 nm.
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Figure 4.9. Tomographic Reconstructions of Cryo-Preserved Hippocampal PSDs.
Ten-nanometer cross-sections through final tomographic reconstruction of cryopreserved hippocampal PSDs. Horizontal arrows indicate areas of dense protein,
vertical arrows indicate areas without protein density and asterisks highlight detergent
resistant membranes attached to the PSDs. Gold is used as a fiducial marker to align
image series during reconstruction. Scale bar = 100 nm.
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Figure 4.10. Tomographic Reconstructions of Cryo-Preserved Cerebellar PSDs with
Dense Morphology.
Ten-nanometer cross-sections through final tomographic reconstruction of cryopreserved cerebellar PSDs categorized as dense in morphology, similar to cortical and
hippocampal PSDs. Horizontal arrows indicate areas of dense protein, vertical arrows
indicate areas without protein density and asterisks highlight detergent resistant
membranes attached to the PSDs. Gold is used as a fiducial marker to align image
series during reconstruction. Scale bar = 100 nm.
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Figure 4.11. Tomographic Reconstructions of Cryo-Preserved Cerebellar PSDs with
Granular Morphology.
Ten-nanometer cross-sections through final tomographic reconstruction of cryopreserved cerebellar PSDs categorized as granular in morphology. Horizontal arrows
indicate small areas of dense protein, approximately 40 nm in diameter, vertical arrows
indicate areas without protein density and asterisks highlight detergent resistant
membranes attached to the PSDs. Gold is used as a fiducial marker to align image
series during reconstruction. Scale bar = 100 nm.
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Figure 4.12. Tomographic Reconstructions of Cryo-Preserved Cerebellar PSDs with
Lacy Morphology.
Ten-nanometer cross-sections through final tomographic reconstruction of cryopreserved cerebellar PSDs categorized as lacy in morphology. Vertical arrows indicate
areas without protein density and asterisks highlight detergent resistant membranes
attached to the PSDs. Gold is used as a fiducial marker to align image series during
reconstruction. Scale bar = 100 nm.
86

Figure 4.13. PSD Protein-to-Volume Ratios Measured from Cryo Tomographic
Reconstructions.
A) Histogram of protein-to-volume ratios for PSDs isolated from each region as
measured from tomographic reconstructions of cryo-preserved PSDs. N = 12. B)
Surface rendering of representative cryo-preserved hippocampal PSD created in
Amira. Scale bar = 100 nm.
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Cerebellar PSDs
Hippocampal PSDs
Cortical PSDs

Surface Area ± SEM (μm2)

Thickness ± SEM (nm)

P-to-V Ratio ± SEM

0.24 ± 0.04
0.28 ± 0.04
0.27 ± 0.06

210 ± 13
112 ± 9
169 ± 22

0.29 ± 0.04
0.31 ± 0.01
0.35 ± 0.03

Table 4.1. PSD Surface Area, Thickness and Protein-to-Volume Ratio Measured from
Cryo Tomographic Reconstructions.
Surface Area, Thickness and PSD Protein-to-Volume Ratios (P-to-V) for PSDs isolated
from each region as measured from tomographic reconstructions of cryo-preserved
PSDs. N = 12.
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Cerebellar PSDs
Hippocampal PSDs
Cortical PSDs

Surface Area ± SEM (μm2)
Cryo-Preserved Negative Stain
0.24 ± 0.04
0.32 ± 0.09
0.28 ± 0.04
0.21 ± 0.04
0.27 ± 0.06
0.37 ± 0.06

Cerebellar PSDs
Hippocampal PSDs
Cortical PSDs

Thickness ± SEM (nm)
Cryo-Preserved Negative Stain
210 ± 13
115 ± 11
112 ± 9
94 ± 7
169 ± 22
93 ± 5

Table 4.2. PSD Surface Area and Thickness Compared from Cryo and Negative Stain
Tomographic Reconstructions.
Surface area and thickness for PSDs isolated from each region as measured from
tomographic reconstructions of cryo-preserved and negatively stained PSDs. N = 12.

89

Chapter 5. Protein Composition of Postsynaptic Densities from Adult Rat
Cerebella, Hippocampi, and Cerebral Cortices
5.1. PSD Protein Staining Patterns
In order to determine whether PSD protein composition differs across the brain,
the global protein staining pattern was first compared between PSDs isolated from
adult rat cortices, hippocampi, and cerebella. PSD fractions from each region were
separated by SDS-PAGE and stained using Amersham Deep Purple Stain (GE
Healthcare) following SDS-PAGE (Figure 5.1). The PSD protein profiles exhibit similar
overall staining patterns; however, there were specific differences in band intensity
between the PSD types, confirming that PSD protein composition does vary across the
brain.

In Figure 5.1, the protein bands whose intensities were at least twice the

average band intensity within each sample were considered major bands and are
identified with asterisks. A band just above 250 kDa is highlighted for all PSD types,
while a band at approximately 100 kDa is only highlighted in cortical and hippocampal
PSDs. The band above 250 kDa could represent Shank scaffolds which are typically
between 190 kDa and 220 kDa, while the band around 100 kDa could represent
scaffold PSD-95, which is abundant in cortical (Cheng et al., 2006) and hippocampal
PSDs (Dosemeci et al., 2007). The band at approximately 100 kDa is present in the
cerebellar PSD fraction; however it was not determined to be a major band within the
cerebellar PSD fraction. Cortical and hippocampal PSDs share an additional intense
band highlighted at 45 kDa, which is the approximate molecular weight of PSD scaffold
Homer.

There are also unique and intensely stained bands within each individual

sample; 70 kDa in cortical PSDs, 50 kDa in hippocampal PSDs, and 27 kDa and 47
kDa in cerebellar PSDs. These results confirm previous studies which have shown
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compositional differences in PSD fractions from different brain regions identifiable by
SDS-PAGE (Carlin et al., 1980) and are consistent with more recent proteomic
approaches (Cheng et al., 2006).

These approaches have been successful in

determining and quantifying the protein composition of PSD fractions, but not of
individual PSDs, which as described before are unique heterogeneous structures.
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Figure 5.1. Comparison of Isolated PSD Protein Profiles.
Amersham Deep Purple stained gel of SDS-PAGE-separated proteins from PSDs
isolated from cortices, hippocampi, and cerebella. The major bands in each lane are
indicated with asterisks and molecular weights (kDa) are indicated to the left of the gel.
Three micrograms of total protein were loaded into each lane.
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5.2. Immunogold Labeling of Major PSD Proteins
To further refine our understanding of PSD composition and structure, and to
determine how PSD protein composition and organization differ across the brain,
immunogold labeling was employed.

Immunogold labeling, described in detail in

Chapter 2.4, combines antibody specific identification of proteins and electron
microscopy through the use of electron dense gold-conjugated secondary antibodies.
Briefly, PSDs are applied to grids, proteins of interest are tagged with a protein specific
primary antibody and gold-conjugated secondary antibody, PSD are then negatively
stained and individually imaged. From the resulting micrographs I can measure the
labeling density and distribution for the protein of interest and determine if there are
differences across and within PSD groups.

Three distinct protein classes were

investigated: scaffolds, signaling proteins, and neurotransmitter receptors and the
results are described in the following sections. Representative examples of the primary
data generated from the immunogold labeling protocol are shown in Figures 5.2-5.6.
The first group of proteins targeted through immunogold labeling were PSD
scaffolds, which form the core structure of the PSD and serve to anchor
neurotransmitter receptors and organize signaling proteins (Okabe, 2007). Antibodies
against eight major PSD scaffolds were employed, including α-actinin, actin, PSD-95,
Homer, SAP102, Shank1, Shank2, and Shank3 to test whether the composition and
organization of the PSD scaffold network differs across brain regions. PSDs isolated
from cerebella, hippocampi, and cortices immunogold labeled for scaffolds α-actinin,
actin, PSD-95, and Homer are shown in Figure 5.2.

PSDs labeled for additional

scaffolds SAP102, Shank1, Shank2, and Shank3 are shown in Figure 5.3.
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The second group of proteins targeted in immunogold labeling experiments
included calcium signaling proteins αCaMKII, βCaMKII, and calmodulin, CaM. CaM is
the calcium-transducing molecule of the synapse, which has many targets including
αCaMKII and βCaMKII.

The αCaMKII and βCaMKII isoforms of CaMKII are the

neuronal isoforms of the protein, which when activated phosphorylate a variety of
synaptic and PSD proteins (Dosemeci and Jaffe) and are crucial for learning and
memory (Lisman et al., 2012).

βCaMKII also binds both monomeric and F-actin,

regulating actin polymerization in response to calcium influxes. This suggests that
βCaMKII plays a role in regulating molecular transport and synaptic architecture
(Swulius and Waxham, 2008, Sanabria et al., 2009, Hoffman et al., 2013). Cerebellar,
hippocampal and cortical PSDs immunogold labeled for αCaMKII, βCaMKII, and CaM
are presented in Figure 5.4.
Neurotransmitter receptors were the third group of proteins targeted through
immunogold

labeling

experiments.

Antibodies

against

several

postsynaptic

neurotransmitter receptors, including glutamate receptors: NR1, NR2a, NR2b, GluR1,
GluR2, GluR1/5, and GluRδ2, and a GABA receptor antibody, were used in an attempt
to determine labeling densities for these proteins in the PSDs isolated from each brain
region. However, I did not detect labeling above background for NR2a, GluR1, GluR2,
GluR1/5, GluRδ2, or GABA; only the antibodies against NR1 and NR2b positively
labeled PSDs. These results may lead one to conclude that these receptors are not
present in the isolated PSDs due to the two detergent treatments which remove the
plasma membranes; however, it is also plausible that the epitopes to which the
antibodies were raised are masked when these proteins are incorporated into the
native PSD structure, preventing labeling under my experimental conditions. Figure 5.5
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includes PSDs isolated from each region immunogold labeled for NMDA receptors
subunits NR1 and NR2b.
Lastly, PSDs were also immunogold labeled for the proteasome, which in
response to synaptic activity, is activated and recruited to synapses (Ehlers, 2003,
Bingol and Schuman, 2006, Djakovic et al., 2009, Bingol et al., 2010) where it can
degrade PSD scaffolds PSD-95 (Colledge et al., 2003), GKAP and Shank (Ehlers,
2003).

This suggests that the ubiquitin proteasome system provides a role in the

activity-dependent structural reorganization of PSDs underlying synaptic plasticity. An
antibody against a subunit of the proteasome lid was used to immunogold PSDs from
each region (Fig 5.6).
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Figure 5.2. PSDs Immunogold Labeled for Scaffolds: α-Actinin, Actin, PSD-95 and
Homer.
Representative negative stain electron micrographs of PSDs isolated from cerebella,
hippocampi, or cortices immunogold labeled for PSD scaffolds: α-actinin, actin, PSD-95
and Homer. Gold = 12 nm. Scale bar = 100 nm.
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Figure 5.3. PSDs Immunogold Labeled for Scaffolds: SAP102, Shank1, Shank2, and
Shank3.
Representative negative stain electron micrographs of PSDs isolated from cerebella,
hippocampi, or cortices immunogold labeled for PSD scaffolds: SAP102, Shank1,
Shank2, and Shank3. Gold = 12 nm. Scale bar = 100 nm.
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Figure 5.4. PSDs Immunogold Labeled for Ca2+ Signaling Proteins.
Representative negative stain electron micrographs of PSDs isolated from cerebella,
hippocampi, or cortices immunogold labeled for calcium signaling proteins: αCaMKII
βCaMKII, and CaM. Gold = 12 nm. Scale bar = 100 nm.
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Figure 5.5. PSDs Immunogold Labeled for Neurotransmitter Receptors.
Representative negative stain electron micrographs of PSDs isolated from cerebella,
hippocampi, or cortices immunogold labeled for neurotransmitter receptor subunits
NR1 and NR2b. Gold = 12 nm. Scale bar = 100 nm.
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Figure 5.6. PSDs Immunogold Labeled for the Proteasome.
Representative negative stain electron micrographs of PSDs isolated from cerebella,
hippocampi, or cortices immunogold labeled for the RPT6 subunit of the proteasome
lid. Gold = 12 nm. Scale bar = 100 nm.
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The results of the immunogold labeling experiments are presented in Tables 5.15.3 as well as Figures 5.7 and 5.8. Table 5.1 reports the average labeling density for
each antibody and each PSD group as the average number of gold per unit of area and
as the average number of gold per PSD. Table 5.2 compares the average labeling
density, measured as gold per unit of area, across the different PSD groups for each
antibody to assess trends in protein composition. Each column in Table 5.2 compares
labeling densities of one PSD group directly to another and reports the ratio of the
labeling densities. Table 5.3 reports the percentage of PSDs from each experiment
with gold labeling density above secondary background control experiments. Typically
at least 90% of PSDs from each experiment were measured to have gold labeling well
above background, however this was not always the case and Table 5.3 provides some
unique information about the diversity of PSD protein composition within brain regions.
Figure 5.7 illustrates the data from Table 5.1 in graphical form to provide visualization
for the average labeling densities, reported as gold per unit area. Figure 5.8 presents
three graphs which report labeling for each antibody as the percentage of total labeling
for that PSD group, giving a better picture for individual protein representation within
PSDs.

5.2.1. Scaffold Proteins within and across PSD Groups
As mentioned previously, scaffolds form the core substructure of the PSD,
anchoring neurotransmitter receptors, and organizing signaling proteins (Okabe, 2007).
Antibodies against α-actinin, actin, PSD-95, Homer, SAP102, Shank1, Shank2, and
Shank3 were employed to test whether the composition and organization of the PSD
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scaffold network differs in PSDs across the brain. In PSDs isolated from adult rat
cortices, the most abundant scaffold was PSD-95 which demonstrated a significantly
greater average labeling density than all other scaffold proteins analyzed (Table 5.1
and Figure 5.7). In cerebellar PSDs, labeling densities for α-actinin, Shank1, Shank3,
and actin were approximately equally abundant, and they were significantly greater
than the average labeling for PSD-95, Homer, SAP102, and Shank2 (Table 5.1 and
Figure 5.7). Labeling for α-actinin was the most abundant of all the scaffolds tested in
hippocampal PSDs, while actin, Shank1, PSD-95, Shank3, and Homer were
moderately abundant (Table 5.1 and Figure 5.7). Labeling for shank2 and SAP102
was found to be the least abundant of the scaffolds in each PSD group (Table 5.1 and
Figure 5.8), which was consistent with previous observations that SAP102 is replaced
with scaffold PSD-95 as PSDs developmentally mature (Sans et al., 2000, Petralia et
al., 2005, Zheng et al., 2011).
Labeling densities for each scaffold were also compared across the different
PSD groups (Table 5.2). Of the scaffold proteins evaluated, Shank1 was the only
scaffold that did not change significantly in labeling density between PSDs isolated
from cerebella, hippocampi and cortices, suggesting a fundamental role for Shank1 in
PSDs across the brain.

In contrast, PSD-95 and Homer were found to differ

significantly between all groups (Table 5.2), which was surprising given that PSD-95 is
thought of as the primary PSD scaffold supporting both NMDA and AMPA receptors in
the synaptic plasma membrane (Zheng et al., 2011). Labeling for PSD-95 and Homer
was most abundant in cortical PSDs and least abundant in cerebellar PSDs (Table 5.1
and 5.2). Cortical PSDs also had significantly increased labeling for actin and Shank3
as compared to hippocampal and cerebellar PSDs (Table 5.2). Labeling densities for
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Shank2 and α-actinin in hippocampal and cortical PSDs were significantly increased in
comparison to cerebellar PSDs (Table 5.2).
Of the cortical and hippocampal PSDs imaged in scaffold immunogold labeling
experiments, at least 85% were measured with gold labeling densities above
background (Table 5.3). With several exceptions, 95% of cerebellar PSDs were found
to have positive labeling for the scaffolds analyzed (Table 5.3). Only 45% of cerebellar
PSDs had positive labeling for Homer, 70% for PSD-95 and 75% for Shank2 (Table
5.3). Given the low labeling densities for cerebellar PSDs labeled for Homer, PSD-95
and Shank2, these percentages were not entirely surprising. However, labeling for
SAP102 was the second lowest within cerebellar PSDs and yet 100% of cerebellar
PSDs positively labeled for SAP102 (Table 5.3). The differential labeling densities for
scaffolds across the PSD groups and the variability of labeling for scaffolds within
cerebellar PSDs, compared to both cortical and hippocampal PSDs, suggest that the
PSD scaffold network changes across the brain even within specific brain areas such
as the cerebellum. It is also of interest to note that while scaffolds were targeted by 8
of the 13 (62%) antibodies used in this analysis, labeling for scaffolds only represented
47% of total gold labeling for cortical PSDs, 36% for cerebellar PSDs and 27% for
hippocampal PSDs (Figure 5.8), suggesting that there are other proteins that comprise
the hippocampal and cerebellar scaffold networks that were not targeted in this
analysis or it is plausible that PSDs from hippocampi and cerebella have less
scaffolding than cortical PSDs.

5.2.2. Signaling Molecules within and across PSD Groups
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Antibodies against the  and  isoforms of CaMKII, the most abundant proteins
in PSDs, and CaM, the calcium signal transducing activator, were used to determine
labeling densities in the region specific PSDs. In PSDs isolated from cerebral cortices,
the average labeling density for αCaMKII was significantly greater than labeling for
βCaMKII, while in PSDs isolated from cerebella and hippocampi the average labeling
densities were reversed with labeling significantly greater for βCaMKII than αCaMKII
(Table 5.1 and Figure 5.7). The ratio of αCaMKII to βCaMKII was approximately 3:2 for
cortical PSDs, 2:3 for hippocampal PSDs and 1:4 for cerebellar PSDs (Table 5.1 and
Figure 5.7). βCaMKII was present in PSDs at higher concentrations than expected,
suggesting stronger interactions between PSDs and the actin network as βCaMKII can
uniquely bind monomeric and F-actin unlike αCaMKII (Swulius and Waxham, 2008,
Sanabria et al., 2009, Hoffman et al., 2013).
Labeling for CaM was present in all PSD groups, although the average labeling
densities were significantly lower than labeling densities for αCaMKII and βCaMKII
(Table 5.1 and Figure 5.7) and labeling for CaM was not statistically different between
the PSD groups (Table 5.2). Labeling densities for βCaMKII were different between all
PSD groups, with labeling ratios between PSD types ranging from 1.6 to 2.9 (Table
5.2). Cortical and hippocampal PSDs had significantly increased labeling, 11x and 8.4x
respectively, for αCaMKII as compared to cerebellar PSDs (Table 5.2). Interestingly,
40% of cerebellar PSDs did not show labeling for αCaMKII over background, while
labeling for αCaMKII was above background in 100% of cortical and hippocampal
PSDs immunogold labeled, further supporting the heterogeneity of PSDs isolated from
the cerebellum (Table 5.3).
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Together the average gold labeling densities for both isoforms of CaMKII
represented 41% of the total labeling within cortical PSDs (Figure 5.8). Cerebellar
PSDs had the lowest labeling densities for both αCaMKII and βCaMKII, which together
represented 26% of the total gold labeling for all proteins targeted within cerebellar
PSDs (Figure 5.8). Hippocampal PSDs had the greatest labeling for βCaMKII and the
labeling for CaMKII represented 50% of the total gold labeling for all proteins targeted
within hippocampal PSDs (Figure 5.8). When combined, labeling for αCaMKII and
CaMKII was 2-4 times greater than for all other proteins evaluated, consistent with a
major role for CaMKII in establishing the structure of PSDs from the three regions
evaluated.

5.2.3. Neurotransmitter Receptors within and across PSD Groups
Immunogold labeling for NMDA receptor subunit NR1 was statistically greater
than the labeling for the NR2b subunit in both cortical and hippocampal PSDs (Table
5.1 and Figure 5.7), while labeling densities for NR1 and NR2b were not different in
PSDs isolated from cerebella (Table 5.1 and Figure 5.7). NR1 is the necessary subunit
to form ion conducting NMDA receptors (Kumar and Mayer, 2013), therefore these
results suggest that NR subunits other than NR2b are likely present in cortical and
hippocampal PSDs to form the obligate heteromeric complexes.

In contrast, the

majority of NMDA receptors in the cerebellum associated with PSDs may be largely
composed of NR1/NR2b subunits. Given that at least 90% of all PSDs labeled above
background for NR1 and 100% of all PSDs labeled for NR2b, it is likely that the majority
of the PSDs analyzed in the immunogold analysis were from glutamatergic synapses.
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Comparing the average labeling densities across PSD types, there were no significant
differences in NR1 or NR2b labeling with the exception that hippocampal PSDs had
1.5x more labeling for NR2b when compared to cortical PSDs (Table 5.3). It is also of
interest to note that while the labeling densities of NR1 and NR2b did not change
significantly between most PSD groups, the labeling for both subunits represented 19%
of total labeling for cerebellar PSDs while only representing 12% and 9% of the total
labeling for hippocampal and cortical PSDs, respectively.

5.2.4. Proteasome within and across PSD Groups
Given recent evidence suggesting that the ubiquitin proteasome system (UPS)
plays a crucial role in activity-dependent plasticity (Ehlers, 2003, Bingol and Schuman,
2006, Djakovic et al., 2009), I performed immunogold labeling experiments on each
PSD group with an antibody against the proteasome. Labeling for the proteasome was
present in all PSD types (Table 5.1 and Figure 5.7), but the labeling density was
significantly increased in hippocampal and cerebellar PSDs compared to cortical PSDs
(Table 5.2). Interestingly, only 65% of cortical PSDs labeled for the proteasome (Table
5.3) and labeling for the proteasome represented only 2% of total labeling in cortical
PSDs as compared to 7% in hippocampal PSDs and 12% in cerebellar PSDs (Figure
5.8). These results confirm that proteasomes are present within PSDs across the brain
and imply that synapses from different regions of the brain may differentially engage
the UPS for structural modification of the PSD scaffold.

5.2.5. Additional Trends across PSD Groups
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Figure 5.8 illustrates the percentage each antibody represents of the total
immunogold labeling for each PSD group, allowing visualization of the protein
composition of each PSD type. In order to further compare the protein composition of
the PSDs isolated from cortices, hippocampi and cerebella, the four most abundant
proteins in each PSD group, as determined by Figure 5.8, were compared. The most
abundant proteins in cortical PSDs were αCaMKII, βCaMKII, PSD-95 and actin (Figure
5.8 and Table 5.1), which was consistent with previous work ranking proteins in PSD
fractions isolated from cerebral cortices (Dosemeci et al., 2007). The most abundant
proteins within hippocampal PSDs were βCaMKII, αCaMKII, NR1, and the proteasome,
while βCaMKII, the proteasome, NR1, and NR2b were the most abundant components
of cerebellar PSDs (Figure 5.8 and Table 5.1). Interestingly PSD-95 was not one of the
four most abundant proteins within hippocampal and cerebellar PSDs, but no other
scaffolds were within the most abundant proteins either for these PSD types. The
proteasome, however, was included in hippocampal and cerebellar PSDs as a major
component, further suggesting that synapses from these brain areas may differentially
utilize proteasomal degradation.
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α-actinin
Actin
PSD-95
Homer
SAP102
Shank1
Shank2
Shank3
αCaMKII
βCaMKII
CaM
NR1
NR2b
Proteasome

Gold/μm2 ± SEM
Cereb.
Hippo.
Cortical
27 ± 4
45 ± 7
52 ± 8
24 ± 3
30 ± 3
66 ± 11
12 ± 4
27 ± 5
87 ± 11
9±3
24 ± 5
49 ± 7
8±2
17 ± 3
10 ± 2
25 ± 5
30 ± 5
33 ± 6
5±2
13 ± 3
16 ± 4
25 ± 4
26 ± 5
59 ± 11
18 ± 7
153 ± 17 199 ± 21
80 ± 17 232 ± 21 127 ± 12
12 ± 3
17 ± 3
9±3
39 ± 8
56 ± 5
45 ± 8
32 ± 4
40 ± 4
26 ± 3
46 ± 9
54 ± 9
13 ± 7

Gold/PSD ± SEM
Cereb.
Hippo.
Cortical
10 ± 2
18 ± 4
21 ± 4
18 ± 2
18 ± 3
31 ± 7
4±1
9±3
32 ± 4
2±1
5±1
14 ± 3
3±1
6±2
4±1
10 ± 2
9±2
11 ± 2
1±1
3±1
3±1
9±2
8±2
17 ± 4
5±2
41 ± 10
52 ± 9
18 ± 3
59 ± 8
39 ± 6
3±1
8±3
3±2
11 ± 2
23 ± 4
14 ± 3
9±2
13 ± 2
11 ± 2
15 ± 3
20 ± 5
4±2

Table 5.1. Summary of Immunogold labeling Experiments.
Average labeling densities reported as gold/μm2 and gold/PSD for all immunogold
labeling experiments. Antibodies were used against a subset of PSD scaffolds,
calcium signaling proteins, neurotransmitters and the proteasome. N = 20 for each
PSD group and antibody combination.
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Figure 5.7. Bar Graph of Immunogold Labeling Results.
Bar graph illustrating the average labeling densities reported as gold/μm2 ± SEM for all
immunogold labeling experiments. Antibodies were used against a subset of PSD
scaffolds, calcium signaling proteins, neurotransmitters and the proteasome. N = 20
for each PSD group and antibody combination.
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α-actinin
Actin
PSD-95
Homer
SAP102
Shank1
Shank2
Shank3
αCaMKII
βCaMKII
CaM
NR1
NR2b
Proteasome

CX vs. CB

CX vs. Hippo

Labeling Density (CX ÷ CB)

Labeling Density (CX ÷ H)

1.9 ↑*
2.7 ↑**
7.3 ↑**
5.6 ↑**
1.2
1.3
3.5 ↑*
2.3 ↑*
11 ↑**
1.6 ↑*
0.7
1.2
0.8
0.3 ↓*

1.1
2.2 ↑*
3.2 ↑**
2.1 ↑*
0.6
1.1
1.3
2.3 ↑*
1.3
0.6 ↓**
0.5
0.8
0.7 ↓*
0.2 ↓*

Hippo vs. CB
Labeling Density (H ÷ CB)

1.7 ↑*
1.2
2.3 ↑**
2.7 ↑*
2.3 ↑*
1.2
2.8 ↑*
1
8.4 ↑**
2.9 ↑**
1.4
1.4
1.2
1.2

Table 5.2. Immunogold Labeling Densities Compared Across Regions.
Comparisons of immunogold labeling across PSD groups. Ratios were considered
significant if P < 0.05 in a 2-tailed t test, indicated with a single asterisk (*); boldface
and double asterisks (**) indicated a P ≤ 0.001. Arrows indicated whether the ratios
represented increased (↑) or decreased (↓) immunogold labeling. N = 20 for each PSD
group and antibody combination.
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α-actinin
Actin
PSD-95
Homer
SAP102
Shank1
Shank2
Shank3
2D5
CBβ1
CaM
NR1
NR2b
RPT6

PSDs with Gold above Background
Cerebellar PSDs Hippocampal PSDs
Cortical PSDs
100%
100%
100%
95%
100%
100%
70%
95%
100%
45%
85%
100%
100%
90%
90%
95%
95%
95%
75%
90%
85%
100%
100%
100%
60%
100%
100%
95%
100%
100%
85%
95%
80%
90%
100%
100%
100%
100%
100%
90%
100%
65%

Table 5.3. Fractions of PSDs with Gold Labeling above Background.
Percentage of PSDs included in the immunogold labeling experiments with gold
labeling above background gold measurements. N = 20 for each PSD group and
antibody combination.
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Figure 5.8. Percentage of Total Immunogold Labeling.
Bar graphs illustrating the percentage of total immunogold labeling each antibody
represented for the different PSD groups.
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5.3. Spatial Analysis of Gold Labeling
While measuring labeling densities for PSDs immunogold labeled for scaffold
PSD-95, it was observed that gold appeared clustered on cerebellar PSDs, a pattern
not observed with cortical or hippocampal PSDs (Fig. 5.9). A Ripley’s K-function based
spatial analysis was employed to test whether the spatial distribution of PSD-95 in
cerebellar PSDs was statistically non-random. A description of the analysis can be
found in Chapter 2, section 2.4, and examples of random and non-random gold labeling
are illustrated in Figure 5.10.

Included in Figure 5.10 are two micrographs of

immunogold labeled PSDs (Fig. 5.10.A), one with random gold distribution and the
other with non-random distribution, the 2D models of the same PSDs (Fig. 5.10.B) and
the H-functions which result from the Ripley’s K-function analysis (Fig. 5.10.C). In
Figure 5.10.C, the horizontal black lines through 0 on the y-axis represents complete
spatial randomness, the black traces represent the minimum and maximum envelopes
for random distribution based on the simulated data of complete spatial randomness,
and the red traces represent the distribution of the gold from the data. If the red trace
falls outside of the minimum or maximum envelope, the distribution is non-random, as
shown in the right column of Figure 5.10. If the red trace stays within the min and max
envelopes, the gold is distribution is considered random as shown in the left column of
Figure 5.10. The PSD with non-random distribution in Figure 5.10 is a cerebellar PSD
immunogold labeled for PSD-95, and the distribution of PSD-95 labeling is clearly nonrandom at both short (~ 200 nm) and long (~ 800 nm) distances, consistent with
statistically significant clustering.
Spatial analysis for PSD-95 labeling was assessed for 21 cerebellar PSDs, of
which 20 PSDs (95%) were determined to have non-random distribution for gold
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labeling PSD-95 (Table 5.4).

Seventeen of the cerebellar PSDs with non-random

distribution deviated from random at larger distances suggesting clustering (Table 5.4)
as opposed to non-random dispersed points, indicating that PSD-95 is typically
organized in clusters within cerebellar PSDs, when present, as labeling for PSD-95 was
below controls in approximately 30% of cerebellar PSDs.

For comparison, spatial

analysis of the gold labeling of PSD-95 in hippocampal and cortical PSDs was also
determined (Table 5.4). In total, 71% (12 of 17) of hippocampal PSDs and only 54%
(13 of 24) of cortical PSDs were categorized as having non-random gold distribution
compared to the 95% (20 of 21) of cerebellar (Table 5.4). The number of hippocampal
(7 of 17, 41%) and cortical PSDs (11 of 24, 46%) with gold distribution categorized as
clustering was also significantly less than cerebellar PSDs (17 of 21, 81%) (Table 5.4),
confirming the visual observation that gold labeling PSD-95 clustered more often in
cerebellar PSDs.
Spatial analysis was also performed on cerebellar, hippocampal, and cortical
PSDs immunogold labeled against βCaMKII, to determine if cerebellar PSDs display
increased non-random distribution for proteins other than PSD-95 as compared to other
PSD types (Table 5.4). Gold distribution for βCaMKII, which was the most abundant
protein in cerebellar and hippocampal PSDs and the second most abundant in cortical
PSDs (Table 5.1), was found to have similar levels of non-random distribution between
the different PSD groups, approximately 64%. Hippocampal PSDs had the highest
percentage of PSDs with clustering of gold targeting βCaMKII (11 of 25, 44%), followed
by cerebellar PSDs (7 of 20, 35%) and cortical (10 of 25, 25%), suggesting that
increased non-random distribution and clustering in cerebellar PSDs is possibly limited
to PSD-95 (Table 5.4). To test this, the spatial distribution of gold targeting the NR1
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subunit of the NMDA receptor complex, which is anchored in the synaptic plasma
membrane by PSD-95, was also analyzed by Ripley’s K-function analysis.
Interestingly, the level of non-random distribution for NR1 followed the same trend as
PSD-95, with 70% (7 of 10) of cerebellar PSDs having gold distribution categorized as
non-random, while only 53% (8 of 15) of hippocampal PSDs and 45% (5 of 11) of
cortical PSDs were categorized as having non-random gold distribution (Table 5.4).
The same trend was also evident for gold distribution consistent with clustering; gold
distribution for NR1 was clustered in 50% of cerebellar PSDs, 33% of hippocampal and
only 18% of cortical PSDs (Table 5.4). These results first illustrate that a threshold
exists for non-random distribution and second suggest that organization of proteins
within cerebellar PSDs deviates from random more often than the organization of
proteins from cortical and hippocampal PSDs.

Future work will be required to

determine the full functional significance of non-random distribution and clustered
distribution. However, given that the trend for both non-random and clustered NR1
gold distribution was consistent with although not as robust as PSD-95, it is plausible
that NR1 clustering may be in part the result of interactions between the NMDA
receptor complex and PSD-95.
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Figure 5.9. PSDs Immunogold Labeled for PSD-95.
Representative electron micrographs of negatively stained cerebellar, hippocampal and
cortical PSDs immunogold labeled for PSD scaffold PSD-95. Gold = 12 nm. Scale Bar
= 100 nm.
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Figure 5.10. Ripley’s K-Function Analysis of Random and Non-Random Gold
Distribution.
A) Electron micrographs are representative immunogold labeled and negatively stained
PSDs with either random or non-random gold distribution.
B) Corresponding
coordinate models for the PSD boundary and gold distribution from the micrographs in
A. C) The H-functions are the result of the Ripley’s K-function analysis comparing
examples of complete spatial randomness to the actual gold distribution. When the red
trace, which represents the distribution of gold from A, deviates outside of the minimum
or maximum envelopes, the black traces, the distribution deviates from random. See
Chapter 2.5 for more information. Scale bar = 100 nm.
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Number of PSDs with Non-Random Gold Distribution
βCaMKII
PSD-95
NR1
Cerebellar
13 of 20 (65%) 20 of 21 (95%) 7 of 10 (70%)
Hippocampal
16 of 25 (64%) 12 of 17 (71%) 8 of 15 (53%)
Cortical
16 of 25 (64%) 13 of 24 (54%) 5 of 11 (45%)
Number of PSDs with Gold Clustering
βCaMKII
PSD-95
NR1
Cerebellar
7 of 20 (35%)
17 of 21 (81%) 5 of 10 (50%)
Hippocampal
11 of 25 (44%)
7 of 17 (41%)
5 of 15 (33%)
Cortical
10 of 25 (25%) 11 of 24 (46%) 2 of 11 (18%)

Table 5.4. Summary of Gold Distribution Data by Ripley’s K-Function Analysis.
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Chapter 6. Discussion
For decades, numerous studies have focused on unraveling the composition
and structure of PSDs, as they play an essential role in establishing and modulating
synaptic transmission (Okabe, 2007, Sheng and Hoogenraad, 2007). Despite these
efforts, there remain significant gaps in the understanding of the detailed anatomical
structure of the PSD and the spatial distribution of the proteins from which it is
composed. This dissertation presents the first study to employ stain and cryo electron
tomography to directly compare PSDs isolated from cerebella, hippocampi and cortices
and couple that analysis with immunogold labeling to advance the understanding of the
fine morphology and protein composition of the PSD.
Biochemical isolation of PSDs, as first established in the 1970’s (Cotman et al.,
1974, Cohen et al., 1977), produces an enriched PSD fraction, that is morphologically
and compositionally similar to PSDs in situ (Kennedy, 1997) and allows for analysis of
individual PSDs which is crucial given that PSDs are heterogeneous in nature
(Petersen et al., 2003, Swulius et al., 2012).

PSDs were isolated from adult rat

cerebella, hippocampi and cortices because these brain regions contain unique
populations of neuronal cells and are amenable to straightforward isolation. Neuronal
cells within cerebral cortices and hippocampi are primarily pyramidal cells, while
purkinje cells and granule cells are the major neuronal cells of the cerebellum (Cotman
et al., 1974, Rollenhagen and Lubke, 2006). Therefore, it is believed that the vast
majorities of PSDs isolated were derived from these neuronal cell types and are from
excitatory glutamatergic synapses as confirmed by immunogold labeling experiments.
However, it is possible that PSDs from other neuronal cell populations were enriched
during the PSD isolation procedure, although they are likely a minor contribution.
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Final PSD fractions, produced by first enriching for synaptosomes and then
removing all detergent soluble membrane and presynaptic material through detergent
treatments and centrifugations on discontinuous sucrose gradients, were all enriched
for PSD scaffold PSD-95 and depleted of synaptic marker SV2 (Figure 3.2) as
previously shown by Western blot analysis (Swulius et al., 2010). Enrichment of PSD95 was expected as PSD-95 is a known component of forebrain (Dosemeci et al.,
2007) and hippocampal PSDs (Dosemeci et al., 2006). Depletion of SV2 was also
anticipated since presynaptic terminals are removed in the isolation procedure as
shown in the negative stain micrographs of synaptic junctions (Figure 3.3), which were
morphologically similar to synaptic junction fractions previously described (Cotman et
al., 1974, Matus and Taff-Jones, 1978). For each region, SDS-PAGE protein profiles
were similar between homogenate and synaptosome fractions (Figure 3.4) as
previously reported for forebrain tissue (Swulius et al., 2010). PSD protein profiles also
shared many of the same bands as homogenate and synaptosomal fractions but
contained protein bands significantly enriched from previous fractions, especially in the
higher molecular weight range (Figure 3.4) which likely represent PSD scaffolds
including PSD-95 (100 kDa) and Shank (~120-240 kDa) (Sheng and Kim, 2011). The
protein profiles for the individual PSD fractions from cerebella, hippocampi and cortices
were also different (Figure 3.4) confirming that the protein composition of PSDs is
varied across brain regions (Carlin et al., 1980, Cheng et al., 2006).
Initial morphologic comparisons of PSDs from negative stain micrographs
revealed both similarities and differences (Figures 3.8-3.10). Overall, they appeared
similar in dimensions and texture, yet some cerebellar PSDs qualitatively appeared to
have less protein density than other cerebellar PSDs and were distinct from both
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hippocampal and cortical PSDs. A quantitative assessment of surface area determined
that PSDs from cerebella, hippocampi and cortices are similar in size with the average
surface areas equivalent at approximately 0.35 μm2 with a peak surface area of 0.2
μm2 (Figure 3.11), comparable to surface areas measured for isolated forebrain PSDs
(Swulius et al., 2010). This was unexpected as PSD areas have been reported to vary
greatly, as measured through serial electron microscopy of fixed tissue sections,
between adult rat hippocampi, 0.069 μm2, (Harris and Stevens, 1989) and cerebella,
0.15 μm2, (Harris and Stevens, 1988), reviewed in (Harris and Weinberg, 2012). Note
that the average PSD areas reported in this dissertation, similar to previously published
PSD areas from this lab (Swulius et al., 2010), are larger than the values reported from
serial sectioning of fixed tissue (Harris and Stevens, 1988, 1989, Harris and Weinberg,
2012) and this will be discussed in more detail later in the discussion.
Negative stain and cryo electron tomographic reconstructions of isolated PSDs
were used to resolve the morphologic structures of PSDs isolated from cerebella,
hippocampi and cortices, and revealed both similarities and differences (Figures 4.24.12).

Overall, the majority of PSDs were similar in texture but there were clear

distinctions in the organization of protein modules within PSDs from the different
regions. Cortical and hippocampal PSDs were disc-shaped and generally displayed
densely packed areas of protein with occasional areas of low or absent protein density.
These morphological features are consistent with previous descriptions of PSDs
isolated from hippocampi (Wu and Siekevitz, 1988) and cerebral cortices (Cohen et al.,
1977, Carlin et al., 1980) where the authors noted the cup or disc-shaped morphology
and also described PSD substructure as being composed of both particles (13-28 nm)
and filaments. Areas of less protein density in the PSD center (Cohen et al., 1977,
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Cohen and Siekevitz, 1978, Carlin et al., 1980) or openings in the PSD mesh (Petersen
et al., 2003) have also been described previously and are consistent with the findings
reported here.
Most striking was comparison of PSDs from the cerebellum. Three distinct types
of morphology were apparent, which could be categorized by the packing and
organization of protein substructures. One type, similar to the morphological features
of PSDs from cortices and hippocampi, showed a relatively high protein packing
density obscuring some of the fine detail.

This dense type of cerebellar PSD

represented ~ 41% of cerebellar PSDs. Cerebellar PSDs more granular in texture
represented ~ 24% of cerebellar PSDs and were composed of smaller (~ 40nm) protein
regions than dense cerebellar PSDs, while latticelike cerebellar PSDs composed ~
35% of all cerebellar PSDs and exhibited less dense packing of the protein
substructure. My description of the latticelike cerebellar PSDs is mostly consistent with
a previous morphologic description of cerebellar PSDs as disc-shaped and latticelike
(Carlin et al., 1980).

The previously described latticelike cerebellar PSDs were

postulated to be inhibitory PSDs (Carlin et al., 1980), however the immunogold labeling
experiments presented here indicate that the vast majority of PSDs isolated using our
protocol were from glutamatergic synapses. Future work will be required to relate
these morphologically distinct PSDs to both their neuronal type of origin and the
functional significance of their structural differences.
I also determined that a high proportion, 62%, 63% and 78% respectively, of
hippocampal, cerebellar and cortical PSDs had tightly associated lipids. The presence
of lipids associated with PSDs was previously noted (Cohen et al., 1977, Petersen et
al., 2003, Swulius et al., 2010, Swulius et al., 2012). These tightly associated lipids are
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hypothesized to be lipid raft-like (Suzuki, 2002, Petersen et al., 2003, Swulius et al.,
2012) as they are composed of GM1, a raft-associated lipid, in forebrain PSD fractions
(Swulius et al., 2012) and therefore may well play an important role in organizing the
overlying synaptic plasma membrane. Interestingly, immunogold labeling of synaptic
membranes found a significant fraction of AMPARs co-localized with GM1 (Cole et al.,
2010), while another study concluded that ~ 40% of synaptic NMDARs are associated
with synaptic lipid rafts (Delint-Ramirez et al., 2010).

These results suggest that

synaptic lipid rafts are crucial for synaptic organization of glutamate receptors and
therefore synaptic transmission. Additionally, PSD-95, a PSD scaffold, is a known
component of synaptic lipid rafts (Delint-Ramirez et al., 2010) which associates with
cell membranes when palmitoylated (Topinka and Bredt, 1998). Ring-like structures,
approximately 15-20 nm in diameter resembling CaMKII, were also evident in
tomographic reconstructions of PSDs from all brain regions. This was expected, as
CaMKII holoenzymes have previously been visually identified in tomographic
reconstructions of PSDs (Fera et al., 2012) and as my immunogold labeling results
(Table 5.1), discussed in further detail later, confirm that CaMKII is the most abundant
protein in PSDs from cerebella, hippocampi, and cortices.
Additional insights into the morphology of regional PSDs was provided by
quantifying the protein-to-volume ratios and thickness of PSDs imaged through electron
cryotomography. As expected based on cerebellar PSD morphology, cerebellar PSDs
had the largest range of protein-to-volume ratios with half of the PSDs evaluated
uniquely clustered near a ratio much smaller than the calculated average (Figure 4.13).
This suggested that a distinct group of less dense cerebellar PSDs exist with respect to
protein volume, consistent with the visual observations. I expect that increasing the
123

pool of cerebellar PSDs analyzed for protein-to-volume ratios to allow separation by
morphologic type would confirm that separate populations of cerebellar PSDs exist with
respect to protein packing, with the lower protein ratios corresponding to the latticelike
cerebellar PSDs. With respect to PSD thickness, hippocampal PSDs were determined
to be significantly thinner (~ 110 nm) than cerebellar (~ 170 nm) and cortical PSDs (~
210 nm) from cryo-preserved tomographic reconstruction.

This lab has previously

reported a disparity in thickness between traditionally prepared and cryo-preserved
forebrain PSDs (Swulius et al., 2012) and a similar increase in thickness was found in
PSDs across the three brain regions analyzed in this dissertation.

Cerebellar,

hippocampal and cortical PSDs were six, two and three times thicker than those
reported previously in serial sections of fixed and plastic embedded isolated PSDs
(Carlin et al., 1980, Wu and Siekevitz, 1988) or from thin sections of fixed, plastic
embedded neuropil isolated from the same brain regions (Harris et al., 1992).
Interestingly, the thickness of PSDs from these earlier studies (~60-80 nm) was quite
similar even though the studies analyzed PSDs prepared in different ways.

Two

studies (Carlin et al., 1980, Wu and Siekevitz, 1988) used isolated PSDs prepared
using a nearly identical protocol to that employed in the present study, while the other
(Harris et al., 1992) analyzed PSD thickness in serial sections of fixed neuropil.
Therefore, isolating the PSDs from the brain does not appear to cause significant
distortions in their overall morphology.
I favor the explanation that the discrepancy in thickness is due to differences in
methods employed to preserve and image the PSDs.

The use of electron

cryotomography to assess the dimensions and morphology of PSDs does not require
dehydration, fixation or heavy metal staining and has advantages in retaining a more
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accurate representation of the structure of macromolecular assemblies (Murphy and
Jensen, 2007, Koning and Koster, 2009). Consistent with this idea, I showed that
negatively stained PSDs, from cerebella and cerebral cortices, were approximately half
as thick as when cryo-preserved and significantly closer to the values historically
reported for thickness of fixed or negative stained PSDs. Additionally PSD surface
areas were consistent between negative stain and cryotomography suggesting that
staining and dehydrating isolated PSDs selectively compresses the structure in the zdimension. Fixation embedding of tissue may cause underestimation of PSD size in all
three dimensions, and this could account for the differences in surface area mentioned
previously between this work and published studies reporting PSD surface area from
serial sectioned fixed neuronal tissue (Harris and Stevens, 1988, 1989). For these
reasons, I conclude that PSDs may be significantly thicker and extend farther into the
spine compartment than previously recognized, potentially facilitating interactions with
the cytoskeleton and/or spine apparatus that reside more deeply in the spine head.
This idea is supported by tomographic reconstructions of sectioned neuronal tissue
where filamentous structures appear to be directly contacting the PSD bridging it with
the cytoskeletal network (Rostaing et al., 2006).

Additionally, another group

investigated the laminar organization of PSD proteins through immunogold labeling of
sectioned neuronal tissue (Tao-Cheng et al., 2010, Yang et al., 2011) and defined the
core of the PSD to be the area approximately 40 nm under the postsynaptic membrane
and the area 40-120 nm under the postsynaptic membrane to be the PSD contiguous
network which labels for the PSD proteins synGAP and Shank (Tao-Cheng et al., 2010,
Yang et al., 2011).

Together, these results strongly suggest that PSDs extend

significantly farther into the spine compartment, presumably interacting directly with the
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cytoskeletal network through Shank and cortactin. The difference in hippocampal PSD
thickness, compared to cortical and cerebellar PSDs, is also intriguing and suggests
that differences exist in the interactions between integral PSD components that
maintain their three-dimensional architecture.
To compliment the morphological analyses, I investigated the composition and
spatial organization of a set of the major PSD associated proteins within individual
morphologically identified PSD by employing immunogold labeling. Such an approach
has been strategically used in past studies to analyze the presence and distribution of
PSD associated proteins (Dosemeci et al., 2001, Valtschanoff and Weinberg, 2001,
Petersen et al., 2003, DeGiorgis et al., 2006, Swulius et al., 2010). In interpreting the
previous work and the results presented here, it is important to acknowledge that
antibodies to individual proteins each bind with a different affinity and epitopes could be
inaccessible within the PSD structure.

Nevertheless, the amount and patterns of

distribution of labeling in PSDs across the different regions provided unique
comparative insights into the roles played by each protein.
PSD-95 was the most abundant scaffold in cortical PSDs, consistent with earlier
studies (Cheng 2006, Dosemeci 2007), but interestingly was found to differ significantly
between all groups and was not the most abundant scaffold in hippocampal or
cerebellar PSDs. This is surprising given that PSD-95 is thought of as the primary
scaffold supporting glutamate receptors in the synaptic plasma membrane (Zheng et
al., 2011).

In fact, 30% of cerebellar showed no significant labeling for PSD-95 and

when present, spatial analysis showed PSD-95 was clustered. PSD-95 clustering was
not prominent in either hippocampal or cortical PSDs, consistent with previous
descriptions of homogenous labeling for PSD-95 within forebrain PSDs (Petersen et al.,
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2003, DeGiorgis et al., 2006).

This suggests that PSD-95 plays a unique role in

forming structural/functional subdomains in cerebellar PSDs. Perhaps the PSD-95 rich
domains function to cluster AMPA receptors as it has been shown by super resolution
fluorescence microscopy that PSD-95 rich domains were associated with increased
AMPA receptor presence, rather than NMDA receptors in hippocampal neurons
(MacGillavry et al., 2013). However, this idea conflicts with my conclusions from the
Ripley’s K-function analysis of cerebellar PSDs. Future experiments will be required to
determine the function of PSD-95 clusters in cerebellar PSDs.

Additionally, the

antibody used against PSD-95 is known to cross-react with PSD-93 (Sans et al., 2000),
thus it is plausible that PSD-93 represents a portion of the labeling seen with the PSD95 antibody. Unfortunately, labeling experiments with a specific PSD-93 antibody did
not yield labeling above background, which was somewhat surprising since PSD-93 is
believed to be the only member of the PSD-95 family in cerebellar purkinje cells, as
determined by immunohistochemistry (McGee et al., 2001). This could well be the
result of the epitope this antibody recognizes being inaccessible for labeling.
Ultimately, the differential labeling for PSD-95 across each PSD group indicates that
PSD-95 may play distinct roles in the synapses from each of these regions.
Interestingly, the most abundant scaffolds in cerebellar PSDs: α-actinin, Shank1,
Shank3, and actin, all suggested that cerebellar PSDs are integrally connected with the
actin cytoskeletal network, as both α-actinin and Shanks bind actin (Sheng and Kim,
2011), confirming the conclusions from the morphologic analysis. Cerebellar PSDs
were also quite variable in scaffold composition; only 45% of cerebellar PSDs had
positive labeling for Homer, 70% for PSD-95 and 75% for Shank2. Given this variability
within cerebellar PSDs and the differential labeling densities for scaffolds across the
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PSD groups, my findings indicate that the PSD scaffold network changes across the
brain even within specific brain areas such as the cerebellum. Figure 6.1 includes my
hypothesized models for the core organization of PSDs from each region based on my
immunogold labeling results and known protein-interactions. The cortical organization
is similar to the “traditional” model of PSD organization as others have predicted
(Sheng and Kim, 2011), while the models of hippocampal and cerebellar PSD
organization rely more heavily on βCaMKII and actin binding proteins (Figure 6.1). It is
also of interest to note that while scaffolds were targeted by 62% of the antibodies used
in this analysis, labeling for scaffolds represented 47% of total gold labeling for cortical
PSDs, and only represented 36% for cerebellar PSDs and 27% for hippocampal PSDs.
This suggests that there are other proteins that make up the hippocampal and
cerebellar scaffold networks that were not targeted in this analysis and it is also
plausible that PSDs from hippocampi and cerebella have less traditional PSD
scaffolding than cortical PSDs.
I hypothesize that the core structure of hippocampal PSDs is composed
primarily of βCaMKII, the most abundant molecule measured in hippocampal PSDs,
and α-actinin, the most abundant scaffold measured in hippocampal PSDs which
interacts with βCaMKII. Through its interactions with actin, βCaMKII is thought to act
more as a structural molecule within PSDs, and given that βCaMKII, α-actinin and actin
can all bind one another to form a multi-protein assembly. It is easy to visualize this
complex functioning as the primary core of hippocampal PSDs (Figure 6.1). Supporting
this idea, hippocampal PSDs had the least labeling for scaffold molecules and were
significantly thinner than cortical and cerebellar PSDs when measured from cryo
tomographic reconstructions; hippocampal PSDs were also resistant to collapse by
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negative staining, perhaps through stabilization by the βCaMKII, α-actinin and actin
complex. I think it would be of interest to further investigate this possibility by treating
hippocampal PSDs with detergents known to strip away additional PSD proteins (Matus
and Taff-Jones, 1978) to visualize and determine through dual immunogold labeling the
composition of hippocampal PSD substructure.

Labeling for scaffolds and CaMKII

molecules within cerebellar PSDs was also much lower than in cortical PSDs, and I
suspect that given that cerebellar PSDs are thicker, there are cerebellar scaffolds not
yet identified. One study employed a proteomic approach to quantify the proteins in
cerebellar PSD and cortical PSD fractions and, of the 287 proteins identified, 43
proteins differed in quantity between the two samples and several novel proteins were
identified within cerebellar PSDs relating to the protein kinase C pathway (Cheng et al.,
2006). Close inspection of such proteomic studies should provide insights into the
most likely candidates for additional scaffold molecules that would be priorities for
future investigations.
Shank1 was the only scaffold for which immunogold labeling did not differ
significantly across all PSD groups in either amount or spatial distribution, suggesting
that it might play a functionally similar role fundamental to all PSDs. Shank1 interacts
with the actin cytoskeleton and ionotropic and metabotropic glutamate receptors
through scaffolds GKAP and Homer (Naisbitt et al., 1999, Tu et al., 1999, Grabrucker et
al., 2011c). Furthermore, Shank1 is also known to bind to neuroligin, an adhesion
molecule involved in aligning the presynaptic and postsynaptic membranes (Meyer et
al., 2004). These results are consistent with a ubiquitous role for Shank1 as a scaffold
to create local domains of glutamate receptors as well as bridging the PSD scaffold to
the cytoskeletal network.
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CaMKII is the most abundant protein in the PSD (Kennedy et al., 1983, Cheng et
al., 2006, Dosemeci et al., 2007) and is an important molecule regulating synaptic
plasticity (Lisman et al., 2002, Colbran and Brown, 2004).

From the immunogold

labeling experiments, I calculated the ratio of αCaMKII and βCaMKII isoforms to be 3:2
in cortical PSDs, which is relatively consistent with previous findings from forebrain
PSDs (ranging from 3:1-6:1) (McGuinness et al., 1985, Miller and Kennedy, 1985,
Cheng et al., 2006). The smaller α/β CaMKII ratio calculated in this study is likely due in
part to the fact that I determined the amounts of CaMKII in morphologically identified
PSDs and not the bulk PSD fraction, which includes variable amounts of non-PSD
material. Additionally, great care was taken to ensure rapid isolation and cooling of the
brains in order to minimize αCaMKII aggregation (Hudmon et al., 2005) and recruitment
to the PSD (Aronowski et al., 1992, Suzuki et al., 1994, Kolb et al., 1995). This is a
known consequence of ischemia unavoidable during brain isolation and αCaMKII
enriched aggregates could contribute to the increased ratio of αCaMKII to βCaMKII in
fractions analyzed previously by Western blot (McGuinness et al., 1985, Miller and
Kennedy, 1985) and proteomics (Cheng et al., 2006). Interestingly, my results showed
an even greater amount of αCaMKII vs. βCaMKII in hippocampal PSDs (2:3 α/β ratio),
so discrepancies with past reports and those presented here cannot be explained by
the fact that separate analyses on hippocampal and cortical PSDs were performed. My
ratio for cerebellar PSDs also favored βCaMKII over aCaMKII (4:1) and was consistent
with previous work (Miller and Kennedy, 1985).

Interestingly, when analyzed by

immunocytochemistry αCaMKII was only present within purkinje cells of the
cerebellum, with βCaMKII being present throughout the cerebellum (Walaas et al.,
1988). From my immunogold labeling experiments, approximately 60% of the isolated
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cerebellar PSDs were labeled for αCaMKII. It is possible that the subset of isolated
cerebellar PSDs that labeled for αCaMKII were PSDs from purkinje cells while the
PSDs that did not label for αCaMKII were from other cells types, such as granule cells
(Voogd and Glickstein, 1998, Rollenhagen and Lubke, 2006). Overall, the α/β-CaMKII
ratios, which are presumably representative of the isoform composition of the average
PSD CaMKII holoenzyme, suggested that βCaMKII subunit plays a more integral role
in the PSD and is present at higher concentration in cortical and hippocampal PSDs
than previously appreciated. One possibility for the increased amount of βCaMKII over
αCaMKII in hippocampal and cerebellar PSDs is to provide additional interactions with
the spine actin network. βCaMKII can bind actin and actin filaments in a Ca2+/CaM
reversible manner (Shen et al., 1998, Colbran and Brown, 2004, Sanabria et al., 2009)
and has proposed structural roles as a scaffold to integrate Ca2+ signals with
modifications of actin associated with PSDs and the actin cytoskeleton in spines.
Additionally, αCaMKII and βCaMKII have different affinities for Ca2+/CaM (Miller and
Kennedy, 1985, Gaertner et al., 2004a) and different frequency-dependent activation
curves (De Koninck and Schulman, 1998).

The results showing that PSDs from

different regions vary in their CaMKII holoenzyme subunit ratios suggests that
differential recruitment of the enzyme could help distinctively tune the ability of a
synapse to respond to the varying frequencies of Ca2+ signals.

The high relative

concentration of βCaMKII compared to αCaMKII in cerebellar PSDs also further
confirms conclusions drawn by the morphologic descriptions and scaffold composition
of cerebellar PSDs in that cerebellar PSDs are likely well-connected to the actin
network. Additionally, labeling for αCaMKII and βCaMKII was 2-4 times greater than
for all other proteins evaluated in all PSD types, consistent with a major role for CaMKII
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in establishing the structure of PSDs from the three regions evaluated. Supporting this
idea, labeling for both αCaMKII and βCaMKII represented 50% of the total labeling for
hippocampal PSD, further suggesting that CaMKII may act as both the major signaling
molecule and as the major scaffold within hippocampal PSDs.
AMPA, NMDA and metabotropic glutamate receptor subunits have been
identified in proteomic studies of forebrain (Jordan et al., 2004, Li et al., 2004, Peng et
al., 2004, Yoshimura et al., 2004, Cheng et al., 2006) and cerebellar PSD fractions
(Cheng et al., 2006), and I expected to detect these receptors in the immunogold
analysis. Additionally I expected to detect GluRδ2, which is thought to be present at
cerebellar parallel fiber-purkinje cell synapses (Takumi et al., 1999) and has been
detected in isolated cerebellar PSDs (Cheng et al., 2006).

In the analyses of

morphologically identified PSDs, significant immunogold labeling was detected for only
the NMDA receptor (NR1 and NR2b subunits) whose levels were consistent between
cerebellar, hippocampal and cortical PSDs.

Perhaps there were minor subcellular

contaminants in the fractions used for the proteomic analyses that contained AMPA
and metabotropic receptors that were avoided in this analysis of morphologically
identified PSDs. Alternatively, these negative results could be due to epitopes on the
receptors being obscured from antibody labeling by their incorporation into PSDs.
Remarkably, despite the double Triton X-100 extraction during PSD isolation, the
NMDA receptor remains tightly anchored, presumably through interactions with scaffold
and signaling proteins. Along with PSD-95, NR2b also binds CaMKII and both NR1
and NR2b can bind α-actinin, creating a multi-protein complex that likely stabilizes the
NMDA receptor in the PSD and prevents its extraction (Strack and Colbran, 1998,
Inoue and Okabe, 2003, Robison et al., 2005, Okabe, 2007, Sheng and Hoogenraad,
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2007). These results suggest that the mobility of the NMDA receptor is restricted,
consistent with work that has demonstrated that a portion (~50%) of NMDA receptors
are immobile at synapses (Groc et al., 2004, Triller and Choquet, 2005).
Finally, I determined that the proteasome is a component of isolated PSDs and
while all cerebellar and hippocampal PSDs were positively labeled, only 65% of cortical
PSDs were labeled. Since the proteasome plays a role in activity-dependent changes
to PSD composition (Ehlers, 2003), it is interesting to propose that some PSDs might
utilize the proteasome pathway while others do not. In response to synaptic activity,
the proteasome was found to be recruited into hippocampal dendritic spines (Bingol
and Schuman, 2006) where it can bind to and be phosphorylated by αCaMKII, thereby
increasing proteasomal activity, (Djakovic et al., 2009, Bingol et al., 2010, Djakovic et
al., 2012).

Once activated, several PSD proteins are targeted for degradation,

including PSD-95 (Colledge et al., 2003), Shank, and GKAP (Ehlers, 2003). From these
results, one can speculate that the increased labeling of hippocampal and cerebellar
PSDs for the proteasome indicates that a higher percentage of synapses in these brain
areas are undergoing active proteasomal remodeling than in cortex. This finding raises
the additional possibility that a population of cortical PSDs is not susceptible to
proteasome-mediated plasticity, although activity-dependent changes in cortical PSD
composition, as determined by Western blot, have been shown to be mediated by
proteasomal activity (Ehlers, 2003). This is an excellent example of the type of unique
information that comes from analyzing individual PSDs. If proteasomal degradation is
a hallmark of plasticity at synapses, one can speculate that a population of synapses in
the cortex are resistant to plasticity and perhaps are the specific sites of long-term
memory storage, as has recently been proposed (Osada et al., 2008, Fuster, 2009,
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Hasan et al., 2013). Future experiments focusing on the proteasomal remodeling of
individual PSDs will be required to determine if there is a population of cortical PSDs
resistant to proteasomal degradation. It is also intriguing that cortical PSDs with the
greatest abundance of αCaMKII, which is the presumed proteasome scaffold within
PSDs, had the lowest labeling for the proteasome, while hippocampal and cerebellar
PSDs, with more βCaMKII than αCaMKII, had significant labeling for the proteasome;
cerebellar PSDs labeled for twice as much proteasome as αCaMKII.

While it is

possible that in response to synaptic activity the additional αCaMKII molecules which
translocate to PSDs act as scaffolds for incoming proteasome molecules, this suggests
that the proteasome may also be binding to other PSD proteins within hippocampal and
cerebellar PSDs.

Dual labeling experiments should be employed in the future to

determine the fraction of CaMKII molecules co-localizing with the proteasome.
Future work will be required to unfold the mechanism of proteasomal
degradation of PSD scaffolds and preliminary work addressing this is presented in
Appendix 1. To begin to understand the level of proteasomal remodeling in PSDs
isolated from hippocampi, cerebella, and cortices, western blotting should be employed
to assess the level of ubiquitin and ubiquitin specific for proteasomal degradation. Dual
labeling experiments or dual Western blotting between ubiquitin and PSD scaffolds
could determine whether PSD scaffolds are being tagged for proteasomal degradation.
Additionally, proteasome activity assays could also be performed to test whether the
proteasomes present in the different PSD fractions are functional. It is also interesting
that PSD populations with lower labeling for two of the proteasome-targeted PSD
scaffolds, PSD-95 and shank, were the PSDs with the most labeling for the
proteasome. While is it plausible that PSD-95 and Shank family members are just less
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abundant in hippocampal and cerebellar derived PSDs, it is interesting to speculate
that their concentration at PSDs is more heavily regulated by proteasomal degradation
in hippocampal and cerebellar PSDs.
Future work will also be required to relate the morphologically distinct cerebellar
PSDs to both their neuronal type of origin and the functional significance of their
structural differences.

Intriguingly, from my immunogold labeling results, 75% of

cerebellar PSDs immunogold labeled positively for Shank2, which is thought to be
specific for purkinje cells, as determined by in situ hybridization (Boeckers et al.,
1999b), and 60% of cerebellar PSDs labeled for αCaMKII, the dominant CaMKII
isoform in purkinje cells as determined by immunocytochemistry (Walaas et al., 1988).
These results suggested that 60-75% of the cerebellar PSDs were isolated from
purkinje cells.

However, 100% of cerebellar PSDs labeled for shank3, which is

believed to be specific for granule cells as determined by in situ hybridization (Boeckers
et al., 1999b), and only 45% of cerebellar PSDs labeled positively for scaffold homer,
which is enriched selectively in purkinje cells as determined by immunohistochemistry
(Xiao et al., 1998, Okabe, 2007), thereby confusing the issue. These conflicting results
suggest that expression of these proteins, especially specific isoforms of the same
protein, may not be as distinctly separate within cerebellar tissue. Future experiments
will be required to further clarify the synaptic molecular composition of the different
populations of cerebellar cells. I also suggest that antibodies specific against PSD-93
and PSD-95, which successfully label PSDs and do not cross-react, be acquired in
order to parse out PSDs from specific cerebellar neurons, as PSD-93 is believed to be
the only member of the PSD-95 family within purkinje cells as previously determined by
immunohistochemistry (McGee et al., 2001). Once a pattern of labeling is consistent
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and suggests that separate identifiable populations of cerebellar PSDs exist, it would
be fascinating to combine immunogold labeling and electron tomography to connect
differences in protein composition to detailed morphologic distinctions in cerebellar
PSD texture. Additionally cerebellar synaptic junction fractions (a fraction one step
preceding the final PSD fraction) could be immunogold labeled for GluRδ2, as the
postsynaptic membrane and presumably neurotransmitter receptors are still attached to
PSDs within this fraction and GluRδ2 is again believed to only be present within
purkinje cells of the cerebellum (Takumi et al., 1999).
Tomographic analysis of synaptic junctions could also prove to be a fruitful
endeavor. Synaptic junctions are composed of PSDs with residual presynaptic and
postsynaptic membranes still attached, as they have only been once treated with
detergent.

Tomographic analysis of synaptic junctions combined with immunogold

labeling could provide valuable information about the organization of proteins in
individual morphologically identified PSDs with respect to the postsynaptic plasma
membrane. For example, synaptic junctions could be dual immunogold labeled with
antibodies against palmitate or scaffold PSD-95 and other markers of lipids rafts in
order to determine how synaptic lipid rafts and the PSD might interact, addressing the
hypothesis that PSDs play a role in organizing the synaptic membrane. Additionally, to
more specifically address PSD dynamics, synaptic junctions could be isolated from
chemically activated hippocampal slices, as the yield is also greater for synaptic
junctions than for PSDs, and the fine morphologic and compositional changes
associated with synaptic activity could be addressed with a combined tomographic and
immunogold approach.
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Overall, my results indicate that there are unique structural and compositional
differences between PSDs isolated from different brain regions. Despite sharing similar
morphology, PSDs were diverse in molecular composition, implying functional
distinctions. The differential labeling for PSD scaffolds and clustering of PSD-95,
suggested that the underlying PSD scaffold varies across the brain, even within brain
regions, a question I am actively investigating. It is quite remarkable to me that PSDs
of similar morphology can have such variable protein compositions and that within the
cerebellum similar protein composition is observed across PSDs with such varying
morphologies. I speculate that the overall structure of the PSD depends more heavily
on protein organization than on protein composition, meaning that the PSD structure is
largely determined by assembling similar smaller modules of proteins in unique ways.
These issues will need to be addressed by identifying the structure of individual
modules within the PSD along with higher resolution structural information about their
organization and binding interactions within PSDs. Lastly, I propose that the differential
ratios of CaMKII isoforms and varying presence of the proteasome suggest that the
regulation of synaptic plasticity might vary significantly at different synapses across the
brain, thereby increasing the complexity of the rules for how specific synapse types
respond to synaptic activity.
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Figure 6.1. Proposed Organization of PSD Scaffolds from Cortical, Hippocampal and
Cerebellar PSDs.
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Appendix 1: Insights into the Dynamic PSD Structure
A.1.1. Introduction
Investigations into the PSD have determined that the protein composition and
structure of PSDs change through development (Petralia et al., 2005, Swulius et al.,
2010, Swulius et al., 2012) and with synaptic activity (Ehlers, 2003, Tao-Cheng et al.,
2010, Yang et al., 2011). The activity-dependent changes to the molecular composition
and organization of the PSD are postulated to mediate the long-term changes in
synaptic strength underlying learning and memory (Swulius et al., Tao-Cheng et al.,
Yang et al., Swulius et al., 2012), although the exact molecular organization of the PSD
as well as how synaptic activity alters PSD organization and architecture remain
unclear. It is reasonable to hypothesize that regulated degradation of key organizing
molecules within PSDs could lead to remodeling, and the ubiquitin proteasome system
(UPS) has recently been shown to mediate activity-dependent changes in PSD
composition (Ehlers, 2003, Sheng and Hoogenraad, 2007). Whether these changes in
PSD composition result in structural changes to the PSD is unknown, as are the
mechanisms in which the UPS alters PSD composition.
The UPS is a highly regulated protein degradation system, where proteins
tagged with polyubiquitin lysine-48 chains are specifically targeted by the proteasome
and degraded (Miller and Gordon, 2005). In 2003, it was demonstrated that several
PSD scaffold proteins are ubiquitinated in response to activity, including Shank, GKAP
(Ehlers, 2003) and PSD-95 (Colledge et al., 2003). Other groups have shown that in
response to activity the level of both ubiquitinated proteins and the proteasome
increases in dendritic spines (Bingol and Schuman, 2006, Djakovic et al., 2009).
Additionally, the activity-induced recruitment of the proteasome to spines was
139

dependent on prior translocation of CaMKII (Djakovic et al., 2009, Bingol et al., 2010).
It is also of interest to note that mutations in and/or dysregulation of PSD-95 (Roselli et
al., 2005) and Shank (Roselli et al., 2009, Grabrucker et al., 2011c, Grabrucker et al.,
2011d) have been associated with neurologic disorders and diseases, characterized by
synaptic dysfunction, such as Autism, the Autism Spectrum Disorders and Alzheimer’s
Disease. These findings strengthen the idea that the structure of the PSD plays an
important role in synaptic function and developing a dynamic molecular model of the
PSD will be crucial in understanding mechanisms underlying synaptic function.
My hypothesis for activity-induced structural reorganization of the PSD by the
ubiquitin proteasome system is modeled in Figure A.1.1., where in response to synaptic
activation, there is initial recruitment of CaMKII into the spine and to the PSD
(Dosemeci et al., 2001, Sheng and Hoogenraad, 2007), along with increased
ubiquitination of PSD scaffolds (Ehlers, 2003). The 12 subunit CaMKII holoenzyme is
known to phosphorylate the proteasome (Djakovic et al., 2009), and act as a target
providing binding sites for the proteasome within the PSD (Figure A.1.1.). The arrival
of the proteasome at the PSD allows for targeted degradation of ubiquitinated PSD
scaffold proteins including Shank, GKAP and PSD-95 (Figure A.1.1.). Loss of these
scaffold proteins allows for molecular rearrangement within the PSD as Shank, GKAP
and PSD-95 have multiple protein-interaction domains forming multiprotein complexes
(Kennedy, 2000, Kim and Sheng, 2004).
Shank molecules can interact with themselves and are hypothesized to
construct the frame of the PSD (Kim and Sheng, 2004) (Figure A.1.1.). Shank and
PSD-95 form receptor modules as Shank is believed to indirectly support metabotropic
glutamate receptors in the membrane, whereas PSD-95 is believed to support both
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NMDA and AMPA receptors in the postsynaptic membrane (Kennedy, 2000, Colledge
et al., 2003, Kim and Sheng, 2004).

Interestingly, GKAP binds both PSD-95 and

Shank bringing the two scaffold modules together (Kennedy, 2000), and loss of GKAP
could directly impact the organization of synaptic receptors.

Therefore targeted

proteasomal degradation of PSD scaffolds could result in the removal of receptors from
the synapse or could rearrange the PSD scaffold in order to support the recruitment of
additional receptors, altering the physiological properties of the synapse. To begin to
test this hypothesis, preliminary experiments were performed in order to investigate
how the composition of PSDs change in response to activity and whether the
proteasome plays a role in PSD structural remodeling throughout development.
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Figure A.1.1. Model for Activity-Induced Structural Reorganization of the PSD by the
Ubiquitin Proteasome System
A) Calcium influx through NMDA receptors triggers immediate activation and
translocation of CaMKII into the PSD. B) Ubiquitination of PSD scaffold proteins
increases. C) In the PSD, CaMKII acts as a scaffold recruiting proteasome molecules
localizing proteasomal degradation within the PSD.
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A.1.2. Additional Methodology
A.1.2.1. Preparation of Hippocampal Slices and Chemical Induction of Neuronal Activity
To prepare hippocampal slices, adult Sprague-Dawley rats were decapitated
immediately after being anesthetized with isoflurane. Brains were removed, placed in
oxygenated ringer’s solution, and hemissected.

Hippocampi were isolated and

transverse 400 μm slices were prepared with a McIlwain tissue chopper. Slices were
then placed in continuously oxygenated ringer’s solution at room temperature to
recover for 1 hr. Since the goal of this proposal was to study the activity-induced
changes to PSD structure, hippocampal slices were synaptically activated with the
potassium channel blocker TEA (Enzo Life Sciences). After the recovery period, slices
were incubated for 10 min in modified oxygenated ringer’s solution either with or
without 25 mM TEA (Lengyel et al., 2004) and returned to ringer’s solution to allow
activity-induced changes to develop, before being immediately frozen in liquid nitrogen
and then homogenized for PSD isolation. PSDs were isolated from hippocampal slices
following the PSD isolation protocol described in Chapter 2, section 2.1, scaled for
starting material.

A.1.2.2. Isolation of Postsynaptic Densities from Forebrains at Postnatal Days 2, 7, 14,
21, and 60
The protocol to isolate forebrain PSDs from Sprague-Dawley rats at postnatal
days 2, 7, 14, 21, and 60 (denoted as P2, P7, P14, P21, and P60 respectively) was
adapted from a widely used PSD enrichment procedure (Cohen et al., 1977) modified
to increase PSD yield (Figure A.1.2). Forebrains were removed within 30 seconds of
decapitation and placed in ice-cold buffer A.
143

For each preparation, a total of 9

forebrains from P60, 12 from P21, 14 from P14, 30 from P7, or 40 from P2 were
homogenized in 108 ml of buffer A with a motor-driven glass/Teflon homogenizer (0.2
mm clearance).

All steps of the following protocol were accomplished at 4˚C.

Homogenates were spun at 3600 g for 10 minutes in a RTH-750 rotor, supernatants
saved. Pellets were resuspended in original volume of buffer A, hand homogenized,
and spun again at 3600 x g for 10 minutes in a RTH-750 rotor. Supernatants were
combined and spun at 10,000 x g in a JA-20 rotor for 10 minutes.

Pellets were

resuspended in original volume of buffer A by hand homogenizing and spun again at
10,000 x g for 10 minutes in a JA-20 rotor. Pellets were resuspended in 28 ml of buffer
B and applied to a sucrose gradient (7 ml sample, 9.5 ml 0.85 M sucrose, 10.5 ml 1.0
M sucrose, 10.5 ml 1.4 M sucrose) which was spun for 2 hours at 125,800 x g in a
SW32 rotor. The band between 1.0 M and 1.4 M sucrose, containing the synaptosome
fraction, was collected and diluted in half with buffer B. An equal volume of triton
extraction buffer was added and the samples rotated for 15 minutes prior to being spun
at 30,000 x g for 20 minutes in the SW32 rotor. Pellets were resuspended in 2.5 ml of
buffer B and applied to a second sucrose gradient (2.5 ml sample, 5 ml 1.0 M sucrose,
5 ml 1.2 M sucrose). The gradient was spun at 167,000 x g for 2 hours in a SW41
rotor. The pellet was resuspended in 1 ml 5 mM HEPES/KOH pH 7.4, 1 ml triton
extraction buffer was added, and the sample was mixed on ice for 15 minutes. Finally
the sample was spun at 38,000 x g for 15 minutes in a SW55 rotor and the resulting
pellet was suspended in 300-500 μl of 20% glycerol in 5 mM HEPES/KOH pH 7.4 and
stored as aliquots at -80˚C. Spins were performed in a Sorvall® RT7 plus centrifuge,
Avanti® J-E Centrifuge and Optima XPN-80 Ultracentrifuge. Gradients were spun with
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acceleration and deceleration program 1, resulting in a 2 minute acceleration to and
deceleration from 170 RPM, respectively.

A.1.2.3. Western Blotting and Immunogold Labeling
Western blotting and immunogold labeling were performed as previously
described in Chapter 2, sections 2.2 and 2.3. Additional primary antibodies included:
pan-Shank (mouse, Neuromab, 75-089), GKAP (mouse, Neuromab, 75-156), CaMKII
(rabbit, Millipore, 04-1079), pT286 (Rabbit, Phosphosolutions, p1005-286), pT286
(mouse, Thermo, MA1-047), pT305 (rabbit, produced in house), and 20S (mouse, Enzo
Life Sciences, PW8195). Antibody information including Western blot and immunogold
labeling dilutions not included in Table 2.1 are listed in Table A.1.1.
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Figure A.1.2. Isolation of PSDs from Forebrains throughout Development.
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Antibody

Species

Manufacturer

Catalog Number

WB Dilution

IG Dilution

pan-Shank

mouse

Neuromab

75-089

1:2500

1:20

GKAP

mouse

Neuromab

75-156

1:2500

1:20

CaMKII

rabbit

Millipore

04-1079

1:1000

1:20

pT286

rabbit

Phosphosolutions

p1005-386

1:1000

1:20

pT286

mouse

Thermo

MA1-047

1:2000

1:20

pT305

rabbit

Waxham Lab

--

1:1000

1:20

20S

mouse

Enzo Life Science

PW8195

1:1000

1:20

Table A.1.1. Antibody Information for all Primary Antibodies Used.
Information includes: the species in which antibody was raised, manufacturer, catalog
number, Western blot dilution and immunogold labeling dilution.
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A.1.3. Results
A.1.3.1. Hippocampal Slice PSDs
In preliminary experiments to address activity-induced changes in PSD
composition and structure, hippocampal slices were prepared, activated with potassium
channel blocker TEA, and PSDs isolated, as described in the methodology section
A.1.2.3. Hippocampal slices were frozen with liquid nitrogen immediately after the 10
min TEA treatment or control treatment, homogenized and PSDs isolated. Negative
stain micrographs of control and TEA treated PSDs were collected to determine if there
were gross morphologic differences associated with activation.

As no obvious

differences were evident in the gross morphology, the surface area was measured for
120 control and TEA treated hippocampal PSDs and average surface area calculated
(Figure A.1.3). The mean surface area was 0.27 ± 0.02 μm2 for control hippocampal
PSDs and 0.18 ± 0.01 μm2 for TEA treated, which was a statistically significant
difference from the control PSDs.

The peak surfaces areas, or mode, were also

different with control hippocampal PSD surface area peaking at 0.15 μm2 while the
surface area for TEA treated hippocampal PSDs peaked at 0.10 μm2 (Figure A.1.3).
This trend is evident in the histograms of PSD surface area shown in Figure A.1.3,
where the surface areas for TEA treated hippocampal PSDs were less variable, tending
toward smaller surface areas. These results suggested that PSDs are smaller as a
result of inducing neuronal activity, further supporting the idea that structural
remodeling of PSDs underlies synaptic plasticity.
Immunogold labeling experiments were performed on the TEA treated and
control hippocampal slice PSDs to directly test how PSD protein composition changes
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in response to synaptic activity.

Antibodies against αCaMKII, βCaMKII, CaMKII

phosphorylated at T286 (pT286), CaMKII phosphorylated at T305 (pT305), and a pan
antibody against the Shank isoforms (pan-Shank) were employed in immunogold
labeling experiments. The results of the immunogold labeling experiments are shown
as gold/μm2 and gold/PSD in Table A.1.2. Secondary controls were included for the
αCaMKII immunogold labeling experiment.

Sample size was 20 PSDs for each

experiment, with the exception of pan-Shank, where 15 non-TEA treated PSDs and 8
TEA treated PSDs were imaged. There were no significant differences in labeling
density when results were reported as gold over surface area; however when labeling
densities were reported as gold per PSD there were statistical differences (Table
A.1.2). These results are easily explained as the average surface areas of TEA treated
PSDs were smaller than controls (Figure A.1.3).
Labeling densities for βCaMKII and pT305 were significantly different and
greater for control non-treated PSDs than for TEA-treated PSDs (Table A.1.2). These
results, while preliminary, were in part not expected; it is known that activation of
synapses results in translocation of CaMKII to PSDs (Strack et al., 1997, Shen and
Meyer, 1999, Dosemeci et al., 2001) and yet there was lower labeling for βCaMKII in
TEA treated hippocampal slice PSDs compared to control and there was no difference
in the level of αCaMKII between groups (Table A.1.2). Additionally, it was expected
that TEA treatment of hippocampal slices would result in increased phosphorylation of
CaMKII at T286, suggesting activation of CaMKII (Miller and Kennedy, 1986), and yet
the labeling densities for pT286 were the same in the control and TEA treated groups,
while phosphorlyation at T305 was increased in control PSDs (Table A.1.2).
Phosphorlyation of CaMKII at T305 is inhibitory autophosphorylation which prevents
149

CaMKII activation by Ca2+/CaM (Hanson and Schulman, 1992) and is believed to be
important in targeting CaMKII to the PSD (Elgersma et al., 2002). Therefore, while less
inhibitory CaMKII phosphorlyation was evident in PSDs which had been treated with
potassium channel blocking TEA, translocation and activation of CaMKII was not
evident as expected. The scaffold Shank is also thought to translocate to PSDs in an
activity-dependent manner (Tao-Cheng et al., 2010), although the labeling of Shank
between TEA treated PSDs and control PSDs was the same.
Additional PSDs were isolated from TEA treated hippocampal slices and control
hippocampal slices, in order to assess the time course of molecular events occurring
after TEA treatment. Hippocampal slices were homogenized either immediately after
or 20 minutes after TEA or control treatment, and PSDs were then isolated and
immunogold labeled (Table A.1.3). The first PSD preparation, termed A, was prepared
20 min after TEA treatment following the same isolation procedure as the hippocampal
slice PSDs previously discussed, to test whether CaMKII translocation and recruitment
of the proteasome could be detected 20 minute after synaptic activation. The results of
the immunogold labeling experiments are shown in Table A.1.3.

There were no

differences in labeling densities of the proteasome between TEA-treated and control
PSDs, however there was significantly more gold targeting βCaMKII per PSD in the
TEA-treated group as compared to the control group (Table A.1.3), suggesting that
activity-dependent CaMKII recruitment to the PSD can be detected within 20 min of
activity induction.
Due to low PSD yields when isolating hippocampal slice PSD through three
separate discontinuous sucrose gradients, the PSD isolation protocol for hippocampal
slices was changed to a two sucrose gradient protocol, as described in section A.1.2.2.
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Hippocampal slice PSD preps B and C were isolated through the two sucrose gradient
protocol to increase yield and thus increasing the number of preliminary experiments
possible. Slices from prep B were homogenized immediately after TEA treatment,
while slices for prep C were homogenized 20 minutes after treatment. Preliminary
immunogold assessment of protein density in the resulting PSDs is shown in Table
A.1.3. Labeling for the lid of the proteasome was determined to be the same in control
and TEA-treated hippocampal slice PSDs from prep B, the immediate time point.
However, labeling for the proteasome lid was increased in TEA-treated hippocampal
slice PSDs, as compared to control PSDs, isolated 20 minutes after activity induction
(Table A.1.3). This result contradicts the proteasome labeling densities calculated for
prep A which was also isolated 20 minutes after TEA-treatment, although the sample
size for prep C was double the sample size for prep A (Table A.1.3). Labeling densities
for αCaMKII were calculated for preps B and C to test whether recruitment of CaMKII
could be detected immediately after or 20 minutes after activity induction, and
surprisingly there were no statistical differences in labeling for αCaMKII between
control and TEA-treated PSDs at either time point, also contradicting the increased
labeling for βCaMKII measured in TEA-treated PSDs from prep A (Table A.1.3). Two
immediate issues should be addressed before continuing this line of investigation.
First, activity induction in hippocampal slices by TEA, although well documented
(Lengyel et al., 2004), will need to be verified by electrophysiology, to ensure the
efficacy of TEA-induced activity.
order to increase the PSD yield.

Second, protocols will need adapted/optimized in
This is presently the major factor limiting this

potentially revealing line of investigation. By increasing the yields, the time course of
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molecular events related to activity-dependent PSD modification can be assessed by
Western blots analysis in addition to immunogold labeling experiments.
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Figure A.1.3. Histograms of Control and TEA Treated Hippocampal Slice PSD
Surface Areas.
The mean surface are for TEA PSDs was statistically smaller than control PSDs as
determined if P < 0.05 in two-tailed t tests. The peak surface areas for control and
TEA treated PSDs were also different, 0.15 μm2 and 0.10 μm2 respectively.
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αCaMKII
βCaMKII
pT286
pT305
pan-Shank

Gold/μm2
Control
TEA
446 ± 45 472 ± 48
238 ± 36 257 ± 57
188 ± 32 227 ± 49
283 ± 35 346 ± 91
41 ± 7
45 ± 5

Gold/PSD
Control
TEA
113 ± 18 103 ± 13
31 ± 9
71 ± 13
62 ± 12
35 ± 8
47 ± 13
93 ± 15
13 ± 3
12 ± 1

Table A.1.2. Preliminary Immunogold Labeling for Hippocampal Slice PSDs treated
with TEA and Controls.
Secondary controls were only included for αCaMKII experiment. Sample size was
20 PSDs for each experiment, with the exception of pan-Shank, where 15 non-TEA
treated PSDs and 8 TEA treated PSDs were imaged.
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Slice Prep
A (20 min)
RPT6

B (0 min)
C (20 min)
B (0 min)

αCaMKII

βCaMKII

C (20 min)
A (20 min)

PSD Group
Control
TEA
Control
TEA
Control
TEA
Control
TEA
Control
TEA
Control
TEA

Gold/um2
56 ± 6
55 ± 3
54 ± 8
60 ± 8
55 ± 9
69 ± 12
126 ± 21
174 ± 21
134 ± 13
127 ± 11
65 ± 9
121 ± 29

Gold/PSD
23 ± 4
15 ± 3
14 ± 2
15 ± 2
9±4
22 ± 4
35 ± 8
59 ± 20
28 ± 4
29 ± 4
25 ± 4
47 ± 7

Sample Size
10
10
20
20
20
20
20
20
20
20
5
5

Table A.1.3. Preliminary Immunogold Labeling for Control and TEA Treated PSDs
Isolated from Hippocampal Slices.
Statistical significance, indicated in bold, was defined as a p-value < 0.05, as
determined through two-tailed t tests in Excel. TEA treatment was 10 minutes long for
each preparation. Hippocampal Slices were homogenized 20 min after TEA treatment
for preparations A and C while slices were homogenized immediately following TEA
treatment for preparation B. Preparation A included the typical 3 gradients, while preps
B and C were shortened to 2 gradients to increase PSD yield.
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A.1.3.2. PSDs during Development
To continue investigating how the composition of PSDs changes and to
investigate the potential role of the proteasome in PSD modifications, a developmental
model was employed as the Waxham Lab has previously done (Swulius et al., 2010,
Swulius et al., 2012). As a preliminary experiment PSDs isolated from rat forebrain at
embryonic day 19 (E19), postnatal day 2 (P2), postnatal day 21 (P21) and postnatal
day 60 (P60) were immunogold labeled for the lid of the proteasome to assess for its
presence and differences in amount over development (Table A.1.4). A bar graph of
the immunogold labeling results from Table A.1.4 is shown in Figure A.1.4 and
developmental regulation of the proteasome at PSDs is clearly evident. Not only was
the proteasome present within PSDs from all ages, labeling densities for the
proteasome were significantly higher in PSDs from early development, peaking at P2,
compared to PSDs isolated from P21 and adult, P60 animals, where the labeling was
lowest.
Given this preliminary result, PSDs were also isolated from rat forebrains at two
additional time points: P7 and P14, in order to further investigate the developmental
profile of the proteasome system. Initial experiments focused on Western blotting to
examine the developmental profile of CaMKII, the proteasome, and scaffolds targeted
by the proteasome (Figure A.1.5). Western blots illustrated that PSD-95 increases in
concentration as PSDs matured (Figure A.1.5), as previously shown by Western blot
(Petralia et al., 2005) and immunogold labeling (Swulius et al., 2010). Scaffolds Shank
and GKAP were also determined to increase in concentration within PSDs through
development (Figure A.1.5) confirming published work (Petralia et al., 2005). However
a subunit of the proteasome lid, RPT6, decreased in concentration within PSDs
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throughout development (Figure A.1.5), confirming the preliminary immunogold labeling
results (Table A.1.4).

PSDs isolated at P2 contained 315% more proteasome lid

subunits than PSDs isolated at P60, as quantified in ImageQuant (GE Healthcare).
The 20S proteasome core was also found to be developmentally regulated in PSDs,
and decreased in amount from P2 to P60 similar to RPT6 (Figure A.1.5). These results
confirm that the proteasome is present in PSDs and that the presence of the
proteasome within PSDs is developmentally regulated, supporting that the ubiquitin
proteasome system plays a role in structural remodeling of the PSD during
development and plausibly in response to synaptic activity.
CaMKII, the hypothesized target for the proteasome in PSDs, was also probed
by Western blot and both αCaMKII and βCaMKII increased from P2 to P60, with
βCaMKII as the dominant isoform until P60, as previously reported (Sahyoun et al.,
1985, Swulius et al., 2010). The blots in Figure A.1.5 demonstrate that at P2,
phosphorlyation of T286 is mainly on βCaMKII (the abundant isoform at that age), and
interestingly decreases from P2 to P60, even though the abundance of βCaMKII
increases through this time frame. Phosphorylation of αCaMKII at Thr286 increases
from P2 to P60, as does abundance of αCaMKII (Figure A.1.5). Of all the known PSD
associated proteins, the only ones identified to decrease through development are
NR2B, SAP102 (Petralia et al., 2005), and CaM (Swulius et al., 2010). Therefore the
decreases seen by Western blot for the proteasome lid (RPT6), core (20s), and
phosphorlyation of βCaMKII at T286 is novel and suggests that the proteasome and
phosphorylation of βCaMKII are correlated with the structural maturation of PSD.
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E19
P2
P21
P60

Gold/μm2 ± SEM
56 ± 17
86 ± 15
19 ± 3
10 ± 3

Gold/PSD ± SEM
29 ± 9
52 ± 11
10 ± 2
5±1

Table A.1.4. Preliminary Immunogold Labeling for RPT6 on Developmental PSDs.
Labeling densities for the proteasome significantly drop between P2 and P21.
Statistical significance, indicated in bold, was defined as a p-value < 0.05, as
determined through two-tailed t tests in Excel. N = 10. No secondary controls were
performed.
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Figure A.1.4. Preliminary Average Labeling Densities for RPT6 on Developmental
PSDs.
No secondary controls were performed. Labeling densities for the proteasome
significantly drop between P2 and P21. Statistical significance, indicated with
asterisks, was defined as a p-value < 0.05, as determined through two-tailed t tests in
Excel. N = 10.
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Figure A.1.5. Western Blots Illustrating the Developmental Profiles for Select PSD
Proteins.
Lanes for each blot were loaded with equal protein, between 5 and 10 μg, using 8%,
10% or 15% polyacrylamide gels. Multiple bands are expected to be detected by the
primary antibodies against Shank, GKAP, 20S, CaMKII and pT286. The pan-Shank
antibody recognizes the entire family of Shank proteins which range in from 120-240
kDa (Sheng and Kim, 2000). The GKAP antibody also recognizes multiple isoforms of
the protein at 110 kDa and 120 kDa; others have reported this as well (Petralia et al.,
2005). The 20S antibody against the core of the proteasome recognizes multiple
subunits which compose the 2000 kDa catalytic core of the proteasome, as shown by
others (Djakovic et al., 2012). The CaMKII antibody and the pT286 antibody recognize
both αCaMKII (55 kDa) and βCaMKII (60 kda).
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A.1.4. Discussion
While some of the preliminary experiments described above were inconclusive,
they have contributed forward progress toward the goal of building a dynamic structural
model for the PSD. PSDs were isolated from chemically activated hippocampal slices
to investigate how PSD composition changes in response to activity and whether the
proteasome is recruited to PSDs in an activity-dependent manner.

The ubiquitin

proteasome system is predicted to degrade PSD proteins in response to activity
providing structural flexibility for reorganization within PSDs supporting synaptic
plasticity. The results of the preliminary hippocampal slice work are inconclusive; while
there were some statistically significant differences between TEA-treated hippocampal
slice PSDs and control hippocampal PSDs, activity induction by TEA requires
verification and a consistent PSD isolation protocol that produces sufficient PSD yield
for Western blotting.
As an alternative preparation to assess the potential role of the UPS in PSD
structural remodeling, PSDs were isolated from different developmental time points.
Western blots showed that both the proteasome lid and core were present at highest
concentrations in PSDs isolated early in development and decreased as PSDs
matured. This suggests that the proteasome plays an important role in the structural
maturation of PSDs early in development, but its role diminishes as synapses mature.
Interestingly the PSD scaffolds targeted by the proteasome including; PSD-95
(Colledge et al., 2003), Shank and GKAP (Ehlers, 2003), increase in concentration
within PSDs through development, as shown here and as previously published (Sans
et al., 2000, Petralia et al., 2005, Swulius et al., 2010) while the proteasome decreases
in concentration. While is it possible that these trends are unrelated, it is interesting to
161

speculate that early in postnatal development while the concentrations of PSD
scaffolds Shank, GKAP and PSD-95 are increasing there is steady proteasomal
turnover of the scaffolds providing flexibility for the maturing PSD structure. To begin to
test this hypothesis proteasome activity assays could be performed on PSD fractions
from each developmental age to determine the level of proteasome activity in PSDs
throughout development. Western blotting of PSD fractions could also be probed for
monomeric ubiquitin and polyubiquitin chains specific for proteasomal degradation to
test whether a subset of PSD components are being tagged for proteasomal
degradation.

Western blots dually probed for polyubiquitin K48, specific for

proteasomal degradation (Miller and Gordon, 2005), and Shank, GKAP or PSD-95
could also determine which scaffolds are specifically targeted by the ubiquitin chains.
Phosphorlyation of βCaMKII at T286 decreased within PSDs as animals
matured, in contrast to the increasing concentration of βCaMKII. This is a novel result
suggesting that the activation of βCaMKII is crucial for the structural maturation of PSD.
This result makes sense in that early in development βCaMKII is the primary isoform of
CaMKII expressed (Sahyoun et al., 1985), therefore the majority of phosphorylated
CaMKII would be on βCaMKII. However the intensities of the pT286 band for βCaMKII
at postnatal day 2 and 7 were significantly more intense than the pT286 bands for both
αCaMKII and βCaMKII together at any other age. This suggested that the majority of
the CaMKII present within PSDs at P2 and P7 are in the autophosphorylated form. It is
intriguing at such early postnatal time points that the majority of βCaMKII is active and
very little αCaMKII is present in PSDs, especially when translocation of αCaMKII, not
βCaMKII, is proposed to be required for activity-dependent recruitment of the
proteasome to the PSD (Djakovic et al., 2009, Bingol et al., 2010). Additionally it is
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believed that αCaMKII acts as the anchoring protein for the proteasome into PSDs
(Bingol et al., 2010) and phosphorlyation of RPT6 by αCaMKII increases proteasomal
activity (Djakovic et al., 2012). Likely, the noted βCaMKII activation is crucial for other
synaptic functions at these stages in development through its interactions with F-actin
(Lin and Redmond, 2008, Sanabria et al., 2009, Hoffman et al., 2013), such as the
formation and expansion of neurites (Fink et al., 2003) although these results suggest a
further investigation of phosphorylated βCaMKII and the proteasome may be
warranted. However, the low levels of αCaMKII measured at P2 and P7 and the idea
that βCaMKII is not acting as the proteasome scaffold suggests that CaMKII is
plausibly not the primary proteasome scaffold molecule early in development. It would
be of interest to affinity-purify proteasomes out of PSDs isolated from P2 and P7 rats
and determine what PSD proteins precipitate alongside the proteasome.
In the future it will also be of interest to investigate the postsynaptic
developmental profiles of deubiquitinases CLYD and UCH-L1. CLYD accumulates in
PSDs in a manner that is dependent on synaptic translocation of CaMKII (Thein et al.,
2014), similar to the proteasome. CaMKII can also phosphorylate CYLD promoting
CYLD’s deubiquitinase activity which preferentially removes ubiquitin from polyubiquitin
lysine-63 chains, which target proteins for non-proteasomal pathways (Thein et al.,
2014). The additional free ubiquitin is then available to form lysine-48 chains, specific
for proteasomal degradation (Miller and Gordon, 2005). It is easy to visualize a model
where in response to synaptic activity CaMKII enzymes translocate to PSDs, followed
by the proteasome and CYLD, active CaMKII then phosphorylates CYLD, resulting in
deubiquitination of lysine-63 chains, providing additionally ubiquitin for formation of
lysine-48 chains, which are specific for proteasomal degradation. CaMKII also
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phosphorylates proteasomes, increasing their activity, which then degrade PSD
scaffolds tagged with lysine-48 chains. Ubiquitin carboxyl-terminal hydrolase L1, UCHL1 also increases levels of free ubiquitin in response to synaptic activation (Cartier et
al., 2009). Inhibition of UCH-L1 resulted in decreased free ubiquitin, changes in spine
morphology and density (Cartier et al., 2009), and increased levels of PSD-95 (Xie et
al., 2014).

Additionally it is believed that α-synuclein accumulation results from

oxidative damage of UCH-L1 in both Alzheimer’s disease and Parkinson’s disease (Liu
et al., 2002, Choi et al., 2004).

A more thorough understanding of how these

deubiquitinases are organized within PSDs, as well how they may influence PSD
structure and function in response to activity and through development is warranted.
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Appendix 2. CaMKII Isoforms Differentially Impact the Structure of Actin
Cytoskeleton
A.2.1. Introduction
This chapter of the appendix is based on previously published work which I
contributed to. The methods, figures and figure legends, pertaining to my contribution,
were taken directly, with permission, from the published work (Hoffman et al., 2013).
The introduction, results and discussion are rewritten and focused on experiments to
which I contributed.
αCaMKII and βCaMKII, the major PSD proteins, are well known for their role
converting variable synaptic calcium signals into enzymatic activity crucial for learning
and memory (Lisman et al., 2002, Colbran and Brown, 2004, Swulius and Waxham,
2008). There are four isoforms of the enzyme, produced from four separate genes
(Hudmon and Schulman, 2002). The α and β isoforms are present within neuronal
tissue, comprising 1-2% of the total protein in the brain (Erondu and Kennedy, 1985),
while the other isoforms of CaMKII, γ and δ are present alongside the α and β isoforms
in cells across the body (Tobimatsu and Fujisawa, 1989, Swulius and Waxham, 2008).
The structures of the isoforms are highly conserved with exception of a variable linker
region, located on the C-terminal side of the shared regulatory domain (Gaertner et al.,
2004a, Swulius and Waxham, 2008), as shown in Figure A.2.1.
This variable region is hypothesized to provide βCaMKII the unique ability to
bind actin and regulate actin polymerization (Fink and Meyer, 2002, O'Leary et al.,
2006, Okamoto et al., 2007, Lin and Redmond, 2009), which is important for molecular
transport throughout cells and establishing cellular structure (Pollard and Cooper, 2009,
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Michelot and Drubin, 2011, Schoenenberger et al., 2011). βCaMKII, unlike αCaMKII,
can bind monomeric G-actin, polymerized F-actin, and can bundle F-actin filaments
due to the dodecameric structure (Ohta et al., 1986, Shen and Meyer, 1999, O'Leary et
al., 2006, Okamoto et al., 2007, Sanabria et al., 2009). CaMKII exists as a mixed
holoenzyme composed of 12 subunits of CaMKII isoforms in two stacked rings of 6
subunits each (Kolb et al., 1998, Brocke et al., 1999, Gaertner et al., 2004a). Therefore
a holoenzyme composed entirely of βCaMKII could presumably bind up to 12 actin
molecules, allowing the kinase to simultaneously bind F-actin and sequester G-actin,
both regulating the rate of polymerization and providing a pool of G-actin available for
polymerization (Hoffman et al., 2013).

While many studies have analyzed the

interactions of βCaMKII and actin (O'Leary et al., 2006, Okamoto et al., 2007, Sanabria
et al., 2009), not much work has evaluated the interactions of the other CaMKII
isoforms and actin. This is an important step in understanding how mixed CaMKII
holoenzymes in neural and non-neural cells interact with and regulate the actin
network.
The goal of the work, which is summarized in this appendix, was to investigate
CaMKII isoform specific interactions with actin (for a full description see Hoffman et al.,
2013).

As described in the paper and performed by Dr. Laurel Hoffman,

cosedimentation experiments between CaMKII isoforms and F-actin suggested that
binding of F-actin is isoform specific with βCaMKII most avidly binding actin followed by
δ, γ, and α (Hoffman et al., 2013). All isoforms also inhibited actin polymerization and
Ca2+/CaM activation of each isoforms resulted in increased polymerization by freeing
monomeric actin from binding to the kinase (Hoffman et al., 2013). In order to visualize
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the interaction of each isoform with actin, I produced negative stain tomographic tilt
series of the actin/CaMKII complexes and these results are described in this appendix.
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Figure A.2.1. Domain map of CaMKII isoforms
The domain structures of all CaMKII isoforms used in these studies are highly
conserved in sequence in the catalytic, regulatory, and association domains. The only
noteworthy differences are found in the variable linker region where alternative splicing
results in inclusion or omission of various exons denoted by Roman numerals. Figure
adapted from (Hoffman et al., 2013).
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A.2.2. Methodology
Tomographic tilt series were collected on a 300 kV FEI Polara F30 electron
microscope equipped with a 4000 × 4000 pixel Tietz CCD camera. Series were
collected at 39000x magnification with a 5 to 10 μm defocus under a dose of ∼400
electrons/Å2. Images were collected at 2° tilt increments from −60° to 60° with 2x
binning that generated a final pixel size of 4.6 Å. Tilt series were aligned and
tomographic reconstructions produced using Etomo, part of the IMOD software
package (Mastronarde, 1997). Protein preparation, F-actin–CaMKII binding reactions,
and grid preparation were completed by Dr. Laurel Hoffman, as published (Hoffman et
al., 2013).

A.2.3. Results
A.2.3.1. Actin Filaments are Bundled Similarly by δCaMKII and βCaMKII
From negative stain micrographs it was evident that there were differences in
the interaction of the CaMKII isoforms and F-actin (Figure A.2.2.A and Figure A.2.3.A),
however the F-actin bundles formed by δCaMKII were structurally indistinguishable
from those formed by βCaMKII (Figure A.2.2.A), which have been described previously
(Okamoto et al., 2007, Sanabria et al., 2009). The F-actin bundles produced by both
δCaMKII and βCaMKII were approximately 100 nm wide and composed of tightly
packed slightly twisting parallel actin filaments (Figure A.2.2.A). The bundles were also
quite variable in length with some extending up to 15 μm in length.
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Negative stain electron tomography was employed to further investigate the
structure of the F-actin bundles. Cross-sections, approximately 10 nm thick, through
final tomographic reconstructions of actin bundles are shown for βCaMKII and δCaMKII
in Figure A.2.2.B, and individual holoenzymes are easily visible within the tightly
packed actin bundles.

For both βCaMKII and δCaMKII, the actin filaments were

organized in a fairly parallel manner, with some twisting, and bundles were
approximately 50-100 nm thick. Close-up views of the same reconstructions shown in
Figure A.2.2.B are shown in C of Figure A.2.2 to highlight individual CaMKII
holoenzymes bridging actin filaments. Interestingly, bundles formed by both βCaMKII
and δCaMKII also appeared to have blunt ends rather than tapered ends (Figure
A.2.2.D), suggesting that the manner of packing produced by both isoforms did not
support extension of individual filaments beyond a certain length.

Presumably the

kinase provided stability for the individual filaments; therefore the individual filaments
could only extend so far past the last kinase, although it is possible that filaments
extending past the end of the bundle were severed during grid preparation.

A.2.3.2. γCaMKII Uniquely Bundles Actin Filaments
The F-actin bundles formed by γCaMKII deviated in structure from the bundles
produced by both δCaMKII and βCaMKII (Figure A.2.2.A and Figure A.2.3.A). The left
panel in Figure A.2.3.A shows a negative stain micrograph of a typical γCaMKII actin
bundle, which were less consistent in width and 2-3 times wider than the βCaMKII and
δCaMKII bundles. The γCaMKII bundles were wide and flat with branching in both the
x and y dimensions (Figure A.2.3.), and a layered structure was evident from the
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tomographic reconstructions (Figure A.2.3).

Individual holoenzymes were visibly

interacting with actin (Figure A.2.3.A right panel) in the γCaMKII bundles, which
appeared to be composed of a single layer of filamentous actin sandwiched between
two layers of CaMKII (Figure A.2.3), roughly 40 nm thick compared to the 50-100 nm
thickness of the βCaMKII and δCaMKII bundles. Representative tomographic slices
through the layers of one bundle are shown in Figure A.2.3.C and a cartoon illustration
comparing the layered γCaMKII bundle to the rod-like δ and βCaMKII in included in
Figure A.2.3.B.
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Figure A.2.2. Structural Analysis of Actin Bundles Formed in the Presence of the β and
δ Isoforms of CaMKII (Hoffman et al., 2013).
A) Left panels illustrate representative 2D projections of low power electron
micrographs of negative stained F-actin in the presence of β (upper) and δ (lower)
isoforms (n > 5). B) Panels show ~10 nm thick slices of two tomographic
reconstructions to illustrate packing of β and δ CaMKII holoenzyme molecules within
bundles. C) Several CaMKII holoenzyme molecules are highlighted by red circles in a
zoomed in region of a representative slice from the same reconstructions shown in
Panel B. D) The right panels show ~ 10 nm slices through two different tomographic
reconstructions that illustrate examples of blunt ended bundles formed with β or δ
CaMKII (Hoffman et al., 2013).
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Figure A.2.3. Structure of Layered γCaMKII Bundle (Hoffman et al., 2013).
A) Left and center panels show representative electron micrographs of F-actin bundles
in the presence of γCaMKII (n = 6). The right panel illustrates a ~10 nm slice from a
tomographic reconstruction where several CaMKII holoenzyme molecules are
highlighted in red circles. B) A cartoon illustrates structural differences between the
layered bundles observed in the presence of the γ isoform (orange spheres) and the
rod-like bundles observed in the presence of the β or δ isoforms (red spheres). C) ~ 10
nm slices from tomograms illustrate the top, center, and bottom z sections of the
layered bundle in the left, center, and right panels, respectively (Hoffman et al., 2013).
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A.2.4. Discussion
The low resolution structure of the different CaMKII isoforms was similar as
previously published (Gaertner et al., 2004a), however the differential actin bundle
structures indicate that there are isoform-specific differences in the interactions
between CaMKII and actin.

The electron microscopic and cosedimentation results

suggest that there is a correlation between actin bundle structure and actin binding
capacity. Each of the CaMKII isoforms did indeed bind actin, with the β, δ, and γ
isoforms forming higher ordered structures with F-actin. αCaMKII showed the lowest
actin binding capacity and did not form detectable actin bundles. Interestingly, the
bundles formed by F-actin and γCaMKII structurally diverged from the bundles formed
by βCaMKII and δCaMKII. The wide and flat bundles produced by γCaMKII appeared
limited in the z dimension, while the bundles formed by βCaMKII and δCaMKII bundles
appeared limited in the x and y dimensions, as they were very consistent in width and
thickness. It is plausible that flexibility of the variable linker region constrains the threedimensional organization of the actin bundles and identification of the actin binding
domain will be crucial for fully understanding the isoform specific differences in actin
binding and bundling. These results are significant step toward our understanding the
complex multifaceted regulation of the actin network by CaMKII holoenzymes
composed of varying ratios of CaMKII isoforms.
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